PRESS RELEASE

Q2 2022 — Press release

Q2 2022PDF · 109 pages658 KB
Barclays PLC
Interim Results Announcement
30 June 2022

-- 1 of 109 --

Results Announcement Page
Notes 1
Performance Highlights 2
Group Finance Director’s Review 5
Results by Business
• Barclays UK 8
• Barclays International 11
• Head Office 16
Quarterly Results Summary 17
Quarterly Results by Business 18
Performance Management
• Margins and Balances 24
Risk Management
• Risk Management and Principal Risks 25
• Credit Risk 27
• Market Risk 49
• Treasury and Capital Risk 50
Statement of Directors' Responsibilities 64
Independent Review Report to Barclays PLC 65
Condensed Consolidated Financial Statements 67
Financial Statement Notes 73
Appendix: Non-IFRS Performance Measures 101
Shareholder Information 107
BARCLAYS PLC, 1 CHURCHILL PLACE, LONDON, E14 5HP, UNITED KINGDOM. TELEPHONE: +44 (0) 20 7116 1000. COMPANY NO. 48839.
Table of Contents
Barclays PLC

-- 2 of 109 --

This document contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014 (as it forms part of
domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended).
The terms Barclays or Group refer to Barclays PLC together with its subsidiaries. Unless otherwise stated, the income statement analysis compares the
six months ended 30 June 2022 to the corresponding six months of 2021 and balance sheet analysis as at 30 June 2022 with comparatives relating to
31 December 2021 and 30 June 2021. The historical financial information used for the purposes of such analysis has been restated. Please refer to
Note 1 to the condensed consolidated interim financial statements contained herein for further information. The abbreviations ‘£m’ and ‘£bn’
represent millions and thousands of millions of Pounds Sterling respectively; the abbreviations ‘$m’ and ‘$bn’ represent millions and thousands of
millions of US Dollars respectively; and the abbreviations ‘€m’ and ‘€bn’ represent millions and thousands of millions of Euros respectively.
There are a number of key judgement areas, for example impairment calculations, which are based on models and which are subject to ongoing
adjustment and modifications. Reported numbers reflect best estimates and judgements at the given point in time.
Relevant terms that are used in this document but are not defined under applicable regulatory guidance or International Financial Reporting
Standards (IFRS) are explained in the results glossary.
The information in this announcement, which was approved by the Board of Directors on 27 July 2022, does not comprise statutory accounts within
the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2021, which contained an unmodified
audit report under Section 495 of the Companies Act 2006 (which did not make any statements under Section 498 of the Companies Act 2006) have
been delivered to the Registrar of Companies in accordance with Section 441 of the Companies Act 2006.
These results will be furnished on Form 6-K with the US Securities and Exchange Commission (SEC) as soon as practicable following their publication.
Once furnished with the SEC, a copy of the Form 6-K will be available from the SEC’s website at www.sec.gov.
Barclays is a frequent issuer in the debt capital markets and regularly meets with investors via formal road-shows and other ad hoc meetings.
Consistent with its usual practice, Barclays expects that from time to time over the coming quarter it will meet with investors globally to discuss these
results and other matters relating to the Group.
Non-IFRS performance measures
Barclays’ management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of
the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses’ performance between financial
periods and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence
or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and
performance is monitored by Barclays’ management. However, any non-IFRS performance measures in this document are not a substitute for IFRS
measures and readers should consider the IFRS measures as well. Refer to the appendix on pages 101 to 106 for further information and calculations
of non-IFRS performance measures included throughout this document, and the most directly comparable IFRS measures.
Forward-looking statements
This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as
amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to the Group. Barclays cautions readers that no forward-
looking statement is a guarantee of future performance and that actual results or other financial condition or performance measures could differ
materially from those contained in the forward-looking statements. Forward-looking statements can be identified by the fact that they do not relate
only to historical or current facts. Forward-looking statements sometimes use words such as ‘may’, ‘will’, ‘seek’, ‘continue’, ‘aim’, ‘anticipate’, ‘target’,
‘projected’, ‘expect’, ‘estimate’, ‘intend’, ‘plan’, ‘goal’, ‘believe’, ‘achieve’ or other words of similar meaning. Forward-looking statements can be made
in writing but also may be made verbally by members of the management of the Group (including, without limitation, during management
presentations to financial analysts) in connection with this document. Examples of forward-looking statements include, among others, statements or
guidance regarding or relating to the Group’s future financial position, income levels, assets and liabilities, impairment charges, provisions, capital,
leverage and other regulatory ratios, capital distributions (including dividend pay-out ratios and expected payment strategies), projected levels of
growth in banking and financial markets, projected expenditures, costs or savings, any commitments and targets (including, without limitation,
environmental, social and governance (ESG) commitments and targets), business strategy, plans and objectives for future operations, group
structure, IFRS impacts and other statements that are not historical or current facts. By their nature, forward-looking statements involve risk and
uncertainty because they relate to future events and circumstances. Forward-looking statements speak only as at the date on which they are made.
Forward-looking statements may be affected by a number of factors, including, without limitation: changes in legislation, regulation and the
interpretation thereof, the development of IFRS and other accounting standards, evolving practices with regard to the interpretation and application
of accounting standards, emerging and developing ESG reporting standards, the outcome of current and future legal proceedings and regulatory
investigations and any related impact on provisions, the policies and actions of governmental and regulatory authorities, the Group’s ability along
with governments and other stakeholders to measure, manage and mitigate the impacts of climate change effectively, environmental, social and
geopolitical risks and incidents or similar events beyond the Group’s control, and the impact of competition. In addition, factors including (but not
limited to) the following may have an effect: capital, leverage and other regulatory rules applicable to past, current and future periods; UK, US,
Eurozone and global macroeconomic and business conditions; volatility in credit and capital markets; market related risks such as changes in interest
rates and foreign exchange rates; changes in valuation of credit market exposures; changes in valuation of issued securities; changes in credit ratings
of any entity within the Group or any securities issued by such entities; changes in counterparty risk; changes in consumer behaviour; the direct and
indirect consequences of the Russia-Ukraine War on European and global macroeconomic conditions, political stability and financial markets; direct
and indirect impacts of the coronavirus (COVID-19) pandemic; instability as a result of the UK’s exit from the European Union (EU), the effects of the
EU-UK Trade and Cooperation Agreement and the disruption that may subsequently result in the UK and globally; the risk of cyber-attacks,
information or security breaches or technology failures on the Group’s reputation, business or operations; the Group’s ability to access funding; and
the success of acquisitions, disposals and other strategic transactions. A number of these influences and factors are beyond the Group’s control. As a
result, the Group’s actual financial position, future results, capital distributions, capital, leverage or other regulatory ratios or other financial and non-
financial metrics or performance measures or ability to meet commitments and targets may differ materially from the statements or guidance set
forth in the Group’s forward-looking statements. Additional risks and factors which may impact the Group’s future financial condition and
performance are identified in Barclays PLC’s filings with the SEC (including, without limitation, Barclays PLC’s Annual Report on Form 20-F, as
amended, for the financial year ended 31 December 2021), which are available on the SEC’s website at www.sec.gov.
Subject to Barclays’ obligations under the applicable laws and regulations of any relevant jurisdiction (including, without limitation, the UK and the
US), in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward-looking statements,
whether as a result of new information, future events or otherwise.
Notes
Barclays PLC 1

-- 3 of 109 --

Barclays delivered profit before tax of £3.7bn and return on tangible equity (RoTE) of 10.1%, with
a half year dividend of 2.25p per share and intends to initiate a further share buyback of up to
£500m
C. S. Venkatakrishnan, Group Chief Executive, commented
“This has been a strong first half with Group income up 17%1 to £13.2bn and a RoTE of 10.1%.
The broad-based income growth that we achieved in the first quarter continued across all three operating businesses into
the second quarter.
Our performance in the first half shows the resilience and advantage that diversification at all levels brings, both across the
bank and within our businesses. It also underlines the value of investment into our three strategic priorities in next
generation consumer finance, sustainable growth across the Corporate and Investment Bank (CIB), and the transition to a
low-carbon economy.
Profit before tax was £3.7bn, and attributable profit was £2.5bn, after absorbing charges net of tax of £0.6bn relating to the
Over-issuance of Securities.
We are alert to the pressure that the rising cost of living will have on our customers and colleagues. We have a range of
measures in place to help and are looking to do more. With our resilient income growth and balance sheet strength, we can
provide that support while distributing excess capital, having announced a half year dividend of 2.25p per share and an
intention to initiate a further share buyback of £500m.”
Key financial metrics:
Income
Cost:
income
ratio
Profit before
tax
Attributable
profit RoTE EPS CET1
ratio
TNAV per
share
Total capital
return
H122 £13.2bn 69% £3.7bn £2.5bn 10.1% 14.8p
13.6% 297p
c.5.25p
equivalent
Q222 £6.7bn 75% £1.5bn £1.1bn 8.7% 6.4p
H122 performance2:
• Attributable profit was £2.5bn (H121: £3.8bn) and RoTE was 10.1% (H121: 16.1%) having reflected a £0.6bn net of
tax impact for the Over-issuance of Securities in the US (Over-issuance of Securities3). Excluding this impact, RoTE was
12.5%
– £0.6bn impact of Over-issuance of Securities is comprised of:
– £0.4bn post tax expected net impact of the rescission offer losses, driven by £1.3bn of costs as a result of market
movements and interest, substantially offset by £0.8bn of income from hedging arrangements
– £0.2bn of costs relating to an estimated monetary penalty from the SEC
– Excluding the impact of Over-issuance of Securities:
– Group income was £12.4bn, up 10% year-on-year, driven by strong client activity in Markets, recovery in both
Consumer, Cards and Payments (CC&P) and Barclays UK more than offsetting the impact of a weak fee pool in
Investment Banking
– Group costs were £7.7bn (H121: £7.2bn) including other litigation and conduct charges of £0.4bn (H121:
£0.1bn), with operating costs (excluding litigation and conduct) up 2% year-on-year
– On a statutory basis, including the impacts of Over-issuance of Securities:
– Group income was £13.2bn, up 17% year-on-year, including the £0.8bn of income from hedging arrangements
related to the Over-issuance of Securities
– Credit impairment charges were £0.3bn (H121: £0.7bn net release) with provision levels broadly retained in
light of an uncertain macroeconomic backdrop
– Group costs were £9.1bn (H121: £7.3bn), including litigation and conduct charges of £1.9bn (H121: £0.2bn),
including £1.5bn estimated impact of rescission offer losses in relation to the Over-Issuance of Securities and
associated estimated monetary penalty from the SEC
• Capital: Common Equity Tier 1 (CET1) ratio of 13.6% (December 2021: 15.1% and March 2022: 13.8%) and tangible net
asset value (TNAV) per share of 297p (December 2021: 291p and March 2022: 294p)
• Increased capital distributions: total capital return equivalent of c.5.25p per share, including a half year dividend of 2.25p
per share. Intend to initiate a further share buyback of up to £0.5bn, which is expected to have a c.15bps CET1 ratio
impact
1 Excluding the Q222 income benefit of £0.8bn from hedging arrangements related to the Over-issuance of Securities, Group income was up 10% to
£12.4bn.
2 2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 56 and
Restatement of financial statements (Note 1) on page 73 for more information.
3 Denotes the Over-issuance of Securities under Barclays Bank PLC’s US shelf registration statements on Form F-3 filed with the SEC in 2018 and 2019.
Performance Highlights
Barclays PLC 2

-- 4 of 109 --

Outlook:
• Returns: Barclays continues to target a RoTE of greater than 10% in 2022
• Income: Barclays’ diversified income streams position the Group well for the current economic and market
environment and rising interest rates
• Costs: given £1.3bn of litigation and conduct charges in Q222 and the appreciation of average USD against GBP,
Barclays now expects FY22 total operating expenses to be around £16.7bn1 versus previous outlook of £15.0bn2
• Impairment: while acknowledging macroeconomic uncertainty, the impairment charge is expected to remain
below pre-pandemic levels in coming quarters given reduced unsecured lending balances and existing coverage
ratios
• Capital: Barclays continues to target a CET1 ratio within the range of 13-14%
• Capital returns: Barclays' capital distribution policy incorporates a progressive ordinary dividend, supplemented
with buybacks as appropriate. Dividends will continue to be paid semi-annually, with the half year dividend
expected to represent, under normal circumstances, around one-third of the total dividend for the year
1 Group cost outlook is based on an average USD/GBP FX rate of 1.23 across H222 and subject to foreign currency movements.
2 Previous FY22 Group cost outlook was based on an average USD/GBP FX rate of 1.31 throughout 2022.
Performance Highlights
Barclays PLC 3

-- 5 of 109 --

Barclays Group results
for the half year ended 30.06.22
Restated1
30.06.21
£m £m % Change
Net interest income 4,763 3,903 22
Net fee, commission and other income 8,441 7,412 14
Total income 13,204 11,315 17
Credit impairment (charges)/releases (341) 742
Net operating income 12,863 12,057 7
Operating costs (7,270) (7,132) (2)
Litigation and conduct (1,857) (176)
Total operating expenses (9,127) (7,308) (25)
Other net (expenses)/ income (3) 153
Profit before tax 3,733 4,902 (24)
Tax charge (823) (742) (11)
Profit after tax 2,910 4,160 (30)
Non-controlling interests (21) (19) (11)
Other equity instrument holders (414) (389) (6)
Attributable profit 2,475 3,752 (34)
Performance measures
Return on average tangible shareholders' equity 10.1% 16.1%
Average tangible shareholders' equity (£bn) 48.9 46.5
Cost: income ratio 69% 65%
Loan loss rate (bps) 17 —
Basic earnings per share 14.8p 21.9p
Dividend per share 2.25p 2.0p
Share buyback announced (£m) 500 500
Total payout equivalent per share c.5.25p 4.9p
Basic weighted average number of shares (m) 16,684 17,140 (3)
Period end number of shares (m) 16,531 16,998 (3)
As at
30.06.22
Restated1
As at
31.12.21
Restated1
As at
30.06.21
Balance sheet and capital management2 £bn £bn £bn
Loans and advances at amortised cost 395.8 361.5 348.5
Loans and advances at amortised cost impairment coverage ratio 1.4% 1.6% 1.8%
Total assets 1,589.2 1,384.3 1,376.3
Deposits at amortised cost 568.7 519.4 500.9
Tangible net asset value per share 297p 291p 280p
Common equity tier 1 ratio 13.6% 15.1% 15.0%
Common equity tier 1 capital 46.7 47.3 46.2
Risk weighted assets 344.5 314.1 307.4
UK leverage ratio 5.1% 5.2% 5.0%
UK leverage exposure 1,151.2 1,137.9 1,154.9
Average UK leverage ratio 4.7% 4.9% 4.8%
Average UK leverage exposure 1,233.5 1,229.0 1,192.7
Funding and liquidity
Group liquidity pool (£bn) 343 291 291
Liquidity coverage ratio 156% 168% 162%
Loan: deposit ratio 70% 70% 70%
1 2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 56 and
Restatement of financial statements (Note 1) on page 73 for more information.
2 Refer to pages 55 to 62 for further information on how capital, Risk Weighted Assets (RWAs) and leverage are calculated.
Performance Highlights
Barclays PLC 4

-- 6 of 109 --

Group performance1, 2
• Barclays' diversified model delivered a profit before tax of £3,733m (H121: £4,902m), RoTE of 10.1% (H121: 16.1%),
and earnings per share (EPS) of 14.8p (H121: 21.9p)
• Total income increased to £13,204m (H121: £11,315m). Barclays UK income increased 5%. Barclays International
income increased 21%, with CIB income up 21% and CC&P income up 20%. Excluding the income benefit of £758m
from hedging arrangements related to the Over-issuance of Securities, total Group income was £12,446m, up 10% year-
on-year, Barclays International income was £9,182m, up 12% year-on-year and CIB income was £7,213m, up 10% year-
on-year
• Credit impairment charges were £341m (H121: £742m net release) reflecting low flows to delinquency and an
improved UK employment outlook, partially offset by a day one charge relating to the acquisition of the GAP Inc. US
credit card portfolio (the GAP portfolio). Expert judgement post-model adjustments have been maintained to incorporate
customer affordability and inflationary headwinds
• Total operating expenses increased to £9,127m (H121: £7,308m). Operating costs increased 2% to £7,270m,
reflecting continued investment and business growth, the impact of inflation and the appreciation of average USD
against GBP, partially offset by efficiency savings and the non-recurrence of structural cost actions, primarily relating to
the real estate review in June 2021. Litigation and conduct charges were £1,857m (H121: £176m) including £1,304m
estimated impact of rescission offer losses in relation to the Over-Issuance of Securities and £165m associated estimated
monetary penalty from the SEC, £181m of customer remediation costs relating to a legacy loan portfolio in CC&P and
£165m related to settlements in principle in respect of industry-wide devices investigations by the SEC and the
Commodity Futures Trading Commission (CFTC)3. This resulted in a cost: income ratio of 69% (H121: 65%)
• The effective tax rate (ETR) was 22.0% (H121: 15.1%). The tax charge included a £346m charge recognised for the re-
measurement of the Group’s UK deferred tax assets (DTAs) due to the enactment of legislation in Q122 which will result
in the UK banking surcharge rate being reduced from 8% to 3% effective from 1 April 2023. The ETR excluding the
impact of this downward re-measurement of UK DTAs was 12.8% which included a 5.8% benefit relating to adjustments
in respect of prior years
• Attributable profit was £2,475m (H121: £3,752m) including the net impact of the Over-issuance of Securities net of tax,
of £581m, of which £341m was in Q222
• Total assets increased to £1,589bn (December 2021: £1,384bn) primarily due to an increase in client and trading
activity, and growth in the liquidity pool
• TNAV per share increased to 297p (December 2021: 291p) primarily reflecting 14.8p of EPS, partially offset by net
negative reserve movements driven by higher interest rates
Group capital and leverage1
• The CET1 ratio decreased by c.150bps to 13.6% (December 2021: 15.1%) as capital decreased by £0.6bn to £46.7bn and
RWAs increased by £30.4bn to £344.5bn
– c.80bps reduction to the CET1 ratio due to the expected impact of regulatory change on 1 January 2022 as CET1
capital decreased £1.7bn and RWAs increased £6.6bn
– c.30bps reduction due to the £1bn buyback announced with FY21 results, which is well progressed
– c.40bps reduction due to the impact of the Over-issuance of Securities. c.20bps due to the £0.6bn net of tax impact
reducing CET1 capital and c.20bps due to a £4.5bn temporary increase in RWAs reflecting the hedging arrangements
designed to manage the risk of the rescission offer. The hedging related RWAs are expected to reverse after the
rescission offer is completed in Q322
– Excluding the impacts above, an increase in CET1 capital of £2.7bn was offset by a £19.3bn increase in RWAs:
– The £2.7bn increase in CET1 capital reflects profits and an increase in the currency translation reserve, offset by
an accrual toward a FY22 dividend, equity coupons paid, and a decrease in the fair value through other
comprehensive income reserve
– The £19.3bn increase in RWAs was primarily due to the appreciation of USD against GBP, increased client activity
within CIB and higher CC&P balances mainly driven by the GAP portfolio acquisition. This was marginally offset by
the partial disposal of Barclays' equity stake in Absa Group Limited (Absa) in April 2022
• The UK leverage ratio decreased to 5.1% (December 2021: 5.2%) primarily due to an increase in the leverage exposure of
£13.3bn to £1,151.2bn
1 2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 56 and
Restatement of financial statements (Note 1) on page 73 for more information.
2 The 6% appreciation of average USD against GBP positively impacted income and profits and adversely impacted credit impairment charges and total
operating expenses.
3 See 'Other matters' on page 6 for further details.
Group Finance Director's Review
Barclays PLC 5

-- 7 of 109 --

Group funding and liquidity
• The liquidity pool was £343bn (December 2021: £291bn) and the liquidity coverage ratio (LCR) remained significantly
above the 100% regulatory requirement at 156% (December 2021: 168%), equivalent to a surplus of £119bn (December
2021: £116bn). The increase in the liquidity pool was driven by deposit growth and an increase in wholesale funding,
which were partly offset by an increase in business funding consumption
• Wholesale funding outstanding, excluding repurchase agreements, was £181.5bn (December 2021: £167.5bn). The
Group issued £3.5bn equivalent of minimum requirement for own funds and eligible liabilities (MREL) instruments from
Barclays PLC (the Parent company) in the year to date. The Group has a strong MREL position with a ratio of 30.9% of
RWAs which is in excess of its regulatory requirement of 28.5%, excluding the confidential institution specific PRA buffer.
The Group remains above its MREL regulatory requirement including the PRA buffer
Other matters
• Over-issuance of Securities: since 31 March 2022, the following developments should be noted with respect to the
Over-issuance of Securities:
– On 23 May 2022, Barclays PLC and Barclays Bank PLC filed amendments to their respective Annual Reports on Form
20-F to, among other matters, restate the financial statements for the financial year ended 31 December 2021 to
reflect certain impacts of the Over-issuance of Securities
– On 23 May 2022, Barclays Bank PLC filed a shelf registration statement on Form F-3 with the SEC, which was
automatically effective and under which an unlimited amount of securities may be registered, on the basis that
Barclays Bank PLC is a “well-known seasoned issuer” (the “2022 F-3”). Barclays PLC also has an automatic shelf
registration statement on Form F-3 filed with the SEC on 1 March 2021
– On 1 August 2022, Barclays Bank PLC intends to launch an offer to rescind the purchase of securities that were
issued in excess of Barclays Bank PLC’s shelf registration statement on Form F-3 declared effective by the SEC in
2019 (2019 F-3) and the predecessor US shelf registration statement filed in 2018 (Predecessor Shelf) by certain
purchasers who purchased such securities in a distribution from Barclays Bank PLC during certain relevant periods
(the rescission offer)
– Following the launch of the rescission offer, Barclays Bank PLC is expected to resume issuances and sales of series of
iPath ETNs that were not affected by the rescission offer. Barclays Bank PLC further expects to resume issuances and
sales of the remaining series of iPath ETNs when the rescission offer has been completed and settlement of the
rescission offer with respect to the relevant series has occurred
– Barclays has recognised a H122 attributable profit impact of £581m relating to this matter net of tax, including a
£1,304m charge recognised in costs, substantially offset by hedging arrangements which generated income of
£758m, as well as an estimated monetary penalty from the SEC of £165m
– The total balance sheet provision as at 30 June 2022 was £1,757m, of which: £1,592m relates to the estimated
rescission offer losses and £165m relates to an estimated SEC monetary penalty. Barclays also expects temporary
RWAs of £4.5bn, which translates to a c.20bps reduction in the CET1 ratio, from the hedging arrangements to
reverse after the rescission offer has been completed in Q322
– Barclays also expects the Review (see pages 25-26 for more detail), assisted by external counsel, of the facts and
circumstances related to this matter to conclude shortly and will continue to engage with regulators
• SEC and CFTC devices investigation: in July 2022, Barclays Bank PLC and Barclays Capital Inc. (BCI) reached an
agreement in principle with the staff of the SEC's Division of Enforcement and the staff of CFTC in connection with
investigations by the SEC and the CFTC of Barclays Bank PLC, BCI and other financial institutions as part of a financial
industry sweep regarding compliance with record-keeping obligations in connection with business-related
communications sent over unapproved electronic messaging platforms (the Devices Settlements In Principle). The SEC
and the CFTC found that Barclays Bank PLC and BCI failed to comply with their respective record keeping and supervisory
obligations, where such communications were sent or received by employees over electronic messaging channels that
had not been approved by the bank for business use by employees. The proposed resolution with the SEC and the CFTC
will include Barclays Bank PLC and BCI paying a combined $125m civil monetary penalty to the SEC and a $75m civil
monetary penalty to the CFTC. Subject to final agreement of the terms of the settlements and related documentation, as
well as the SEC's and CFTC's approval, the civil monetary penalties are expected to be paid during the third quarter of
2022
• GAP portfolio acquisition: on 21 June 2022, Barclays completed the acquisition of a US credit card portfolio of $3.3bn of
receivables, in partnership with GAP Inc. The acquisition reduced the Group CET1 ratio by approximately 15bps. The
partnership broadens Barclays product offering in the retail sector and store cards, advancing our strategy and growth
ambitions in the United States
• Kensington Mortgage Company acquisition: on 24 June 2022 Barclays PLC announced that Barclays Bank UK PLC has
agreed to acquire UK specialist mortgage lender Kensington Mortgage Company Limited, thereby broadening Barclays'
capabilities and product offering in the UK mortgage market. The transaction is subject to regulatory approval and is
expected to complete in late Q422 or early Q123
Group Finance Director's Review
Barclays PLC 6

-- 8 of 109 --

Other matters (continued)
• Legacy Loan Portfolio: a customer remediation provision of £181m was recognised in Q122 in relation to a legacy
timeshare loan portfolio brokered by Azure Services Limited (ASL). The provision represents the best estimate as at 30
June 2022. Barclays continues to review complaints regarding legacy partner finance loans, however it is not currently
possible to predict the outcome of this review
• Absa sale: on 21 April 2022, Barclays sold 63m ordinary shares in Absa (7.4% of Absa’s issued share capital) at a price of
ZAR 164.0 per share, raising aggregate gross sale proceeds of ZAR 10.3bn (£516m1)
• Pensions: during 2019 and 2020, the UK Retirement Fund (UKRF), the Group’s main pension scheme, subscribed for
non-transferable listed senior fixed rate notes for £1.25bn. Following the PRA's statement on 13 April 2022, Barclays is
planning to unwind these transactions, which would result in a c.30bps reduction to the CET1 ratio, being accelerated to
Q422 from 2023, 2024 and 2025. For more details, see note 16 on page 89
Capital distributions
• Barclays is committed to maintaining an appropriate balance between delivering attractive total cash returns to
shareholders, investment in the business and maintaining a strong capital position. Barclays pays a progressive ordinary
dividend, taking into account these objectives and the earnings outlook of the Group. The Board will also continue to
supplement the ordinary dividends as appropriate, including with share buybacks
• Announced a half year dividend of 2.25p per share and intention to initiate a further share buyback of up to £500m
• Dividends will continue to be paid semi-annually, with the half year dividend expected to represent, under normal
circumstances, around one-third of the total dividend for the year
• The £1.0bn buyback programme announced in FY21 results is expected to complete before the end of September 2022
Group targets
Barclays continues to target the following over the medium term:
• Returns: RoTE of greater than 10%
• Cost efficiency: cost: income ratio below 60%
• Capital adequacy: CET1 ratio in the range of 13-14%
Anna Cross, Group Finance Director
1 Exchange rate GBP/ZAR 20.04 as of 21 April 2022.
Group Finance Director's Review
Barclays PLC 7

-- 9 of 109 --

Barclays UK Half year ended Half year ended
30.06.22 30.06.21
Income statement information £m £m % Change
Net interest income 2,732 2,586 6
Net fee, commission and other income 641 613 5
Total income 3,373 3,199 5
Credit impairment (charges)/releases (48) 443
Net operating income 3,325 3,642 (9)
Operating costs (2,083) (2,114) 1
Litigation and conduct (25) (22) (14)
Total operating expenses (2,108) (2,136) 1
Other net income — —
Profit before tax 1,217 1,506 (19)
Attributable profit 854 1,019 (16)
As at 30.06.22 As at 31.12.21 As at 30.06.21
Balance sheet information £bn £bn £bn
Loans and advances to customers at amortised cost 205.9 208.8 207.8
Total assets 318.8 321.2 311.2
Customer deposits at amortised cost 261.5 260.6 255.5
Loan: deposit ratio 85% 85% 87%
Risk weighted assets 72.2 72.3 72.2
Period end allocated tangible equity 9.9 10.0 9.9
Half year ended Half year ended
Key facts 30.06.22 30.06.21
Average loan to value of mortgage portfolio1 51% 51%
Average loan to value of new mortgage lending1 69% 69%
Number of branches 593 755
Mobile banking active customers 10.1m 9.4m
30 day arrears rate - Barclaycard Consumer UK 1.0% 1.4%
Performance measures
Return on average allocated tangible equity 17.0% 20.6%
Average allocated tangible equity (£bn) 10.0 9.9
Cost: income ratio 62% 67%
Loan loss rate (bps) 4 —
Net interest margin 2.67% 2.54%
1 Average loan to value of mortgages is balance weighted and reflects both residential and buy-to-let mortgage portfolios within the Home Loans portfolio.
Results by Business
Barclays PLC 8

-- 10 of 109 --

Analysis of Barclays UK Half year ended Half year ended
30.06.22 30.06.21
Analysis of total income £m £m % Change
Personal Banking 2,099 1,910 10
Barclaycard Consumer UK 541 605 (11)
Business Banking 733 684 7
Total income 3,373 3,199 5
Analysis of credit impairment (charges)/releases
Personal Banking (21) 50
Barclaycard Consumer UK 40 398 (90)
Business Banking (67) (5)
Total credit impairment (charges)/releases (48) 443
As at 30.06.22 As at 31.12.21 As at 30.06.21
Analysis of loans and advances to customers at amortised cost £bn £bn £bn
Personal Banking 167.1 165.4 162.4
Barclaycard Consumer UK 8.8 8.7 8.8
Business Banking 30.0 34.7 36.6
Total loans and advances to customers at amortised cost 205.9 208.8 207.8
Analysis of customer deposits at amortised cost
Personal Banking 197.0 196.4 191.0
Barclaycard Consumer UK — — 0.1
Business Banking 64.5 64.2 64.4
Total customer deposits at amortised cost 261.5 260.6 255.5
Results by Business
Barclays PLC 9

-- 11 of 109 --

Barclays UK delivered a RoTE of 17.0% (H121: 20.6%), and a lower cost: income ratio of 62% (H121: 67%), reflecting
improved income performance across Personal Banking and Business Banking, alongside reduced total operating expenses,
while impairment returned to a charge following a net release in H121. Barclays UK remains well positioned, with a strong
focus on supporting customers in an increasingly difficult and uncertain environment.
Income statement - H122 compared to H121
• Profit before tax decreased to £1,217m (H121: £1,506m). RoTE was 17.0% (H121: 20.6%) reflecting the non-recurrence
of a prior year credit impairment release, partially offset by the rising rate environment in the UK
• Total income increased 5% to £3,373m. Net interest income increased 6% to £2,732m with a net interest margin (NIM)
of 2.67% (H121: 2.54%) primarily driven by the rising interest rate environment in the UK. Net fee, commission and other
income increased 5% to £641m
– Personal Banking income increased 10% to £2,099m, driven by rising interest rates and the benefit of strong
mortgage origination in 2021, partially offset by mortgage margin compression
– Barclaycard Consumer UK income decreased 11% to £541m as higher transaction based revenues from improved
customer spend volumes were more than offset by lower interest earning lending (IEL) balances. Lower IEL balances
were impacted by higher customer repayments and reduced borrowing
– Business Banking income increased 7% to £733m driven by rising interest rates alongside improved transaction
based revenues, partially offset by lower government scheme lending income as repayments continue
• Credit impairment charge of £48m (H121: £443m net release) driven by low flows to delinquency, improved UK
employment data and reduced uncertainty around the possible effects of COVID-19, offset by increased concerns around
customers' vulnerability to high inflation. As at 30 June 2022, 30 and 90 day arrears rates in UK cards were 1.0% (H121:
1.4%) and 0.2% (H121: 0.6%) respectively. The credit card and consumer loan businesses maintain appropriate
provision levels in light of affordability headwinds, as reflected in a total coverage ratio of 9.2% (December 2021: 10.9%)
• Total operating expenses decreased 1% to £2,108m driven by lower operational costs and efficiency savings, partially
offset by increased investment spend and the impact of inflation
Balance sheet - 30 June 2022 compared to 31 December 2021
• Loans and advances to customers at amortised cost decreased 1% to £205.9bn as £1.5bn of mortgage growth was more
than offset by a £4.7bn decrease in Business Banking balances due to the repayment of government scheme lending and
the yield curve impact from rising interest rates on the Education, Social Housing and Local Authority portfolio carrying
value
• Customer deposits at amortised cost remained broadly stable at £261.5bn, maintaining a strong loan: deposit ratio of
85% (December 2021: 85%)
• RWAs remained stable at £72.2bn (December 2021: £72.3bn)
Results by Business
Barclays PLC 10

-- 12 of 109 --

Barclays International Half year ended
Restated1
Half year ended
30.06.22 30.06.21
Income statement information £m £m % Change
Net interest income 1,965 1,559 26
Net trading income 5,212 3,389 54
Net fee, commission and other income 2,763 3,270 (16)
Total income 9,940 8,218 21
Credit impairment (charges)/releases (310) 293
Net operating income 9,630 8,511 13
Operating costs (5,042) (4,606) (9)
Litigation and conduct (1,832) (161)
Total operating expenses (6,874) (4,767) (44)
Other net income 13 22 (41)
Profit before tax 2,769 3,766 (26)
Attributable profit 2,083 2,638 (21)
As at 30.06.22 As at 31.12.21 As at 30.06.21
Balance sheet information £bn £bn £bn
Loans and advances at amortised cost 167.3 133.8 121.9
Trading portfolio assets 126.9 146.9 147.1
Derivative financial instrument assets 343.5 261.5 255.4
Financial assets at fair value through the income statement 209.3 188.2 190.4
Cash collateral and settlement balances 128.5 88.1 108.5
Other assets 275.1 225.6 223.5
Total assets 1,250.6 1,044.1 1,046.8
Deposits at amortised cost 307.4 258.8 245.4
Derivative financial instrument liabilities 321.2 256.4 246.9
Loan: deposit ratio 54% 52% 50%
Risk weighted assets 263.8 230.9 223.2
Period end allocated tangible equity 38.0 33.2 31.8
Half year ended Restated1
Half year ended
Performance measures 30.06.22 30.06.21
Return on average allocated tangible equity 11.5% 16.3%
Average allocated tangible equity (£bn) 36.2 32.3
Cost: income ratio 69% 58%
Loan loss rate (bps) 37 —
Net interest margin 4.34% 3.95%
1 2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 56 and
Restatement of financial statements (Note 1) on page 73 for more information.
Results by Business
Barclays PLC 11

-- 13 of 109 --

Analysis of Barclays International
Corporate and Investment Bank Half year ended
Restated1
Half year ended
30.06.22 30.06.21
Income statement information £m £m % Change
Net interest income 795 640 24
Net trading income 5,188 3,411 52
Net fee, commission and other income 1,988 2,522 (21)
Total income 7,971 6,573 21
Credit impairment (charges)/releases (32) 272
Net operating income 7,939 6,845 16
Operating costs (3,791) (3,509) (8)
Litigation and conduct (1,632) (79)
Total operating expenses (5,423) (3,588) (51)
Other net income — 1
Profit before tax 2,516 3,258 (23)
Attributable profit 1,895 2,252 (16)
As at 30.06.22 As at 31.12.21 As at 30.06.21
Balance sheet information £bn £bn £bn
Loans and advances at amortised cost 125.8 100.0 91.0
Trading portfolio assets 126.7 146.7 147.0
Derivative financial instrument assets 343.4 261.5 255.3
Financial assets at fair value through the income statement 209.2 188.1 190.3
Cash collateral and settlement balances 127.7 87.2 107.7
Other assets 237.2 195.8 192.5
Total assets 1,170.0 979.3 983.8
Deposits at amortised cost 229.5 189.4 178.2
Derivative financial instrument liabilities 321.2 256.4 246.8
Risk weighted assets 227.6 200.7 194.3
Half year ended Restated1
Half year ended
Performance measures 30.06.22 30.06.21
Return on average allocated tangible equity 11.9% 15.9%
Average allocated tangible equity (£bn) 31.8 28.3
Cost: income ratio 68% 55%
Analysis of total income £m £m % Change
FICC 3,173 2,099 51
Equities 2,463 1,709 44
Global Markets 5,636 3,808 48
Advisory 421 381 10
Equity capital markets 84 469 (82)
Debt capital markets 697 882 (21)
Investment Banking fees 1,202 1,732 (31)
Corporate lending 78 244 (68)
Transaction banking 1,055 789 34
Corporate 1,133 1,033 10
Total income 7,971 6,573 21
1 2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 56 and
Restatement of financial statements (Note 1) on page 73 for more information.
Results by Business
Barclays PLC 12

-- 14 of 109 --

Analysis of Barclays International
Consumer, Cards and Payments Half year ended Half year ended
30.06.22 30.06.21
Income statement information £m £m % Change
Net interest income 1,170 919 27
Net fee, commission, trading and other income 799 726 10
Total income 1,969 1,645 20
Credit impairment (charges)/releases (278) 21
Net operating income 1,691 1,666 2
Operating costs (1,251) (1,097) (14)
Litigation and conduct (200) (82)
Total operating expenses (1,451) (1,179) (23)
Other net income 13 21 (38)
Profit before tax 253 508 (50)
Attributable profit 188 386 (51)
As at 30.06.22 As at 31.12.21 As at 30.06.21
Balance sheet information £bn £bn £bn
Loans and advances at amortised cost 41.5 33.8 30.9
Total assets 80.6 64.8 63.0
Deposits at amortised cost 77.9 69.4 67.2
Risk weighted assets 36.2 30.2 29.0
Half year ended Half year ended
Key facts 30.06.22 30.06.21
30 day arrears rate – Barclaycard US 1.4% 1.6%
US cards customer FICO score distribution
<660 10% 10%
>660 90% 90%
Total number of Barclaycard payments clients c.391,000 c.372,000
Value of payments processed (£bn)1 190 160
Performance measures
Return on average allocated tangible equity 8.5% 19.1%
Average allocated tangible equity (£bn) 4.4 4.0
Cost: income ratio 74% 72%
Loan loss rate (bps) 128 —
Analysis of total income £m £m % Change
International Cards and Consumer Bank 1,229 1,050 17
Private Bank 459 393 17
Payments 281 202 39
Total income 1,969 1,645 20
1 Includes £145bn (H121: £129bn) of merchant acquiring payments.
Results by Business
Barclays PLC 13

-- 15 of 109 --

Barclays International delivered a RoTE of 11.5% reflecting the benefits of being a diversified business. CIB delivered a RoTE
of 11.9% reflecting a strong performance in FICC, partially offset by a decrease in Investment Banking fees, against a strong
prior year comparative, and provisions for litigation and conduct. CC&P RoTE decreased to 8.5% as an increase in income
was offset by a provision for higher customer remediation costs relating to a legacy loan portfolio and continued investment
in the business.
Income statement - H122 compared to H1211
• Profit before tax decreased 26% to £2,769m with a RoTE of 11.5% (H121: 16.3%), reflecting a RoTE of 11.9% (H121:
15.9%) in CIB and 8.5% (H121: 19.1%) in CC&P
• The 6% appreciation of average USD against GBP positively impacted income and profits and adversely impacted
impairment charges and total operating expenses
• Total income increased to £9,940m (H121: £8,218m)
– CIB income increased 21% to £7,971m reflecting the benefit of a diversified business model and impact of hedging
arrangements
– Global Markets income increased 48% to £5,636m. FICC income increased 51% to £3,173m, mainly in macro,
reflecting higher levels of activity as we supported our clients through a period of market volatility. Equities
income increased £754m to £2,463m including £758m of income related to hedging arrangements in relation to
managing the risks from the rescission offer to be launched by Barclays Bank PLC in relation to the Over-issuance
of Securities
– Investment Banking fees income decreased 31% to £1,202m due to the reduced fee pool, particularly in Equity
capital markets2, and a strong prior year comparative
– Within Corporate, Transaction banking income increased 34% to £1,055m driven by deposit balance growth,
improved margins and higher payments volumes. Corporate lending income decreased 68% to £78m due to
losses on certain fair value lending positions and higher costs of hedging and credit protection, partially offset by
the non-recurrence of a prior year fair value loan write-off on a single name
– CC&P income increased 20% to £1,969m
– International Cards and Consumer Bank income increased 17% to £1,229m as higher average cards balances
were partially offset by higher customer acquisition costs
– Private Bank income increased 17% to £459m, reflecting client balance growth and improved margins partially
offset by the non-recurrence of a gain on a property sale in the prior year
– Payments income increased 39% to £281m driven by turnover growth following the easing of lockdown
restrictions in the past year
• Credit impairment charges were £310m (H121: £293m net release)
– CIB credit impairment charge of £32m (H121: £272m net release) was driven by a net increase in modelled
impairment whilst there continue to be limited material single name wholesale loan charges, with the prior year
including a net release resulting from an improved macroeconomic outlook scenario refresh
– CC&P credit impairment charges increased to £278m (H121: £21m net release) driven by higher balances in US
cards, including the day one impact of acquiring the GAP portfolio, partially offset by lower provisions held for
uncertainty. As at 30 June 2022, 30 and 90 day arrears in US cards were 1.4% (H121: 1.6%) and 0.7% (H121: 0.9%)
respectively. The US cards business continues to maintain appropriate provision levels in light of affordability
headwinds
• Total operating expenses increased 44% to £6,874m
– CIB total operating expenses increased 51% to £5,423m. Operating costs increased 8% to £3,791m driven by
investment in talent, systems and technology, and the impact of inflation. Litigation and conduct charges were
£1,632m (H121: £79m) including £1,304m estimated impact of rescission offer losses in relation to the Over-
Issuance of Securities and £165m associated estimated monetary penalty from the SEC, and £165m provision
relating to the Devices Settlements in Principle
– CC&P total operating expenses increased 23% to £1,451m primarily driven by £200m of litigation and conduct costs,
including a provision for higher customer remediation costs relating to a legacy loan portfolio. Operating costs
increased 14% driven by higher investment spend reflecting an increase in marketing and costs for existing and new
partnerships
1 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on
page 73 for more information.
2 Data source: Dealogic for the period covering 1 January to 30 June 2022.
Results by Business
Barclays PLC 14

-- 16 of 109 --

Balance sheet - 30 June 2022 compared to 31 December 2021
• Loans and advances at amortised cost increased £33.5bn to £167.3bn due to increased lending across CIB and CC&P,
inclusive of the £2.7bn GAP portfolio acquisition and appreciation of USD against GBP, and increased investment in debt
securities
• Trading portfolio assets decreased £20.0bn to £126.9bn due to a reduction in equity securities driven by facilitation of
client activity, partially offset by increased trading activity in debt securities
• Derivative assets and liabilities increased £82.0bn and £64.8bn respectively to £343.5bn and £321.2bn driven by market
volatility and increased activity in FICC and Equities
• Financial assets at fair value through the income statement increased £21.1bn to £209.3bn driven by increased secured
lending
• Deposits at amortised cost increased £48.6bn to £307.4bn primarily due to an increase in short-term money market
deposits and growth in Corporate deposits
• RWAs increased to £263.8bn (December 2021: £230.9bn) resulting from the impact of the appreciation of USD against
GBP, regulatory changes that took effect from 1 January 2022, increased client activity within CIB, an increase in respect
of hedging arrangements designed to manage the risks of the rescission offer relating to the Over-issuance of Securities
and higher CC&P balances driven mainly by the GAP portfolio acquisition
Results by Business
Barclays PLC 15

-- 17 of 109 --

Head Office Half year ended Half year ended
30.06.22 30.06.21
Income statement information £m £m % Change
Net interest income 66 (242)
Net fee, commission and other income (175) 140
Total income (109) (102) (7)
Credit impairment releases 17 6
Net operating income (92) (96) 4
Operating costs (145) (412) 65
Litigation and conduct — 7
Total operating expenses (145) (405) 64
Other net (expenses)/income (16) 131
Loss before tax (253) (370) 32
Attributable (loss)/profit (462) 95
As at 30.06.22
Restated1
As at 31.12.21
Restated1
As at 30.06.21
Balance sheet information £bn £bn £bn
Total assets 19.8 19.0 18.3
Risk weighted assets 8.6 11.0 12.0
Period end allocated tangible equity 1.1 5.5 5.9
Half year ended Half year ended
Performance measures 30.06.22 30.06.21
Average allocated tangible equity (£bn) 2.7 4.3
Income statement - H122 compared to H121
• Loss before tax was £253m (H121: £370m)
• Total income was an expense of £109m (H121: £102m expense) which primarily reflected hedge accounting, funding
costs on legacy capital instruments, treasury items as well as a £42m loss on sale from the partial disposal of Barclays’
equity stake in Absa in April 2022. This was partially offset by a one-off gain of £86m from the sale and leaseback of UK
data centres and the recognition of dividends on Barclays’ equity stake in Absa
• Total operating expenses reduced to £145m (H121: £405m) reflecting the non-recurrence of the £266m charge related
to structural cost actions taken as part of the real estate review in June 2021
• Other net income was an expense of £16m (H121: £131m income) driven by a fair value loss in Barclays associate
investment holding in the Business Growth Fund
Balance sheet - 30 June 2022 compared to 31 December 2021
• RWAs reduced to £8.6bn (December 2021: £11.0bn) reflecting the partial sale of Barclays' equity stake in Absa in April
2022. The sale resulted in an increase to Barclays' CET1 ratio of c.10bps
1 2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 56 and
Restatement of financial statements (Note 1) on page 73 for more information.
Results by Business
Barclays PLC 16

-- 18 of 109 --

Barclays Group
Q222 Q122 Q4211 Q3211 Q2211 Q121 Q420 Q320
Income statement information £m £m £m £m £m £m £m £m
Net interest income 2,422 2,341 2,230 1,940 2,052 1,851 1,845 2,055
Net fee, commission and other income 4,286 4,155 2,930 3,525 3,363 4,049 3,096 3,149
Total income 6,708 6,496 5,160 5,465 5,415 5,900 4,941 5,204
Credit impairment (charges)/releases (200) (141) 31 (120) 797 (55) (492) (608)
Net operating income 6,508 6,355 5,191 5,345 6,212 5,845 4,449 4,596
Operating costs (3,682) (3,588) (3,514) (3,446) (3,587) (3,545) (3,480) (3,391)
UK bank levy — — (170) — — — (299) —
Litigation and conduct (1,334) (523) (92) (129) (143) (33) (47) (76)
Total operating expenses (5,016) (4,111) (3,776) (3,575) (3,730) (3,578) (3,826) (3,467)
Other net income/(expenses) 7 (10) 13 94 21 132 23 18
Profit before tax 1,499 2,234 1,428 1,864 2,503 2,399 646 1,147
Tax charge (209) (614) (104) (292) (246) (496) (163) (328)
Profit after tax 1,290 1,620 1,324 1,572 2,257 1,903 483 819
Non-controlling interests (20) (1) (27) (1) (15) (4) (37) (4)
Other equity instrument holders (199) (215) (218) (197) (194) (195) (226) (204)
Attributable profit 1,071 1,404 1,079 1,374 2,048 1,704 220 611
Performance measures
Return on average tangible shareholders' equity 8.7% 11.5% 9.0% 11.4% 17.6% 14.7% 1.8% 5.1%
Average tangible shareholders' equity (£bn) 49.0 48.8 48.0 48.3 46.5 46.5 47.6 48.3
Cost: income ratio 75% 63% 73% 65% 69% 61% 77% 67%
Loan loss rate (bps) 20 15 — 13 — 6 56 69
Basic earnings per share 6.4p 8.4p 6.4p 8.0p 11.9p 9.9p 1.3p 3.5p
Basic weighted average number of shares (m) 16,684 16,682 16,985 17,062 17,140 17,293 17,300 17,298
Period end number of shares (m) 16,531 16,762 16,752 16,851 16,998 17,223 17,359 17,353
Balance sheet and capital management2 £bn £bn £bn £bn £bn £bn £bn £bn
Loans and advances at amortised cost 395.8 371.7 361.5 353.0 348.5 345.8 342.6 344.4
Loans and advances at amortised cost impairment
coverage ratio 1.4% 1.5% 1.6% 1.7% 1.8% 2.2% 2.4% 2.5%
Total assets 1,589.2 1,496.1 1,384.3 1,406.5 1,376.3 1,379.7 1,349.5 1,421.7
Deposits at amortised cost 568.7 546.5 519.4 510.2 500.9 498.8 481.0 494.6
Tangible net asset value per share 297p 294p 291p 286p 280p 267p 269p 275p
Common equity tier 1 ratio 13.6% 13.8% 15.1% 15.3% 15.0% 14.6% 15.1% 14.6%
Common equity tier 1 capital 46.7 45.3 47.3 47.2 46.2 45.9 46.3 45.5
Risk weighted assets 344.5 328.8 314.1 307.7 307.4 313.4 306.2 310.7
UK leverage ratio 5.1% 5.0% 5.2% 5.1% 5.0% 5.0% 5.3% 5.2%
UK leverage exposure 1,151.2 1,123.5 1,137.9 1,162.7 1,154.9 1,145.4 1,090.9 1,095.1
Average UK leverage ratio 4.7% 4.8% 4.9% 4.9% 4.8% 4.9% 5.0% 5.1%
Average UK leverage exposure 1,233.5 1,179.4 1,229.0 1,201.1 1,192.7 1,174.9 1,146.9 1,111.1
Funding and liquidity
Group liquidity pool (£bn) 343 320 291 293 291 290 266 327
Liquidity coverage ratio 156% 159% 168% 161% 162% 161% 162% 181%
Loan: deposit ratio 70% 68% 70% 69% 70% 69% 71% 70%
1 The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of
preparation on page 56 and Restatement of financial statements (Note 1) on page 73 for more information.
2 Refer to pages 55 to 62 for further information on how capital, RWAs and leverage are calculated.
Quarterly Results Summary
Barclays PLC 17

-- 19 of 109 --

Barclays UK
Q222 Q122 Q421 Q321 Q221 Q121 Q420 Q320
Income statement information £m £m £m £m £m £m £m £m
Net interest income 1,393 1,339 1,313 1,303 1,305 1,281 1,317 1,280
Net fee, commission and other income 331 310 386 335 318 295 309 270
Total income 1,724 1,649 1,699 1,638 1,623 1,576 1,626 1,550
Credit impairment (charges)/releases — (48) 59 (137) 520 (77) (170) (233)
Net operating income 1,724 1,601 1,758 1,501 2,143 1,499 1,456 1,317
Operating costs (1,085) (998) (1,202) (1,041) (1,078) (1,036) (1,134) (1,095)
UK bank levy — — (36) — — — (50) —
Litigation and conduct (16) (9) (5) (10) (19) (3) 4 (25)
Total operating expenses (1,101) (1,007) (1,243) (1,051) (1,097) (1,039) (1,180) (1,120)
Other net (expenses)/income — — (1) 1 — — 6 (1)
Profit before tax 623 594 514 451 1,046 460 282 196
Attributable profit 458 396 420 317 721 298 160 113
Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn
Loans and advances to customers at amortised cost 205.9 207.3 208.8 208.6 207.8 205.7 205.4 203.9
Total assets 318.8 317.2 321.2 312.1 311.2 309.1 289.1 294.5
Customer deposits at amortised cost 261.5 260.3 260.6 256.8 255.5 247.5 240.5 232.0
Loan: deposit ratio 85% 85% 85% 86% 87% 88% 89% 91%
Risk weighted assets 72.2 72.7 72.3 73.2 72.2 72.7 73.7 76.2
Period end allocated tangible equity 9.9 10.1 10.0 10.0 9.9 10.0 9.7 10.0
Performance measures
Return on average allocated tangible equity 18.4% 15.6% 16.8% 12.7% 29.1% 12.0% 6.5% 4.5%
Average allocated tangible equity (£bn) 10.0 10.1 10.0 10.0 9.9 9.9 9.8 10.1
Cost: income ratio 64% 61% 73% 64% 68% 66% 73% 72%
Loan loss rate (bps) — 9 — 24 — 14 31 43
Net interest margin 2.71% 2.62% 2.49% 2.49% 2.55% 2.54% 2.56% 2.51%
Quarterly Results by Business
Barclays PLC 18

-- 20 of 109 --

Analysis of Barclays UK Q222 Q122 Q421 Q321 Q221 Q121 Q420 Q320
Analysis of total income £m £m £m £m £m £m £m £m
Personal Banking 1,077 1,022 983 990 987 923 895 833
Barclaycard Consumer UK 265 276 352 293 290 315 354 362
Business Banking 382 351 364 355 346 338 377 355
Total income 1,724 1,649 1,699 1,638 1,623 1,576 1,626 1,550
Analysis of credit impairment (charges)/releases
Personal Banking (42) 21 8 (30) 72 (22) (68) (48)
Barclaycard Consumer UK 84 (44) 114 (108) 434 (36) (78) (106)
Business Banking (42) (25) (63) 1 14 (19) (24) (79)
Total credit impairment (charges)/releases — (48) 59 (137) 520 (77) (170) (233)
Analysis of loans and advances to customers at
amortised cost £bn £bn £bn £bn £bn £bn £bn £bn
Personal Banking 167.1 166.5 165.4 164.6 162.4 160.4 157.3 155.7
Barclaycard Consumer UK 8.8 8.4 8.7 8.6 8.8 8.7 9.9 10.7
Business Banking 30.0 32.4 34.7 35.4 36.6 36.6 38.2 37.5
Total loans and advances to customers at amortised
cost 205.9 207.3 208.8 208.6 207.8 205.7 205.4 203.9
Analysis of customer deposits at amortised cost
Personal Banking 197.0 196.6 196.4 193.3 191.0 186.0 179.7 173.2
Barclaycard Consumer UK — — — — 0.1 0.1 0.1 0.1
Business Banking 64.5 63.7 64.2 63.5 64.4 61.4 60.7 58.7
Total customer deposits at amortised cost 261.5 260.3 260.6 256.8 255.5 247.5 240.5 232.0
Quarterly Results by Business
Barclays PLC 19

-- 21 of 109 --

Barclays International
Q222 Q122 Q4211 Q3211 Q2211 Q121 Q420 Q320
Income statement information £m £m £m £m £m £m £m £m
Net interest income 1,029 936 955 749 811 748 614 823
Net trading income 2,766 2,446 789 1,515 1,455 1,934 1,372 1,528
Net fee, commission and other income 1,321 1,442 1,766 1,673 1,553 1,717 1,500 1,430
Total income 5,116 4,824 3,510 3,937 3,819 4,399 3,486 3,781
Credit impairment (charges)/releases (209) (101) (23) 18 271 22 (291) (370)
Net operating income 4,907 4,723 3,487 3,955 4,090 4,421 3,195 3,411
Operating costs (2,537) (2,505) (2,160) (2,310) (2,168) (2,438) (2,133) (2,227)
UK bank levy — — (134) — — — (240) —
Litigation and conduct (1,319) (513) (84) (100) (140) (21) (9) (28)
Total operating expenses (3,856) (3,018) (2,378) (2,410) (2,308) (2,459) (2,382) (2,255)
Other net income 5 8 3 15 13 9 9 9
Profit before tax 1,056 1,713 1,112 1,560 1,795 1,971 822 1,165
Attributable profit 783 1,300 818 1,191 1,207 1,431 441 782
Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn
Loans and advances at amortised cost 167.3 144.8 133.8 125.9 121.9 123.5 122.7 128.0
Trading portfolio assets 126.9 134.1 146.9 144.8 147.1 131.1 127.7 122.3
Derivative financial instrument assets 343.5 288.8 261.5 257.0 255.4 269.4 301.8 295.9
Financial assets at fair value through the income
statement 209.3 203.8 188.2 200.5 190.4 197.5 170.7 178.2
Cash collateral and settlement balances 128.5 132.0 88.1 115.9 108.5 109.7 97.5 121.8
Other assets 275.1 255.5 225.6 231.8 223.5 221.7 221.4 261.7
Total assets 1,250.6 1,159.0 1,044.1 1,075.9 1,046.8 1,052.9 1,041.8 1,107.9
Deposits at amortised cost 307.4 286.1 258.8 253.3 245.4 251.2 240.5 262.4
Derivative financial instrument liabilities 321.2 277.2 256.4 252.3 246.9 260.2 300.4 293.3
Loan: deposit ratio 54% 51% 52% 50% 50% 49% 51% 49%
Risk weighted assets 263.8 245.1 230.9 222.7 223.2 230.0 222.3 224.7
Period end allocated tangible equity 38.0 35.6 33.2 31.8 31.8 32.7 30.2 30.5
Performance measures
Return on average allocated tangible equity 8.4% 14.8% 9.9% 14.9% 14.9% 17.7% 5.8% 10.2%
Average allocated tangible equity (£bn) 37.3 35.1 32.9 31.8 32.4 32.3 30.5 30.6
Cost: income ratio 75% 63% 68% 61% 60% 56% 68% 60%
Loan loss rate (bps) 49 28 7 — — (7) 90 112
Net interest margin 4.52% 4.15% 4.14% 4.02% 3.96% 3.92% 3.41% 3.79%
1 The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of
preparation on page 56 and Restatement of financial statements (Note 1) on page 73 for more information.
Quarterly Results by Business
Barclays PLC 20

-- 22 of 109 --

Analysis of Barclays International
Corporate and Investment Bank Q222 Q122 Q4211 Q3211 Q2211 Q121 Q420 Q320
Income statement information £m £m £m £m £m £m £m £m
Net interest income 410 385 432 279 370 270 110 305
Net trading income 2,738 2,450 774 1,467 1,494 1,917 1,397 1,535
Net fee, commission and other income 885 1,103 1,426 1,383 1,115 1,407 1,131 1,065
Total income 4,033 3,938 2,632 3,129 2,979 3,594 2,638 2,905
Credit impairment (charges)/releases (65) 33 73 128 229 43 (52) (187)
Net operating income 3,968 3,971 2,705 3,257 3,208 3,637 2,586 2,718
Operating costs (1,870) (1,921) (1,562) (1,747) (1,623) (1,886) (1,603) (1,716)
UK bank levy — — (128) — — — (226) —
Litigation and conduct (1,314) (318) (59) (99) (78) (1) 2 (3)
Total operating expenses (3,184) (2,239) (1,749) (1,846) (1,701) (1,887) (1,827) (1,719)
Other net income — — 1 — — 1 2 1
Profit before tax 784 1,732 957 1,411 1,507 1,751 761 1,000
Attributable profit 579 1,316 695 1,085 989 1,263 413 627
Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn
Loans and advances at amortised cost 125.8 109.6 100.0 93.8 91.0 94.3 92.4 96.8
Trading portfolio assets 126.7 134.0 146.7 144.7 147.0 130.9 127.5 122.2
Derivative financial instruments assets 343.4 288.7 261.5 256.9 255.3 269.4 301.7 295.9
Financial assets at fair value through the income
statement 209.2 203.8 188.1 200.4 190.3 197.3 170.4 177.9
Cash collateral and settlement balances 127.7 131.2 87.2 115.1 107.7 108.8 96.7 121.0
Other assets 237.2 222.5 195.8 200.4 192.5 190.8 194.9 228.9
Total assets 1,170.0 1,089.8 979.3 1,011.3 983.8 991.5 983.6 1,042.7
Deposits at amortised cost 229.5 214.7 189.4 185.8 178.2 185.2 175.2 195.6
Derivative financial instrument liabilities 321.2 277.1 256.4 252.2 246.8 260.2 300.3 293.2
Risk weighted assets 227.6 213.5 200.7 192.5 194.3 201.3 192.2 193.3
Performance measures
Return on average allocated tangible equity 7.1% 17.1% 9.7% 15.6% 14.0% 17.9% 6.3% 9.5%
Average allocated tangible equity (£bn) 32.7 30.8 28.7 27.8 28.4 28.2 26.3 26.4
Cost: income ratio 79% 57% 66% 59% 57% 53% 69% 59%
Analysis of total income £m £m £m £m £m £m £m £m
FICC 1,529 1,644 546 803 895 1,204 812 1,000
Equities 1,411 1,052 501 757 777 932 542 691
Global Markets 2,940 2,696 1,047 1,560 1,672 2,136 1,354 1,691
Advisory 236 185 287 253 218 163 232 90
Equity capital markets 37 47 158 186 226 243 104 122
Debt capital markets 281 416 511 532 429 453 418 398
Investment Banking fees 554 648 956 971 873 859 754 610
Corporate lending (47) 125 176 168 38 206 186 232
Transaction banking 586 469 453 430 396 393 344 372
Corporate 539 594 629 598 434 599 530 604
Total income 4,033 3,938 2,632 3,129 2,979 3,594 2,638 2,905
1 The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of
preparation on page 56 and Restatement of financial statements (Note 1) on page 73 for more information.
Quarterly Results by Business
Barclays PLC 21

-- 23 of 109 --

Analysis of Barclays International
Consumer, Cards and Payments Q222 Q122 Q421 Q321 Q221 Q121 Q420 Q320
Income statement information £m £m £m £m £m £m £m £m
Net interest income 619 551 522 471 441 478 504 518
Net fee, commission, trading and other income 464 335 356 337 399 327 344 358
Total income 1,083 886 878 808 840 805 848 876
Credit impairment (charges)/releases (144) (134) (96) (110) 42 (21) (239) (183)
Net operating income 939 752 782 698 882 784 609 693
Operating costs (667) (584) (598) (563) (545) (552) (530) (511)
UK bank levy — — (6) — — — (14) —
Litigation and conduct (5) (195) (25) (1) (62) (20) (11) (25)
Total operating expenses (672) (779) (629) (564) (607) (572) (555) (536)
Other net income 5 8 2 15 13 8 7 8
Profit/(loss) before tax 272 (19) 155 149 288 220 61 165
Attributable profit/(loss) 204 (16) 123 106 218 168 28 155
Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn
Loans and advances at amortised cost 41.5 35.2 33.8 32.1 30.9 29.2 30.3 31.2
Total assets 80.6 69.2 64.8 64.6 63.0 61.4 58.2 65.2
Deposits at amortised cost 77.9 71.4 69.4 67.5 67.2 66.0 65.3 66.8
Risk weighted assets 36.2 31.6 30.2 30.2 29.0 28.8 30.1 31.4
Performance measures
Return on average allocated tangible equity 17.8% (1.5)% 11.7% 10.5% 21.8% 16.5% 2.7% 14.7%
Average allocated tangible equity (£bn) 4.6 4.3 4.2 4.0 4.0 4.1 4.2 4.2
Cost: income ratio 62% 88% 72% 70% 72% 71% 65% 61%
Loan loss rate (bps) 132 145 105 127 — 27 286 211
Analysis of total income £m £m £m £m £m £m £m £m
International Cards and Consumer Bank 691 538 552 490 517 533 576 600
Private Bank 245 214 200 188 214 179 174 171
Payments 147 134 126 130 109 93 98 105
Total income 1,083 886 878 808 840 805 848 876
Quarterly Results by Business
Barclays PLC 22

-- 24 of 109 --

Head Office
Q222 Q122 Q421 Q321 Q221 Q121 Q420 Q320
Income statement information £m £m £m £m £m £m £m £m
Net interest income — 66 (38) (112) (64) (178) (86) (48)
Net fee, commission and other income (132) (43) (11) 2 37 103 (85) (79)
Total income (132) 23 (49) (110) (27) (75) (171) (127)
Credit impairment releases/(charges) 9 8 (5) (1) 6 — (31) (5)
Net operating expenses (123) 31 (54) (111) (21) (75) (202) (132)
Operating costs (60) (85) (152) (95) (341) (71) (213) (69)
UK bank levy — — — — — — (9) —
Litigation and conduct 1 (1) (3) (19) 16 (9) (42) (23)
Total operating expenses (59) (86) (155) (114) (325) (80) (264) (92)
Other net income/(expenses) 2 (18) 11 78 8 123 8 10
Loss before tax (180) (73) (198) (147) (338) (32) (458) (214)
Attributable (loss)/profit (170) (292) (159) (134) 120 (25) (381) (284)
Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn
Total assets 19.8 19.9 19.0 18.5 18.3 17.7 18.6 19.3
Risk weighted assets1 8.6 11.0 11.0 11.8 12.0 10.7 10.2 9.8
Period end allocated tangible equity1 1.1 3.6 5.5 6.3 5.9 3.3 6.8 7.1
Performance measures1
Average allocated tangible equity (£bn) 1.7 3.6 5.1 6.5 4.2 4.3 7.3 7.6
1 The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of
preparation on page 56 and Restatement of financial statements (Note 1) on page 73 for more information.
Quarterly Results by Business
Barclays PLC 23

-- 25 of 109 --

Margins and balances
Half year ended 30.06.22 Half year ended 30.06.21
Net interest
income
Average
customer
assets
Net interest
margin
Net interest
income
Average
customer
assets
Net interest
margin
£m £m % £m £m %
Barclays UK 2,732 206,524 2.67 2,586 204,930 2.54
Barclays International1 1,883 88,607 4.29 1,518 77,413 3.95
Total Barclays UK and Barclays International 4,615 295,131 3.15 4,104 282,343 2.93
Other2 148 (201)
Total Barclays Group 4,763 3,903
1 Barclays International margins include the lending related investment bank business.
2 Other includes Head Office and the non-lending related investment bank businesses not included in Barclays International margins.
The Group’s combined product and equity structural hedge notional as at 30 June 2022 was £256bn (30 June 2021:
£198bn), with an average duration of close to 3 years (2021: average duration close to 3 years). Gross structural hedge
contributions of £879m (H121: £689m) and net structural hedge contributions of £83m (H121: £592m) are included in
Group net interest income. Gross structural hedge contributions represent the absolute level of interest earned from the
fixed receipts on swaps in the structural hedge, while the net structural hedge contributions represent the net interest
earned on the difference between the structural hedge rate and prevailing floating rates.
Quarterly analysis for Barclays UK and Barclays International
Net interest
income
Average
customer
assets Net interest
margin
Three months ended 30.06.22 £m £m %
Barclays UK 1,393 205,834 2.71
Barclays International1 1,016 92,371 4.41
Total Barclays UK and Barclays International 2,409 298,205 3.24
Three months ended 31.03.22
Barclays UK 1,339 207,607 2.62
Barclays International1 867 84,838 4.15
Total Barclays UK and Barclays International 2,206 292,445 3.06
Three months ended 31.12.21
Barclays UK 1,313 209,064 2.49
Barclays International1 848 81,244 4.14
Total Barclays UK and Barclays International 2,161 290,308 2.95
Three months ended 30.09.21
Barclays UK 1,303 207,692 2.49
Barclays International1 783 77,364 4.02
Total Barclays UK and Barclays International 2,086 285,056 2.90
Three months ended 30.06.21
Barclays UK 1,305 205,168 2.55
Barclays International1 763 77,330 3.96
Total Barclays UK and Barclays International 2,068 282,498 2.94
1 Barclays International margins include the lending related investment bank business.
Performance Management
Barclays PLC 24

-- 26 of 109 --

Risk management and principal risks
The roles and responsibilities of the business groups, Risk and Compliance in the management of risk in the Group are
defined in the Enterprise Risk Management Framework. The purpose of the framework is to identify the principal risks of the
Group, the process by which the Group sets its appetite for these risks in its business activities, and the consequent limits
which it places on related risk taking. The framework identifies nine principal risks: credit risk, market risk, treasury and
capital risk, climate risk, operational risk, model risk, conduct risk, reputation risk and legal risk. Further detail on the Group’s
principal risks and previously identified material existing and emerging risks and how such risks are managed is available in
the Barclays PLC Annual Report 2021 (pages 202 to 223), or online at home.barclays/annualreport. There have been no
significant changes to these principal risks or previously identified material existing and emerging risks in the period other
than as set out below.
Material existing and emerging risks
Set out below are details of two additional material risks identified in H122 which potentially impact one or more principal
risks.
Internal control over financial reporting and disclosure controls and procedures
The Group is subject to requirements under the Sarbanes-Oxley Act of 2002, as amended, to perform system and process
evaluation and testing of its internal control over financial reporting to allow management to assess the effectiveness of its
internal controls. In connection with the offer and sale of securities by Barclays Bank PLC in excess of the amounts registered
under the 2019 F-3 and Predecessor Shelf (see “Over-issuance of US securities under Barclays Bank PLC's US shelf
registration statements” below), management has concluded that the Group had a material weakness in relation to certain
aspects of its internal control environment and that, as a consequence, its internal control over financial reporting as at 31
December 2021 was not effective under the applicable Committee of Sponsoring Organizations Framework and its
disclosure controls and procedures were not effective as at such date. The material weakness that has been identified relates
to a weakness in controls over the identification of external regulatory limits related to securities issuance and monitoring
against these limits. As a result of this weakness, Barclays Bank PLC issued securities in excess of the amounts under the US
shelf registration statements referred to above.
Remediation efforts have begun and the Group is taking steps to strengthen internal controls relating to securities issuance
to address the material weakness. However, internal control systems (no matter how well designed) have inherent
limitations and may not prevent or detect further misstatements or errors (whether of a similar or different character to the
foregoing). If the Group fails to maintain an effective internal control environment or its disclosure controls and procedures
are not effective, the Group could suffer material misstatements in its financial statements and fail to meet its reporting
obligations, which could cause investors to lose confidence in the Group's reported financial information. This could in turn
limit the Group's access to capital markets, negatively impact its results of operations, and lead to a negative impact on the
trading price of its securities. Additionally, ineffective internal control over financial reporting could expose the Group to
increased risk of fraud or misuse of corporate assets and subject it to potential regulatory investigations and civil or criminal
sanctions. Any of the foregoing could have a material adverse effect on Barclays Bank PLC’s and the Group's business,
financial condition, results of operations and reputation as a frequent issuer in the securities markets.
Over-issuance of US securities under Barclays Bank PLC's US shelf registration statements
The Group may be subject to claims for rescission or damages and regulatory enforcement actions in connection with
certain sales of securities issued by Barclays Bank PLC materially in excess of the amounts set forth in prior registration
statements as set out under “Internal control over financial reporting and disclosure controls and procedures” above.
The securities that were issued in excess of these amounts comprise structured notes and exchange traded notes (ETNs). As
such, certain offers and sales were not made in compliance with the US Securities Act of 1933, as amended (Securities Act),
giving rise to rights of rescission for certain purchasers of the securities. As a result, Barclays Bank PLC has elected to make a
rescission offer (Rescission Offer) to eligible purchasers of the relevant affected securities, which it intends to launch on 1
August 2022.
As previously disclosed, the Group is conducting a review (the Review), assisted by external counsel, of the facts and
circumstances relating to the sale of the relevant affected securities in excess of amounts registered under such US shelf
registration statements and, among other things, the control environment related to such sales. The Review is at an
advanced stage and reports on its progress have been made to the Group’s management team, the Group Board, and
regulators, including the SEC Divisions of Enforcement and Corporation Finance. Such reports have included, among other
things: (i) an assessment that the issuance of securities in excess of the maximum aggregate offering price for BBPLC’s 2019
US Shelf resulted from a failure to monitor issuances during the period in which Barclays Bank PLC’s status changed from a
Risk Management
Barclays PLC 25

-- 27 of 109 --

“well-known seasoned issuer” to an “ineligible issuer” for US securities law purposes, which required Barclays Bank PLC to
pre-register a set amount of securities to be issued under its US Shelf with the SEC; (ii) confirmation that the Review has not
identified any evidence of intentional misconduct; and (iii) the discovery that, while the vast majority of the over-issuance
occurred under the 2019 US Shelf, a small portion of the over-issuance also occurred under the Predecessor Shelf.
The Group is also conducting an internal review involving a five-year look-back at limits in other issuance programmes.
Management has assessed as remote the risk of material financial impact associated with issuance limits other than where
pre-registration of securities is required; therefore the focus of the review has been on programmes with external regulatory
limits related to securities issuance. This review has not identified any other breach of an external regulatory limit in any
issuance programme used by a member of the Group. Management has identified an instance where a limit imposed solely
for internal governance reasons was exceeded when taking into account a large security held on the Group's own balance
sheet issued under a non-SEC registered debt issuance programme which did not have an external limit, although the breach
of the internal limit did not give rise to any rights on the part of investors and did not constitute a material weakness.
Nevertheless, there can be no assurance that the ongoing internal or external counsel reviews will not identify additional
facts and information that could be material to an evaluation of this aspect of the Group's control environment.
Under Section 12(a)(1) of the Securities Act, certain purchasers of unregistered securities have a right to recover, upon the
tender of such security, the consideration paid for such security with interest, less the amount of any income received, or
damages if the purchaser no longer owns the security (Rescission Price). Pursuant to the Rescission Offer, Barclays Bank PLC
will offer to repurchase the relevant affected securities at the Rescission Price. Although the Rescission Offer is expected to
reduce liability with respect to potential private civil claims, it will not necessarily prevent such claims from being asserted
against Barclays Bank PLC and/or its affiliates, including claims under applicable US federal securities laws.
Further, the Rescission Offer does not bar the SEC or other authorities from pursuing enforcement actions against Barclays
Bank PLC and its affiliates, which are expected to result in fines, penalties and/or other sanctions. The Group is engaged
with, and responding to inquiries and requests for information from, various regulators, including the SEC. The SEC’s
investigation into this matter is at an advanced stage and the Group has had preliminary discussions with the staff of the
SEC’s Division of Enforcement about resolving this matter.
As at 30 June 2022, Barclays PLC has recognised a balance sheet provision of £1,757m (December 2021: £220m) in relation
to this matter, out of which £1,592m (December 2021: £220m) relates to the over-issuance of structured notes and £165m
(December 2021: nil) relates to liabilities that could be incurred arising out of ongoing discussions in respect of a potential
SEC resolution. A contingent liability exists in relation to the over-issuance of ETNs due to evidentiary challenges and the
high level of trading in the securities. A contingent liability also exists in relation to any potential civil claims or enforcement
actions taken against Barclays Bank PLC and its affiliates but Barclays Bank PLC is unable to assess the likelihood of liabilities
that may arise out of such claims or actions, there is currently no indication of the exact timing for resolution and it is not
practicable to provide an estimate of the financial effects.
The final cost of the Rescission Offer will be impacted by a number of factors, including prevailing market conditions. Prior to
the completion of the Rescission Offer, the amount of the provision in relation to the over-issuance of structured notes will
fluctuate, perhaps materially, due, in part, to the volatility of the market prices for the structured notes subject to the
Rescission Offer. While Barclays Bank PLC and/or its affiliates have entered into hedging arrangements designed to minimise
the volatility, such arrangements cannot by their very nature completely hedge the exposures, which may mean the final
impact of the Rescission Offer may materially differ from the £1,592m provision reflected as at 30 June 2022. In addition, the
hedging arrangements may be modified, may not prove effective (in existing or modified form), may expire prior to the end
of the Rescission Offer and do not cover any other losses arising out of potential private civil claims or enforcement actions.
The provision of £165m in relation to the potential SEC resolution may also be impacted by the ultimate outcome of the
ongoing discussions. Any of the foregoing could result in material additional losses for the Group.
Any liabilities, claims or actions in connection with the over-issuance of securities under the 2019 F-3 and the Predecessor
Shelf could have a material adverse effect on Barclays Bank PLC's and the Group's business, financial condition, results of
operations and reputation as a frequent issuer in the securities markets.
Management has concluded that, by virtue of the fact that there was a weakness in controls over the identification of
external regulatory limits related to securities issuance and monitoring against these limits, the Group had a material
weakness in relation to certain aspects of its internal control environment and, as a consequence, its internal control over
financial reporting and disclosure controls and procedures as at 31 December 2021 were not effective. Further details on
such material weakness are set out under “Internal control over financial reporting and disclosure controls and procedures”
above.
Risk Management
Barclays PLC 26

-- 28 of 109 --

Loans and advances at amortised cost by stage
The table below presents an analysis of loans and advances at amortised cost by gross exposure, impairment allowance,
impairment charge and coverage ratio by stage allocation and business segment as at 30 June 2022. Also included are off-
balance sheet loan commitments and financial guarantee contracts by gross exposure, impairment allowance and coverage
ratio by stage allocation as at 30 June 2022.
Impairment allowance under IFRS 9 considers both the drawn and the undrawn counterparty exposure. For retail portfolios,
the total impairment allowance is allocated to the drawn exposure to the extent that the allowance does not exceed the
exposure, as expected credit loss (ECL) is not reported separately. Any excess is reported on the liability side of the balance
sheet as a provision. For wholesale portfolios, the impairment allowance on the undrawn exposure is reported on the
liability side of the balance sheet as a provision.
Gross exposure Impairment allowance Net
exposure	Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total
As at 30.06.22 £m £m £m £m £m £m £m £m £m
Barclays UK 160,110 23,805 3,012 186,927 218 780 753 1,751 185,176
Barclays International 32,053 3,251 1,674 36,978 679 821 826 2,326 34,652
Head Office 3,852 215 688 4,755 2 16 346 364 4,391
Total Barclays Group retail 196,015 27,271 5,374 228,660 899 1,617 1,925 4,441 224,219
Barclays UK 35,915 2,267 862 39,044 131 49 117 297 38,747
Barclays International 120,470 11,916 1,022 133,408 254 198 287 739 132,669
Head Office 186 1 23 210 — — 21 21 189
Total Barclays Group wholesale1 156,571 14,184 1,907 172,662 385 247 425 1,057 171,605
Total loans and advances at
amortised cost 352,586 41,455 7,281 401,322 1,284 1,864 2,350 5,498 395,824
Off-balance sheet loan commitments
and financial guarantee contracts2 373,544 24,429 1,146 399,119 275 233 17 525 398,594
Total3 726,130 65,884 8,427 800,441 1,559 2,097 2,367 6,023 794,418
As at 30.06.22 Half year ended 30.06.22
Coverage ratio
Loan impairment charge/(release) and
loan loss rate
Stage 1 Stage 2 Stage 3 Total Loan impairment
charge/(release) Loan loss rate
% % % % £m bps
Barclays UK 0.1 3.3 25.0 0.9 14 2
Barclays International 2.1 25.3 49.3 6.3 253 138
Head Office 0.1 7.4 50.3 7.7 (18) —
Total Barclays Group retail 0.5 5.9 35.8 1.9 249 22
Barclays UK 0.4 2.2 13.6 0.8 36 19
Barclays International 0.2 1.7 28.1 0.6 75 11
Head Office — — 91.3 10.0 — —
Total Barclays Group wholesale1 0.2 1.7 22.3 0.6 111 13
Total loans and advances at
amortised cost 0.4 4.5 32.3 1.4 360 18
Off-balance sheet loan commitments
and financial guarantee contracts2 0.1 1.0 1.5 0.1 (42)
Other financial assets subject to
impairment3 23
Total4 0.2 3.2 28.1 0.8 341
1 Includes Wealth UK and Private Banking exposures measured on an individual customer exposure basis, and excludes Business Banking exposures,
including lending under the government backed Bounce Back Loan Scheme (BBLS) of £8.1bn that are managed on a collective basis and reported within
BUK Retail. The net impact is a difference in total exposure of £4.3bn of balances reported as wholesale loans on page 29 in the Loans and advances at
amortised cost by product disclosure.
2 Excludes loan commitments and financial guarantees of £21.1bn carried at fair value.
3 Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value
through other comprehensive income and other assets. These have a total gross exposure of £197.3bn and impairment allowance of £149m. This
comprises £11m ECL on £195.0bn Stage 1 assets, £2m on £2.1bn Stage 2 fair value through other comprehensive income assets, cash collateral and
settlement balances and £136m on £143m Stage 3 other assets.
4 The loan loss rate is 17bps after applying the total impairment charge of £341m.
Credit Risk
Barclays PLC 27

-- 29 of 109 --

Gross exposure Impairment allowance Net
exposure	Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total
As at 31.12.21 £m £m £m £m £m £m £m £m £m
Barclays UK 160,695 22,779 2,915 186,389 261 949 728 1,938 184,451
Barclays International 25,981 2,691 1,566 30,238 603 795 858 2,256 27,982
Head Office 3,735 429 705 4,869 2 36 347 385 4,484
Total Barclays Group retail 190,411 25,899 5,186 221,496 866 1,780 1,933 4,579 216,917
Barclays UK 35,571 1,917 969 38,457 153 43 111 307 38,150
Barclays International 92,341 13,275 1,059 106,675 187 192 458 837 105,838
Head Office 542 2 21 565 — — 19 19 546
Total Barclays Group wholesale1 128,454 15,194 2,049 145,697 340 235 588 1,163 144,534
Total loans and advances at
amortised cost 318,865 41,093 7,235 367,193 1,206 2,015 2,521 5,742 361,451
Off-balance sheet loan
commitments and financial
guarantee contracts2
312,142 34,815 1,298 348,255 217 302 23 542 347,713
Total3 631,007 75,908 8,533 715,448 1,423 2,317 2,544 6,284 709,164
As at 31.12.21 Half year ended 31.12.21
Coverage ratio
Loan impairment charge/(release) and
loan loss rate
Stage 1 Stage 2 Stage 3 Total Loan impairment
charge/(release) Loan loss rate
% % % % £m bps
Barclays UK 0.2 4.2 25.0 1.0 (227) —
Barclays International 2.3 29.5 54.8 7.5 181 60
Head Office 0.1 8.4 49.2 7.9 — —
Total Barclays Group retail 0.5 6.9 37.3 2.1 (46) —
Barclays UK 0.4 2.2 11.5 0.8 122 32
Barclays International 0.2 1.4 43.2 0.8 (197) —
Head Office — — 90.5 3.4 — —
Total Barclays Group wholesale1 0.3 1.5 28.7 0.8 (75) —
Total loans and advances at
amortised cost 0.4 4.9 34.8 1.6 (121) —
Off-balance sheet loan
commitments and financial
guarantee contracts2
0.1 0.9 1.8 0.2 (514)
Other financial assets subject to
impairment3 (18)
Total 0.2 3.1 29.8 0.9 (653)
1 Includes Wealth and Private Banking exposures measured on an individual basis, and excludes Business Banking exposures, including BBLS of £9.4bn that
are managed on a collective basis and reported within Barclays UK Retail. The net impact is a difference in total exposure of £6.0bn of balances reported as
wholesale loans on page 29 in the Loans and advances at amortised cost by product disclosure.
2 Excludes loan commitments and financial guarantees of £18.8bn carried at fair value.
3 Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value
through other comprehensive income and other assets. These have a total gross exposure of £155.2bn and impairment allowance of £114m. This
comprises £6m ECL on £154.9bn Stage 1 assets, £1m on £157.0bn Stage 2 fair value through other comprehensive income assets, other assets and cash
collateral and settlement balances and £107m on £110m Stage 3 other assets.
Credit Risk
Barclays PLC 28

-- 30 of 109 --

Loans and advances at amortised cost by product
The table below presents a breakdown of loans and advances at amortised cost and the impairment allowance with stage
allocation by asset classification.
Stage 2
As at 30.06.22 Stage 1
Not past
due
<=30
days past
due
>30 days
past due Total Stage 3 Total
Gross exposure £m £m £m £m £m £m £m
Home loans 150,883 16,269 1,700 765 18,734 2,110 171,727
Credit cards, unsecured loans and other retail lending 43,628 5,918 303 273 6,494 2,510 52,632
Wholesale loans 158,075 15,814 84 329 16,227 2,661 176,963
Total 352,586 38,001 2,087 1,367 41,455 7,281 401,322
Impairment allowance
Home loans 19 29 6 6 41 398 458
Credit cards, unsecured loans and other retail lending 860 1,329 100 126 1,555 1,448 3,863
Wholesale loans 405 264 2 2 268 504 1,177
Total 1,284 1,622 108 134 1,864 2,350 5,498
Net exposure
Home loans 150,864 16,240 1,694 759 18,693 1,712 171,269
Credit cards, unsecured loans and other retail lending 42,768 4,589 203 147 4,939 1,062 48,769
Wholesale loans 157,670 15,550 82 327 15,959 2,157 175,786
Total 351,302 36,379 1,979 1,233 39,591 4,931 395,824
Coverage ratio % % % % % % %
Home loans — 0.2 0.4 0.8 0.2 18.9 0.3
Credit cards, unsecured loans and other retail lending 2.0 22.5 33.0 46.2 23.9 57.7 7.3
Wholesale loans 0.3 1.7 2.4 0.6 1.7 18.9 0.7
Total 0.4 4.3 5.2 9.8 4.5 32.3 1.4
As at 31.12.21
Gross exposure £m £m £m £m £m £m £m
Home loans 148,058 17,133 1,660 707 19,500 2,122 169,680
Credit cards, unsecured loans and other retail lending 37,840 5,102 300 248 5,650 2,332 45,822
Wholesale loans 132,967 15,246 306 391 15,943 2,781 151,691
Total 318,865 37,481 2,266 1,346 41,093 7,235 367,193
Impairment allowance
Home loans 19 46 6 7 59 397 475
Credit cards, unsecured loans and other retail lending 824 1,493 85 123 1,701 1,504 4,029
Wholesale loans 363 248 4 3 255 620 1,238
Total 1,206 1,787 95 133 2,015 2,521 5,742
Net exposure
Home loans 148,039 17,087 1,654 700 19,441 1,725 169,205
Credit cards, unsecured loans and other retail lending 37,016 3,609 215 125 3,949 828 41,793
Wholesale loans 132,604 14,998 302 388 15,688 2,161 150,453
Total 317,659 35,694 2,171 1,213 39,078 4,714 361,451
Coverage ratio % % % % % % %
Home loans — 0.3 0.4 1.0 0.3 18.7 0.3
Credit cards, unsecured loans and other retail lending 2.2 29.3 28.3 49.6 30.1 64.5 8.8
Wholesale loans 0.3 1.6 1.3 0.8 1.6 22.3 0.8
Total 0.4 4.8 4.2 9.9 4.9 34.8 1.6
Credit Risk
Barclays PLC 29

-- 31 of 109 --

Loans and advances at amortised cost by selected sectors
The table below presents a breakdown of drawn exposure and impairment allowance for loans and advances at amortised
cost with stage allocation for selected industry sectors within the wholesale loans portfolio. As the nature of
macroeconomic uncertainty has evolved from the COVID-19 pandemic towards high inflation, supply chain constraints and
consumer demand headwinds, so has the selected population under management focus.
The gross loans and advances to selected sectors have remained stable over the year. The small increase in provisions is
informed by the improved macroeconomic outlook used in the Q222 scenario refresh, offset by management judgments to
reflect the risk of uncertainty still prevailing within these sectors. The wholesale portfolio also benefits from a hedge
protection programme that enables effective risk management against credit losses. An additional £0.1bn (December 2021:
£0.1bn) impairment allowance has been applied to the undrawn exposures not included in the table below.
Gross exposure Impairment allowance
Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total
As at 30.06.22 £m £m £m £m £m £m £m £m
Autos 914 370 2 1,286 10 5 — 15
Consumer manufacture 3,498 1,587 215 5,300 45 27 47 119
Discretionary retail and wholesale 5,811 1,311 240 7,362 34 21 45 100
Hospitality and leisure 3,817 1,755 352 5,924 33 35 41 109
Passenger travel 807 318 107 1,232 11 5 12 28
Real estate 14,001 2,509 550 17,060 89 45 107 241
Steel and aluminium manufacturers 610 75 7 692 6 1 1 8
Total 29,458 7,925 1,473 38,856 228 139 253 620
Total of wholesale exposures (%) 19% 49% 55% 22% 56% 52% 50% 53%
Gross exposure Impairment allowance
Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total
As at 31.12.21 £m £m £m £m £m £m £m £m
Autos 656 295 2 953 3 3 — 6
Consumer manufacture 3,904 1,304 211 5,419 18 22 43 83
Discretionary retail and wholesale 5,413 1,197 230 6,840 47 20 54 121
Hospitality and leisure 4,348 1,613 384 6,345 28 33 44 105
Passenger travel 856 285 143 1,284 30 8 40 78
Real estate 13,620 3,314 518 17,452 65 53 93 211
Steel and aluminium manufacturers 415 75 6 496 2 3 1 6
Total 29,212 8,083 1,494 38,789 193 142 275 610
Total of wholesale exposures (%) 22% 51% 54% 26% 53% 56% 44% 49%
UK Commercial real estate exposure continues to remain well collateralised, however it has been included within the latest
selected sector scoping as the broader real estate sector remains under pressure due to pricing and affordability concerns,
as well as construction input costs and supply chain issues adding to the uncertainty, in particular across non-investment
grade exposures.
The coverage ratio for selected sectors has broadly remained consistent at 1.6% as at 30 June 2022. Non-default coverage
has marginally increased from 0.9% as at 31 December 2021 to 1.0% as at 30 June 2022.
Credit Risk
Barclays PLC 30

-- 32 of 109 --

Movement in gross exposures and impairment allowance including provisions for loan commitments and
financial guarantees
The following tables present a reconciliation of the opening to the closing balance of the exposure and impairment
allowance. An explanation of the methodology used to determine credit impairment provisions is included in the Barclays
PLC Annual Report 2021 (Page 348). Transfers between stages in the table have been reflected as if they had taken place at
the beginning of the year. The movements are measured over a 6-month period.
Loans and advances at amortised cost
Stage 1 Stage 2 Stage 3 Total
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Home loans £m £m £m £m £m £m £m £m
As at 1 January 2022 148,058 19 19,500 59 2,122 397 169,680 475
Transfers from Stage 1 to Stage 2 (5,725) (1) 5,725 1 — — — —
Transfers from Stage 2 to Stage 1 5,131 18 (5,131) (18) — — — —
Transfers to Stage 3 (197) — (234) (5) 431 5 — —
Transfers from Stage 3 19 1 133 3 (152) (4) — —
Business activity in the period1 14,723 4 339 1 1 — 15,063 5
Refinements to models used for calculation — — — — — — — —
Net drawdowns, repayments, net re-
measurement and movement due to
exposure and risk parameter changes
(4,151) (22) (506) 2 (69) 16 (4,726) (4)
Final repayments (6,975) — (1,092) (2) (210) (3) (8,277) (5)
Disposals — — — — — — — —
Write-offs2 — — — — (13) (13) (13) (13)
As at 30 June 20223 150,883 19 18,734 41 2,110 398 171,727 458
Credit cards, unsecured loans and other retail lending
As at 1 January 2022 37,840 824 5,650 1,701 2,332 1,504 45,822 4,029
Transfers from Stage 1 to Stage 2 (2,572) (67) 2,572 67 — — — —
Transfers from Stage 2 to Stage 1 1,689 422 (1,689) (422) — — — —
Transfers to Stage 3 (444) (11) (516) (222) 960 233 — —
Transfers from Stage 3 30 13 49 9 (79) (22) — —
Business activity in the period1 8,231 354 294 32 20 5 8,545 391
Refinements to models used for calculation4 — 43 — 187 — 96 — 326
Net drawdowns, repayments, net re-
measurement and movement due to
exposure and risk parameter changes5
1,678 (691) 413 240 94 285 2,185 (166)
Final repayments (2,673) (23) (251) (27) (140) (29) (3,064) (79)
Disposals6 (151) (4) (28) (10) (122) (69) (301) (83)
Write-offs2 — — — — (555) (555) (555) (555)
As at 30 June 20223 43,628 860 6,494 1,555 2,510 1,448 52,632 3,863
1 Business activity in the period does not include additional drawdowns on the existing facility which are reported under 'Net drawdowns, repayments, net re-
measurement and movements due to exposure and risk parameter changes'. Business activity reported within Credit cards, unsecured loans and other
retail lending portfolio includes GAP portfolio acquisition in US cards of £2.7bn.
2 In H122, gross write-offs amounted to £768m (H121: £1,001m) and post write-off recoveries amounted to £36m (H121: £31m). Net write-offs represent
gross write-offs less post write-off recoveries and amounted to £732m (H121: £970m).
3 Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value
through other comprehensive income and other assets. These have a total gross exposure of £197.3bn (December 21: £155.2bn) and an impairment
allowance of £149m (December 21: £114m). This comprises £11m ECL (December 21: £6m) on £195.0bn stage 1 assets (December 21: £154.9bn), £2m
(December 21: £1m) on £2.1bn stage 2 fair value through other comprehensive income assets, other assets and cash collateral and settlement balances
(December 21: £0.2bn) and £136m (FY21: £107m) on £143m stage 3 other assets (December 21: £110m).
4 Refinements to models used for calculation reported within Credit cards, unsecured loans and other retail lending portfolio include a £0.3bn movement in
US cards. These reflect methodology changes made during the year. Barclays continually review the output of models to determine accuracy of the ECL
calculation including review of model monitoring, external benchmarking and experience of model operation over an extended period of time. This ensures
that the models used continue to reflect the risks inherent across the businesses.
5 Transfers and risk parameter changes include a £0.2bn (December 21: £0.3bn) net release in ECL arising from a reclassification of £1.4bn (December 21:
£1.9bn) gross loans and advances from Stage 2 to Stage 1 in Credit cards, unsecured loans and other retail lending portfolio. The reclassification followed a
review of back-testing of results which indicated that accuracy of origination probability of default characteristics required management adjustments to
correct. The re-classification was first established in Q220.
6 The £0.3bn disposals reported within Credit cards, unsecured loans and other retail lending portfolio includes £0.2bn sale of NFL portfolio within US cards
and £0.1bn of debt sales undertaken during the year.
Credit Risk
Barclays PLC 31

-- 33 of 109 --

Loans and advances at amortised cost
Stage 1 Stage 2 Stage 3 Total
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Wholesale loans £m £m £m £m £m £m £m £m
As at 1 January 2022 132,967 363 15,943 255 2,781 620 151,691 1,238
Transfers from Stage 1 to Stage 2 (5,129) (29) 5,129 29 — — — —
Transfers from Stage 2 to Stage 1 5,544 41 (5,544) (41) — — — —
Transfers to Stage 3 (676) (3) (405) (6) 1,081 9 — —
Transfers from Stage 3 114 9 200 17 (314) (26) — —
Business activity in the period1 28,927 40 1,670 14 108 14 30,705 68
Refinements to models used for calculation2 — (66) — (42) — (374) — (482)
Net drawdowns, repayments, net re-
measurement and movement due to
exposure and risk parameter changes3
12,529 79 1,048 70 (634) 555 12,943 704
Final repayments (16,201) (29) (1,783) (28) (115) (48) (18,099) (105)
Disposals4 — — (31) — (46) (46) (77) (46)
Write-offs5 — — — — (200) (200) (200) (200)
As at 30 June 20226 158,075 405 16,227 268 2,661 504 176,963 1,177
Reconciliation of ECL movement to impairment charge/(release) for the period £m
Home loans (4)
Credit cards, unsecured loans and other retail lending 472
Wholesale loans 185
ECL movement excluding assets derecognised due to disposals and write-offs 653
Recoveries and reimbursements7 (47)
Exchange and other adjustments8 (246)
Impairment release on loan commitments and other financial guarantees (42)
Impairment charge on other financial assets6 23
Income statement charge for the period 341
1 Business activity in the period does not include additional drawdowns on the existing facility which are reported under 'Net drawdowns, repayments, net re-
measurement and movements due to exposure and risk parameter changes'.
2 Refinements to models used for calculation reported within Wholesale loans relates to a £0.5bn movement in Business Banking. This relates to an update in
the underlying ECL model that now fully recognises the 100% government guarantee against Barclays Bounce Back Loans exposure.
3 "Net drawdowns, repayments, net re-measurement and movements due to exposure and risk parameter changes" reported within Wholesale loans also
include assets of £0.5bn de-recognised due to payment received on defaulted loans from government guarantees issued under government’s Bounce Back
Loans Scheme.
4 The £0.1bn disposals reported within Wholesale loans relates to debt sales undertaken during the year.
5 In H122, gross write-offs amounted to £768m (H121: £1,001m) and post write-off recoveries amounted to £36m (H121: £31m). Net write-offs represent
gross write-offs less post write-off recoveries and amounted to £732m (H121: £970m).
6 Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value
through other comprehensive income and other assets. These have a total gross exposure of £197.3bn (December 21: £155.2bn) and impairment
allowance of £149m (December 21: £114m). This comprises £11m ECL (December 21: £6m) on £195.0bn stage 1 assets (December 21: £154.9bn), £2m
(December 21: £1m) on £2.1bn stage 2 fair value through other comprehensive income assets, other assets and cash collateral and settlement balances
(December 21: £157.0bn) and £136m (December 21: £107m) on £143m stage 3 other assets (December 21: £110m).
7 Recoveries and reimbursements includes a net gain in relation to reimbursements from financial guarantee contracts held with third parties of £11m (H121
loss: £216m) and post write off recoveries of £36m (H121: £31m).
8 Exchange and other adjustments includes foreign exchange and interest and fees in suspense.
Credit Risk
Barclays PLC 32

-- 34 of 109 --

Loan commitments and financial guarantees
Stage 1 Stage 2 Stage 3 Total
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Home loans £m £m £m £m £m £m £m £m
As at 1 January 2022 10,833 — 532 — 3 — 11,368 —
Net transfers between stages 39 — (39) — — — — —
Business activity in the period 8,146 — — — — — 8,146 —
Net drawdowns, repayments, net re-
measurement and movement due to
exposure and risk parameter changes
(6,354) — (12) — — — (6,366) —
Limit management and final repayments (172) — (22) — — — (194) —
As at 30 June 2022 12,492 — 459 — 3 — 12,954 —
Credit cards, unsecured loans and other retail lending
As at 1 January 2022 122,819 50 5,718 61 218 20 128,755 131
Net transfers between stages (1,277) 23 935 (18) 342 (5) — —
Business activity in the period 26,892 1 212 — — — 27,104 1
Net drawdowns, repayments, net re-
measurement and movement due to
exposure and risk parameter changes
9,385 3 (1,267) 20 (288) 2 7,830 25
Limit management and final repayments (3,740) (1) (209) (3) (36) — (3,985) (4)
As at 30 June 2022 154,079 76 5,389 60 236 17 159,704 153
Wholesale loans
As at 1 January 2022 178,490 167 28,565 241 1,077 3 208,132 411
Net transfers between stages 9,775 36 (9,709) (37) (66) 1 — —
Business activity in the period 37,358 19 2,864 24 1 — 40,223 43
Net drawdowns, repayments, net re-
measurement and movement due to
exposure and risk parameter changes
17,712 (9) 1,510 (22) 140 (5) 19,362 (36)
Limit management and final repayments (36,362) (14) (4,649) (33) (245) 1 (41,256) (46)
As at 30 June 2022 206,973 199 18,581 173 907 — 226,461 372
Credit Risk
Barclays PLC 33

-- 35 of 109 --

Management adjustments to models for impairment
Management adjustments to impairment models are applied in order to factor in certain conditions or changes in policy
that are not fully incorporated into the impairment models, or to reflect additional facts and circumstances at the period
end. Management adjustments are reviewed and incorporated into future model development where applicable.
Total management adjustments to impairment allowance are presented by product below:
Overview of management adjustments to models for impairment allowance1
As at 30.06.22 As at 31.12.21
Management
adjustments to
impairment
allowances
Proportion of
total impairment
allowances
Management
adjustments to
impairment
allowances
Proportion of
total impairment
allowances
£m % £m %
Home loans 76 16.6 103 21.7
Credit cards, unsecured loans and other retail lending 785 19.6 1,362 32.7
Wholesale loans2 426 27.5 21 1.3
Total 1,287 21.4 1,486 23.6
Management adjustments to models for impairment allowance1
Impairment
allowance
pre
management
adjustments3
Economic
uncertainty
adjustments
Other
adjustments
Total
Adjustments
Total
impairment
allowance4
(a) (b) (a+b)
As at 30.06.22 £m £m £m £m £m
Home loans 382 43 33 76 458
Credit cards, unsecured loans and other retail lending 3,229 578 207 785 4,014
Wholesale loans 1,125 417 9 426 1,551
Total 4,736 1,038 249 1,287 6,023
As at 31.12.21
Home loans 372 72 31 103 475
Credit cards, unsecured loans and other retail lending 2,798 1,217 145 1,362 4,160
Wholesale loans 1,628 403 (382) 21 1,649
Total 4,798 1,692 (206) 1,486 6,284
1 Positive values reflect an increase in impairment allowance and negative values reflect a reduction in the impairment allowance.
2 Proportion of management adjustments to impairment allowances has increased in wholesale loans primarily driven by release of offsetting PMA to
recognise BBLS government guarantees of £0.4bn; now captured through the model. Excluding this, proportion of management adjustments to impairment
allowances remain materially stable compare to previous year.
3 Includes £4.1bn (December 2021: £4.1bn) of modelled ECL, £0.4bn (December 2021: £0.5bn) of individually assessed impairments and £0.2bn (December
2021: £0.2bn) ECL from non-modelled exposures.
4 Total impairment allowance consists of ECL stock on drawn and undrawn exposure.
Economic uncertainty adjustments
Throughout the COVID-19 pandemic in 2020 and 2021, macroeconomic forecasts anticipated lasting impacts to
unemployment levels and customer and client stress. However, the most recent macroeconomic outlook suggests the
concerns over the spread of COVID-19 in major economies has receded and normalisation of customer behaviour has been
observed, but uncertainty persists: Russia’s invasion of Ukraine is affecting global energy markets and food prices; China’s
‘zero-COVID’ policy is putting pressure on stretched supply chains; and labour markets continue to generate inflationary
pressures. Credit deterioration could still occur as emerging supply chain disruption and inflationary pressures challenge
economic stability; and economic consensus may not capture the range of arising economic uncertainty.
Given this backdrop, COVID-19 related expert judgements have been materially replaced by provisions for customers and
clients considered most vulnerable to rising costs and supply chain disruption. This uncertainty continues to be captured in
two distinct ways. Firstly, customer uncertainty: the identification of customers and clients who may be more vulnerable to
the emerging economic instability; and secondly, model uncertainty: to capture the impact from model limitations and
sensitivities to specific macroeconomic parameters which are applied at a portfolio level.
Credit Risk
Barclays PLC 34

-- 36 of 109 --

The economic uncertainty adjustments of £1.0bn (FY21: £1.7bn) include customer and client uncertainty provisions of
£0.8bn (FY21: £1.5bn) and model uncertainty provisions of £0.2bn (FY21: £0.2bn).
Customer and client uncertainty provisions include an adjustment of £0.8bn (FY21: £1.5bn) which has been applied to
customers and clients considered potentially vulnerable to the emerging economic instability in light of inflationary and
supply chain concerns. This adjustment is split between credit cards, unsecured loans and other retail lending £0.5bn (FY21:
£0.8bn) and wholesale loans £0.3bn (FY21: £0.3bn). The reduction in the credit cards, unsecured loans and other retail
lending-related adjustment is due to unwinding of COVID-19 related expert judgements partially offset by provisions
booked for customers and clients considered more vulnerable to rising costs and slowing consumer demand.
Furthermore, a previously held 2021 adjustment of £0.4bn to amend probabilities of default (PDs), informed by pre
COVID-19 levels, is no longer required as the normalisation of customer behaviour is now captured within the modelled
output.
Model uncertainty provisions £0.2bn (2021: £0.2bn) informed by modelled provisions following the updated Q222
scenario.
Other adjustments
Other adjustments are operational in nature and are expected to remain in place until they can be corrected in the
underlying models. These adjustments result from data limitations and model performance related issues identified through
established governance processes. The quantum of adjustments has reduced in response to the macroeconomic variable
refresh in Q222 as well as model enhancements made during H122. Material adjustments comprise the following:
Home loans: The low average loan to value (LTV) nature of the UK Home Loans portfolio means that modelled ECL
estimates are low. An adjustment is made to maintain an appropriate level of ECL informed by model monitoring.
Credit cards, unsecured loans and other retail lending: Includes the estimated ECL impact from adoption of the new
definition of default under the Capital Requirements Regulation, the Day 1 provision for the GAP portfolio acquisition in US
cards, an annual update to the qualitative measures used in high risk account management (HRAM) and adjustments for
model inaccuracies informed by model monitoring; partially offset by a reclassification of loans and advances from Stage 2
to Stage 1 in credit cards. The reclassification followed a review of back-testing results which indicated that accuracy of
origination probability of default characteristics requires management adjustments to correct and was first established in
Q220. This adjustment has been reduced, driven by the improved macroeconomic scenarios in Q222.
Wholesale loans: Management adjustments of £(0.4)bn within wholesale loans in 2021 principally comprised an
adjustment applied on bounce back loans of £(0.4)bn to reverse out the modelled charge which did not consider the
government guarantee when calculating the ECL. This adjustment is no longer needed due to model enhancements.
Credit Risk
Barclays PLC 35

-- 37 of 109 --

Measurement uncertainty
Management has applied economic uncertainty and other adjustments to modelled ECL outputs. Economic uncertainty
adjustments have been applied to customers and clients considered most vulnerable to rising costs and supply chain
disruption. As a result, ECL is higher than would be the case if it were based on forecast economic scenarios alone.
The measurement of modelled ECL involves complexity and judgement, including estimation of probabilities of default (PD),
loss given default (LGD), a range of unbiased future economic scenarios, estimation of expected lives, estimation of
exposures at default (EAD) and assessing significant increases in credit risk. The Group uses a five-scenario model to
calculate ECL. An external consensus forecast is assembled from key sources, including HM Treasury (short and medium
term forecasts), Bloomberg (based on median of economic forecasts) and the Urban Land Institute (for US House Prices),
which forms the Baseline scenario. In addition, two adverse scenarios (Downside 1 and Downside 2) and two favourable
scenarios (Upside 1 and Upside 2) are derived, with associated probability weightings. The adverse scenarios are calibrated
to a broadly similar severity to Barclays’ internal stress tests and stress scenarios provided by regulators whilst also
considering IFRS 9 specific sensitivities and non-linearity. The favourable scenarios are designed to reflect plausible upside
risks to the Baseline scenario which are broadly consistent with the economic narrative approved by the Senior Scenario
Review Committee. All scenarios are regenerated at a minimum semi-annually. The scenarios include key economic
variables, (including GDP, unemployment, House Price Index (HPI) and base rates in both the UK and US markets), and
expanded variables using statistical models based on historical correlations. The upside and downside shocks are designed
to evolve over a five-year stress horizon, with all five scenarios converging to a steady state after approximately seven years.
Scenarios used to calculate the Group’s ECL charge were refreshed in Q222. The current Baseline scenario reflects the latest
consensus economic forecasts. Unemployment rates remain low, close to current levels. As inflation expectations drift
higher, central banks tighten monetary policy sharply. In 2023, the UK Bank Rate reaches 2.75%, while the US Federal Funds
Rate peaks at 3.25%. Rising borrowing charges and falling real wages subtract from growth through lower investment and
household consumption. In the Downside 2 scenario, with inflation expectations rising, the central banks have to raise
interest rates very sharply. The UK Bank Rate and the US Federal Funds Rate both reach 5.0% in Q223. Higher borrowing
costs derail the economy and unemployment peaks in Q124 at 9.2% in the UK and 9.5% in the US. Given already stretched
valuations, the sharp increase in mortgage servicing costs sees house prices decrease very sharply. In the Upside 2 scenario,
supply disruptions get resolved, while the aggregate demand is supported by a release of household savings. GDP growth
accelerates. Recovering labour force participation limits domestic inflationary pressures, while lower energy prices add some
downward pressure on prices globally.
The methodology for estimating probability weights used in calculating ECL involves simulating a range of future paths for
UK and US GDP using historical data. The five scenarios are mapped against the distribution of these future paths, with the
median centred around the Baseline such that scenarios further from the Baseline attract a lower weighting. A single set of
five scenarios is used across all portfolios and all five weights are normalised to equate to 100%. The same scenarios and
weights that are used in the ECL estimation are also used for Barclays’ internal planning purposes. The impacts across the
portfolios are different because of the sensitivities of each of the portfolios to specific macroeconomic variables. For
example, mortgages are highly sensitive to house prices; credit cards and unsecured consumer loans are highly sensitive to
unemployment.
The decrease in the Upside scenario weightings and increase in the Baseline weighting were driven by: (i) continued growth
in UK/US GDP which resulted in a narrower fan of future GDP paths; and (ii) generally less favourable GDP projections
across scenarios, increasing the distance between Upside 2 and Baseline scenario paths. For further details see page 40.
COVID-19 related expert judgements have been materially replaced by provisions for customers and clients considered
most vulnerable to rising costs and supply chain disruption. The economic uncertainty adjustments of £1.0bn (FY21:
£1.7bn) have been applied as overlays to the modelled ECL output. These adjustments consist of a customer and client
uncertainty provision of £0.8bn (FY21: £1.5bn) and a model uncertainty provision of £0.2bn (FY21: £0.2bn). For further
details, see pages 34 to 35.
The tables below show the key consensus macroeconomic variables used in the scenarios (5-year annual paths), the
probability weights applied to each scenario and the macroeconomic variables by scenario using ‘specific bases’ i.e. the
most extreme position of each variable in the context of the scenario, for example, the highest unemployment for downside
scenarios and the lowest unemployment for upside scenarios. The 5-year average table provides additional transparency.
Credit Risk
Barclays PLC 36

-- 38 of 109 --

Baseline average macroeconomic variables used in the calculation of ECL
2022 2023 2024 2025 2026
As at 30.06.22 % % % % %
UK GDP1 3.9 1.7 1.6 1.6 1.6
UK unemployment2 4.0 4.1 3.9 3.9 3.9
UK HPI3 4.3 1.0 2.2 2.5 2.8
UK bank rate 1.5 2.7 2.4 2.1 2.0
US GDP1 3.3 2.2 2.1 2.1 2.1
US unemployment4 3.6 3.5 3.5 3.5 3.5
US HPI5 4.1 3.4 3.4 3.4 3.4
US federal funds rate 1.5 3.2 2.9 2.7 2.5
2021 2022 2023 2024 2025
As at 31.12.21 % % % % %
UK GDP1 6.2 4.9 2.3 1.9 1.7
UK unemployment2 4.8 4.7 4.5 4.3 4.2
UK HPI3 4.7 1.0 1.9 1.9 2.3
UK bank rate 0.1 0.8 1.0 1.0 0.8
US GDP1 5.5 3.9 2.6 2.4 2.4
US unemployment4 5.5 4.2 3.6 3.6 3.6
US HPI5 11.8 4.5 5.2 4.9 5.0
US federal funds rate 0.2 0.3 0.9 1.2 1.3
1 Average Real GDP seasonally adjusted change in year.
2 Average UK unemployment rate 16-year+.
3 Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.
4 Average US civilian unemployment rate 16-year+.
5 Change in year end US HPI = FHFA House Price Index, relative to prior year end.
Credit Risk
Barclays PLC 37

-- 39 of 109 --

Downside 2 average economic variables used in the calculation of ECL
2022 2023 2024 2025 2026
As at 30.06.22 % % % % %
UK GDP1 3.1 (4.8) (0.4) 4.3 3.6
UK unemployment2 5.2 8.4 8.6 6.8 5.9
UK HPI3 0.2 (26.2) (3.6) 17.9 10.2
UK bank rate 1.8 4.7 4.3 2.6 2.3
US GDP1 2.4 (4.1) (0.2) 3.4 2.7
US unemployment4 4.6 8.0 9.0 7.1 5.8
US HPI5 (0.2) (11.7) (0.2) 5.5 3.5
US federal funds rate 1.8 4.8 4.6 3.6 3.0
2021 2022 2023 2024 2025
As at 31.12.21 % % % % %
UK GDP1 6.2 0.2 (4.0) 2.8 4.3
UK unemployment2 4.8 7.2 9.0 7.6 6.3
UK HPI3 4.7 (14.3) (21.8) 11.9 15.2
UK bank rate 0.1 2.2 3.9 3.1 2.2
US GDP1 5.5 (0.8) (3.5) 2.5 3.2
US unemployment4 5.5 6.4 9.1 8.1 6.4
US HPI5 11.8 (6.6) (9.0) 5.9 6.7
US federal funds rate 0.2 2.1 3.4 2.6 2.0
1 Average Real GDP seasonally adjusted change in year.
2 Average UK unemployment rate 16-year+.
3 Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.
4 Average US civilian unemployment rate 16-year+.
5 Change in year end US HPI = FHFA House Price Index, relative to prior year end.
Downside 1 average economic variables used in the calculation of ECL
2022 2023 2024 2025 2026
As at 30.06.22 % % % % %
UK GDP1 3.5 (1.6) 0.6 3.0 2.6
UK unemployment2 4.6 6.2 6.2 5.3 4.9
UK HPI3 2.3 (13.2) (0.8) 10.0 6.5
UK bank rate 1.6 3.8 3.4 2.4 2.0
US GDP1 2.7 (1.0) 1.1 2.9 2.5
US unemployment4 4.1 5.7 6.2 5.3 4.6
US HPI5 1.9 (4.4) 1.6 4.4 3.4
US federal funds rate 1.7 3.9 3.8 3.2 2.8
2021 2022 2023 2024 2025
As at 31.12.21 % % % % %
UK GDP1 6.2 2.8 (0.7) 2.3 2.9
UK unemployment2 4.8 6.2 6.8 6.0 5.3
UK HPI3 4.7 (6.8) (10.5) 6.9 8.6
UK bank rate 0.1 1.6 2.7 2.3 1.6
US GDP1 5.5 1.6 (0.4) 2.4 2.7
US unemployment4 5.5 5.4 6.6 6.1 5.2
US HPI5 11.8 (1.2) (2.1) 4.8 5.2
US federal funds rate 0.2 1.3 2.3 2.1 1.8
1 Average Real GDP seasonally adjusted change in year.
2 Average UK unemployment rate 16-year+.
3 Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.
4 Average US civilian unemployment rate 16-year+.
5 Change in year end US HPI = FHFA House Price Index, relative to prior year end.
Credit Risk
Barclays PLC 38

-- 40 of 109 --

Upside 2 average economic variables used in the calculation of ECL
2022 2023 2024 2025 2026
As at 30.06.22 % % % % %
UK GDP1 5.0 5.2 3.1 2.4 2.0
UK unemployment2 3.8 3.7 3.6 3.6 3.6
UK HPI3 6.5 11.2 6.2 4.7 3.7
UK bank rate 1.2 1.5 1.4 1.3 1.3
US GDP1 4.0 4.9 3.6 3.4 3.4
US unemployment4 3.4 3.0 3.1 3.1 3.1
US HPI5 5.4 5.5 4.6 4.5 4.5
US federal funds rate 1.1 2.2 1.9 1.7 1.5
2021 2022 2023 2024 2025
As at 31.12.21 % % % % %
UK GDP1 6.2 7.2 4.0 2.7 2.1
UK unemployment2 4.8 4.5 4.1 4.0 4.0
UK HPI3 4.7 8.5 9.0 5.2 4.2
UK bank rate 0.1 0.2 0.5 0.5 0.3
US GDP1 5.5 5.3 4.1 3.5 3.4
US unemployment4 5.5 3.9 3.4 3.3 3.3
US HPI5 11.8 10.6 8.5 7.2 6.6
US federal funds rate 0.2 0.3 0.4 0.7 1.0
1 Average Real GDP seasonally adjusted change in year.
2 Average UK unemployment rate 16-year+.
3 Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.
4 Average US civilian unemployment rate 16-year+.
5 Change in year end US HPI = FHFA House Price Index, relative to prior year end.
Upside 1 average economic variables used in the calculation of ECL
2022 2023 2024 2025 2026
As at 30.06.22 % % % % %
UK GDP1 4.5 3.5 2.4 2.0 1.8
UK unemployment2 3.9 3.8 3.8 3.8 3.8
UK HPI3 5.4 6.3 4.1 3.6 3.2
UK bank rate 1.3 2.0 1.6 1.5 1.5
US GDP1 3.7 3.7 3.0 2.9 2.9
US unemployment4 3.5 3.2 3.3 3.3 3.3
US HPI5 4.7 4.4 4.0 3.9 3.9
US federal funds rate 1.3 2.4 2.2 1.9 1.8
2021 2022 2023 2024 2025
As at 31.12.21 % % % % %
UK GDP1 6.2 6.0 3.1 2.3 1.9
UK unemployment2 4.8 4.6 4.3 4.2 4.1
UK HPI3 4.7 5.0 5.0 3.9 3.3
UK bank rate 0.1 0.6 0.8 0.8 0.5
US GDP1 5.5 4.6 3.4 2.9 2.9
US unemployment4 5.5 4.0 3.5 3.5 3.5
US HPI5 11.8 8.3 7.0 6.0 5.7
US federal funds rate 0.2 0.3 0.6 1.0 1.1
1 Average Real GDP seasonally adjusted change in year.
2 Average UK unemployment rate 16-year+.
3 Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.
4 Average US civilian unemployment rate 16-year+.
5 Change in year end US HPI = FHFA House Price Index, relative to prior year end.
Credit Risk
Barclays PLC 39

-- 41 of 109 --

Scenario probability weighting
Upside 2 Upside 1 Baseline Downside 1 Downside 2
% % % % %
As at 30.06.22
Scenario probability weighting 14.0 25.6 37.8 15.2 7.4
As at 31.12.21
Scenario probability weighting 20.9 27.2 30.1 14.8 7.0
Specific bases show the most extreme position of each variable in the context of the scenario, for example, the highest
unemployment for downside scenarios, average unemployment for baseline scenarios and lowest unemployment for upside
scenarios. GDP and HPI downside and upside scenario data represents the lowest and highest points relative to the start
point in the 20 quarter period.
Macroeconomic variables (specific bases)1
Upside 2 Upside 1 Baseline Downside 1 Downside 2
As at 30.06.22 % % % % %
UK GDP2 16.8 12.8 2.1 (1.1) (5.9)
UK unemployment3 3.6 3.8 4.0 6.6 9.2
UK HPI4 36.7 24.8 2.6 (13.6) (30.8)
UK bank rate 0.8 0.8 2.1 4.0 5.0
US GDP2 20.2 16.1 2.4 (0.5) (5.0)
US unemployment3 3.0 3.2 3.5 6.5 9.5
US HPI4 27.0 22.9 3.5 (2.6) (13.4)
US federal funds rate 0.3 0.3 2.6 4.1 5.0
As at 31.12.21
UK GDP2 21.4 18.3 3.4 (1.6) (1.6)
UK unemployment3 4.0 4.1 4.5 7.0 9.2
UK HPI4 35.7 23.8 2.4 (12.7) (29.9)
UK bank rate 0.1 0.1 0.7 2.8 4.0
US GDP2 22.8 19.6 3.4 1.5 (1.3)
US unemployment3 3.3 3.5 4.1 6.8 9.5
US HPI4 53.3 45.2 6.2 2.2 (5.0)
US federal funds rate 0.1 0.1 0.8 2.3 3.5
1 UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK unemployment rate 16-year+; UK HI = Halifax All Houses, All Buyers Index; US GDP
= Real GDP growth seasonally adjusted; US unemployment = US civilian unemployment rate 16-year+; US HPI = FHFA House Price Index. 20 quarter period
starts from Q122 (2021: Q121).
2 Maximum growth relative to Q421 (2021: Q420), based on 20 quarter period in Upside scenarios; 5-year yearly average Compound Annual Growth Rate
(CAGR) in Baseline; minimum growth relative to Q421 (2021: Q420), based on 20 quarter period in Downside scenarios.
3 Lowest quarter in 20 quarter period in Upside scenarios; 5-year average in Baseline; highest quarter 20 quarter period in Downside scenarios.
4 Maximum growth relative to Q421 (2021: Q420), based on 20 quarter period in Upside scenarios; 5-year quarter end CAGR in Baseline; minimum growth
relative to Q421 (2021: Q420), based on 20 quarter period in Downside scenarios.
Average basis represents the average quarterly value of variables in the 20 quarter period with GDP and HPI based on yearly
average and quarterly CAGRs respectively.
Credit Risk
Barclays PLC 40

-- 42 of 109 --

Macroeconomic variables (5-year averages)1
Upside 2 Upside 1 Baseline Downside 1 Downside 2
As at 30.06.22 % % % % %
UK GDP2 3.5 2.8 2.1 1.6 1.1
UK unemployment3 3.7 3.8 4.0 5.5 7.0
UK HPI4 6.4 4.5 2.6 0.6 (1.5)
UK bank rate 1.3 1.6 2.1 2.7 3.1
US GDP2 3.9 3.2 2.4 1.6 0.8
US unemployment3 3.1 3.3 3.5 5.2 6.9
US HPI4 4.9 4.2 3.5 1.4 (0.8)
US federal funds rate 1.7 1.9 2.6 3.1 3.6
As at 31.12.21
UK GDP2 4.4 3.9 3.4 2.7 1.8
UK unemployment3 4.3 4.4 4.5 5.8 7.0
UK HPI4 6.3 4.4 2.4 0.3 (2.0)
UK bank rate 0.3 0.5 0.7 1.7 2.3
US GDP2 4.4 3.9 3.4 2.4 1.3
US unemployment3 3.9 4.0 4.1 5.7 7.1
US HPI4 8.9 7.7 6.2 3.6 1.4
US federal funds rate 0.5 0.6 0.8 1.5 2.1
1 UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK unemployment rate 16-year+; UK HPI = Halifax All Houses, All Buyers Index; US GDP
= Real GDP growth seasonally adjusted; US unemployment = US civilian unemployment rate 16-year+; US HPI = FHFA House Price Index.
2 5-year yearly average CAGR, starting 2021 (2021: 2020).
3 5-year average. Period based on 20 quarters from Q122 (2021: Q121).
4 5-year quarter end CAGR, starting Q421 (2021: Q420).
Credit Risk
Barclays PLC 41

-- 43 of 109 --

ECL under 100% weighted scenarios for modelled portfolios
The table below shows the ECL assuming scenarios have been 100% weighted. Model exposures are allocated to a stage
based on the individual scenario rather than through a probability-weighted approach as required for Barclays reported
impairment allowances. As a result, it is not possible to back solve to the final reported weighted ECL from the individual
scenarios as a balance may be assigned to a different stage dependent on the scenario. Model exposure uses exposure at
default (EAD) values and is not directly comparable to gross exposure used in prior disclosures. For Credit cards, unsecured
loans and other retail lending, an average EAD measure is used (12-month or lifetime, depending on stage allocation in each
scenario). Therefore, the model exposure movement into Stage 2 is higher than the corresponding Stage 1 reduction.
All ECL using a model is included, with the exception of Treasury assets (£7.7m of ECL). Non-modelled exposures and
management adjustments are excluded. Management adjustments can be found in the Management adjustments to models
for impairment section.
Model exposures allocated to Stage 3 do not change in any of the scenarios as the transition criteria relies only on
observable evidence of default as at 30 June 2022 and not on macroeconomic scenarios.
The Downside 2 scenario represents a severe global recession with substantial falls in both UK and US GDP. Unemployment
in UK markets rises towards 9.2% and US markets rises towards 9.5% and there are substantial falls in asset prices including
housing. Under the Downside 2 scenario, model exposure moves between stages as the economic environment weakens.
This can be seen in the movement of £22.1bn of model exposure into Stage 2 between the Weighted and Downside 2
scenario. ECL increases in Stage 2 predominantly due to unsecured portfolios as economic conditions deteriorate.
Credit Risk
Barclays PLC 42

-- 44 of 109 --

Scenarios
As at 30 June 2022 Weighted Upside 2 Upside 1 Baseline Downside 1 Downside 2
Stage 1 Model Exposure (£m)
Home loans 142,668 144,569 143,881 142,882 141,536 139,553
Credit cards, unsecured loans and other retail lending 46,225 46,906 46,692 46,446 45,324 44,057
Wholesale loans 183,356 189,252 187,709 183,570 178,233 167,303
Stage 1 Model ECL (£m)
Home loans 3 2 2 2 4 10
Credit cards, unsecured loans and other retail lending 341 329 333 338 353 372
Wholesale loans 250 210 224 237 296 329
Stage 1 Coverage (%)
Home loans — — — — — —
Credit cards, unsecured loans and other retail lending 0.7 0.7 0.7 0.7 0.8 0.8
Wholesale loans 0.1 0.1 0.1 0.1 0.2 0.2
Stage 2 Model Exposure (£m)
Home loans 18,684 16,783 17,471 18,470 19,815 21,799
Credit cards, unsecured loans and other retail lending 8,699 7,741 8,048 8,448 9,932 11,658
Wholesale loans 23,702 17,806 19,349 23,489 28,825 39,755
Stage 2 Model ECL (£m)
Home loans 13 8 9 11 20 40
Credit cards, unsecured loans and other retail lending 1,531 1,306 1,378 1,468 1,840 2,318
Wholesale loans 463 348 382 438 604 1,091
Stage 2 Coverage (%)
Home loans 0.1 — 0.1 0.1 0.1 0.2
Credit cards, unsecured loans and other retail lending 17.6 16.9 17.1 17.4 18.5 19.9
Wholesale loans 2.0 2.0 2.0 1.9 2.1 2.7
Stage 3 Model Exposure (£m)
Home loans 1,631 1,631 1,631 1,631 1,631 1,631
Credit cards, unsecured loans and other retail lending 1,797 1,797 1,797 1,797 1,797 1,797
Wholesale loans1 2,431 2,431 2,431 2,431 2,431 2,431
Stage 3 Model ECL (£m)
Home loans 313 301 305 309 328 357
Credit cards, unsecured loans and other retail lending 1,207 1,183 1,191 1,222 1,218 1,212
Wholesale loans1 61 56 58 60 66 73
Stage 3 Coverage (%)
Home loans 19.2 18.5 18.7 18.9 20.1 21.9
Credit cards, unsecured loans and other retail lending 67.2 65.8 66.3 68.0 67.8 67.4
Wholesale loans1 2.5 2.3 2.4 2.5 2.7 3.0
Total Model ECL (£m)
Home loans 329 311 316 322 352 407
Credit cards, unsecured loans and other retail lending 3,079 2,818 2,902 3,028 3,411 3,902
Wholesale loans1 774 614 664 735 966 1,493
Total Model ECL 4,182 3,743 3,882 4,085 4,729 5,802
1 Material wholesale loan defaults are individually assessed across different recovery strategies. As a result, ECL of £376m is reported as individually assessed
impairments in the table below.
Reconciliation to total ECL £m
Total model ECL 4,182
ECL from individually assessed impairments 376
ECL from non-modelled and other management adjustments1 1,465
Total ECL 6,023
1 Includes £1.3bn post-model adjustments of which £0.1bn is included as part of total model ECL and £0.2bn ECL from non-modelled exposures.
Credit Risk
Barclays PLC 43

-- 45 of 109 --

The dispersion of results around the Baseline is an indication of uncertainty around the future projections. The disclosure
highlights the results of the alternative scenarios enabling the reader to understand the extent of the impact on exposure
and ECL from the upside/downside scenarios. Consequently, the use of five scenarios with associated weightings results in a
total weighted ECL uplift from the Baseline ECL of 2.4%, largely driven by credit card losses which have more linear loss
profiles than UK home loans and wholesale loan positions.
Home loans: Total weighted ECL of £329m represents a 2.2% increase over the Baseline ECL (£322m), and coverage ratios
remain steady across the Upside scenarios, Baseline and Downside 1 scenario. However, total ECL increases in the Downside
2 scenario to £407m, driven by a significant fall in UK HPI (30.8%) reflecting the non-linearity of the UK portfolio.
Credit cards, unsecured loans and other retail lending: Total weighted ECL of £3,079m represents a 1.7% increase over the
Baseline ECL (£3,028m) reflecting the range of economic scenarios used, mainly impacted by unemployment and other key
retail variables. Total ECL increases to £3,902m under Downside 2 scenario, mainly driven by Stage 2, where coverage rates
increase to 19.9% from a weighted scenario approach of 17.6% and circa £3.0bn increase in model exposure that meets the
Significant Increase in Credit Risk criteria and transitions from Stage 1 to Stage 2.
Wholesale loans: Total weighted ECL of £774m represents an 5.3% increase over the Baseline ECL (£735m) reflecting the
range of economic scenarios used, with exposures in the Corporate and Investment Bank particularly sensitive to the
Downside 2 scenario.
Credit Risk
Barclays PLC 44

-- 46 of 109 --

Scenarios
As at 31 December 2021 Weighted Upside 2 Upside 1 Baseline Downside 1 Downside 2
Stage 1 Model Exposure (£m)
Home loans 137,279 139,117 138,424 137,563 135,544 133,042
Credit cards, unsecured loans and other retail lending 45,503 46,170 45,963 45,751 43,131 38,820
Wholesale loans 174,249 177,453 176,774 175,451 169,814 161,998
Stage 1 Model ECL (£m)
Home loans 4 2 2 3 6 14
Credit cards, unsecured loans and other retail lending 324 266 272 279 350 418
Wholesale loans 290 240 262 286 327 350
Stage 1 Coverage (%)
Home loans — — — — — —
Credit cards, unsecured loans and other retail lending 0.7 0.6 0.6 0.6 0.8 1.1
Wholesale loans 0.2 0.1 0.1 0.2 0.2 0.2
Stage 2 Model Exposure (£m)
Home loans 22,915 21,076 21,769 22,631 24,649 27,151
Credit cards, unsecured loans and other retail lending 7,200 6,260 6,521 6,795 9,708 14,290
Wholesale loans 32,256 29,052 29,732 31,054 36,692 44,507
Stage 2 Model ECL (£m)
Home loans 15 10 11 12 22 47
Credit cards, unsecured loans and other retail lending 1,114 925 988 1,058 1,497 3,295
Wholesale loans 572 431 467 528 851 1,510
Stage 2 Coverage (%)
Home loans 0.1 — 0.1 0.1 0.1 0.2
Credit cards, unsecured loans and other retail lending 15.5 14.8 15.2 15.6 15.4 23.1
Wholesale loans 1.8 1.5 1.6 1.7 2.3 3.4
Stage 3 Model Exposure (£m)
Home loans 1,724 1,724 1,724 1,724 1,724 1,724
Credit cards, unsecured loans and other retail lending 1,922 1,922 1,922 1,922 1,922 1,922
Wholesale loans1 1,811 1,811 1,811 1,811 1,811 1,811
Stage 3 Model ECL (£m)
Home loans 303 292 295 299 320 346
Credit cards, unsecured loans and other retail lending 1,255 1,236 1,245 1,255 1,277 1,297
Wholesale loans1 323 321 322 323 326 332
Stage 3 Coverage (%)
Home loans 17.6 16.9 17.1 17.3 18.6 20.1
Credit cards, unsecured loans and other retail lending 65.3 64.3 64.8 65.3 66.4 67.5
Wholesale loans1 17.8 17.7 17.8 17.8 18.0 18.3
Total Model ECL (£m)
Home loans 322 304 308 314 348 407
Credit cards, unsecured loans and other retail lending 2,693 2,427 2,505 2,592 3,124 5,010
Wholesale loans1 1,185 992 1,051 1,137 1,504 2,192
Total Model ECL 4,200 3,723 3,864 4,043 4,976 7,609
1 Material wholesale loan defaults are individually assessed across different recovery strategies. As a result, ECL of £524m is reported as individually assessed
impairments in the table below.
Reconciliation to total ECL1 £m
Total model ECL 4,200
ECL from individually assessed impairments 524
ECL from non-modelled and other management adjustments 1,560
Total ECL 6,284
1 Includes £1.5bn of post-model adjustments and £0.2bn ECL from non-modelled exposures.
Credit Risk
Barclays PLC 45

-- 47 of 109 --

Analysis of specific portfolios and asset types
Secured home loans
The UK home loan portfolio primarily comprises first lien mortgages and accounts for 93% (December 2021: 93%) of the
Group’s total home loans balance.
Barclays UK
Home loans principal portfolios As at
30.06.22 As at
31.12.21
Gross loans and advances (£m) 159,676 158,192
90 day arrears rate, excluding recovery book (%) 0.1 0.1
Annualised gross charge-off rates - 180 days past due (%) 0.5 0.5
Recovery book proportion of outstanding balances (%) 0.6 0.6
Recovery book impairment coverage ratio (%) 4.6 4.2
Average marked to market LTV
Balance weighted % 50.8 50.7
Valuation weighted % 37.8 37.5
New lending
Half year
ended
30.06.22
Half year
ended
30.06.21
New home loan bookings (£m) 14,117 19,120
New home loan proportion > 90% LTV (%) 2.6 0.9
Average LTV on new home loans: balance weighted (%) 68.6 68.7
Average LTV on new home loans: valuation weighted (%) 60.4 61.3
Home loans principal portfolios – distribution of balances by LTV1
Distribution of balances Distribution of impairment
allowance Coverage ratio
Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total
Barclays UK % % % % % % % % % % % %
As at 30.06.22
<=75% 79.2 10.9 0.6 90.7 6.7 17.3 34.5 58.5 — 0.1 2.9 —
>75% and <=90% 8.2 0.5 — 8.7 4.2 10.8 12.2 27.2 — 1.2 29.1 0.2
>90% and <=100% 0.6 — — 0.6 0.4 0.6 2.2 3.2 — 2.5 72.9 0.3
>100% — — — — 0.1 1.5 9.5 11.1 0.4 20.7 100.0 23.1
As at 31.12.21
<=75% 77.2 11.3 0.7 89.2 8.3 17.7 31.9 57.9 — 0.1 2.4 —
>75% and <=90% 9.3 0.6 — 9.9 4.8 10.7 11.7 27.2 — 1.0 22.6 0.1
>90% and <=100% 0.9 — — 0.9 0.9 1.0 2.9 4.8 0.1 1.9 87.5 0.3
>100% — — — — 0.2 1.0 8.9 10.1 0.4 6.4 100.0 14.1
1 Portfolio mark to market based on the most updated valuation including recovery book balances. Updated valuations reflect the application of the latest
HPI available as at 30 June 2022.
New lending reduced to £14.1bn, a level more consistent with pre-COVID-19 periods, from £19.1bn in H121 when market
dynamics drove high levels of new business due to stamp duty relief and property ownership led demand. The proportion of
new lending with LTV >85% was 18%, more consistent with levels seen pre-COVID-19, compared to 7% in H121 when high
LTV products were gradually being reintroduced following COVID-19 restrictions.
Head Office: Italian home loans and advances at amortised cost reduced to £4.6bn (2021: £4.7bn). The portfolio is secured
on residential property with an average balance weighted mark to market LTV of 59.0% (2021: 60.4%). 90 day arrears
remained stable at 1.3% (2021: 1.3%), gross charge-off rates increased to 0.4% (2021: 0.3%).
Credit Risk
Barclays PLC 46

-- 48 of 109 --

Credit cards, unsecured loans and other retail lending
The principal portfolios listed below accounted for 83% (December 2021: 82%) of the Group’s total credit cards, unsecured
loans and other retail lending.
Principal portfolios
Gross
exposure
30 day
arrears rate,
excluding
recovery
book
90 day
arrears rate,
excluding
recovery
book
Annualised
gross write-
off rate
Annualised
net write-off
rate
As at 30.06.22 £m % % % %
Barclays UK
UK cards 9,901 1.0 0.2 2.4 2.3
UK personal loans 4,188 1.3 0.6 2.0 1.6
Barclays Partner Finance 2,459 0.5 0.2 0.8 0.8
Barclays International
US cards 23,037 1.4 0.7 2.9 2.7
Germany consumer lending 3,993 1.5 0.7 0.7 0.7
As at 31.12.21
Barclays UK
UK cards 9,933 1.0 0.2 4.1 4.0
UK personal loans 4,011 1.5 0.7 3.5 3.2
Barclays Partner Finance 2,471 0.4 0.2 1.4 1.4
Barclays International
US cards 17,779 1.6 0.8 4.3 4.2
Germany consumer lending 3,559 1.5 0.7 0.9 0.8
UK cards: 30 and 90 day arrears rates remained stable at 1.0% and 0.2%, with balances flat at £9.9bn. Gross and net write-
off rates returned to more stable levels of 2.4% and 2.3% following the higher rates in 2021 caused by the sharp reductions
in overall balances through COVID-19 and heightened debt sale activity.
UK personal loans: 30 and 90 day arrears rates reduced by 0.2% and 0.1% to 1.3% and 0.6% respectively. This marginal
reduction was driven by the portfolio growing through new lending post the COVID-19 reductions, and these newer
vintages performing better than the historical stock. Gross and net write-off rates returned to more stable levels of 2.0% and
1.6% following the higher rates in 2021 caused by the sharp reductions in overall balances through COVID-19 and
heightened debt sale activity.
Barclays Partner Finance: 30 and 90 day arrears rates remain stable and in line with December 2021.
US cards: Balances increased due to the acquisition of the GAP portfolio in June 2022, movement in the USD/GBP exchange
rate and core portfolio growth. 30 and 90 day arrears rates improved due to the GAP portfolio acquisition.
Germany consumer lending: 30 and 90 day arrears rates were stable. 30 day arrears rates are below pre-COVID levels.
Credit Risk
Barclays PLC 47

-- 49 of 109 --

Government supported loans
Throughout the COVID-19 pandemic Barclays has supported its customers and clients by participating in the UK
government's Bounce Back Loan Scheme (BBLS), Coronavirus Business Interruption Loan Scheme (CBILS), Coronavirus
Large Business Interruption Loan Scheme (CLBILS) and the Recovery Loan Scheme (RLS).
Gross exposure Impairment allowance Impairment coverage
Government
guaranteed
exposure
Stage 1 Stage 2 Stage 3 Total
Modelled
impairment
Management
adjustment
Impairment
post-
management
adjustment
Pre-
management
adjustment
Post-
management
adjustment Total
As at 30.06.22 £m £m £m £m £m £m £m % % £m
Barclays UK
BBLS 5,231 1,982 893 8,106 22 — 22 0.3 0.3 8,083
CBILS 606 234 54 894 18 (4) 14 2.1 1.6 715
RLS 17 2 1 20 — — — — — 16
Barclays
International
CBILS 458 145 7 610 3 — 3 0.5 0.5 488
CLBILS 96 79 6 181 1 — 1 0.6 0.6 145
RLS 16 4 1 21 — — — 0.5 0.5 16
Total 6,424 2,446 962 9,832 44 (4) 40 0.4 0.4 9,463
As at 31.12.21
Barclays UK
BBLS 7,881 797 704 9,382 396 (380) 16 4.2 0.2 9,366
CBILS 900 110 47 1,057 12 (7) 5 1.1 0.5 845
RLS 11 — 1 12 — — — 2.7 2.7 10
Barclays
International
CBILS 619 146 6 771 5 — 5 0.6 0.6 617
CLBILS 163 56 2 221 1 — 1 0.4 0.4 177
RLS 1 — — 1 — — — 4.7 4.7 1
Total 9,575 1,109 760 11,444 414 (387) 27 3.6 0.2 11,016
The BBLS and CBILS schemes were launched to provide financial support to smaller and medium-sized businesses and
CLBILS for larger businesses in the UK who may experience financial difficulties as a result of the COVID-19 outbreak. The
RLS aims to help UK businesses access finance as they recover and grow following the COVID-19 pandemic. These loans are
guaranteed by the government at 100% for BBLS and 80% for CBILS, CLBILS and RLS (70% for RLS issued post January 1,
2022) as at the balance sheet date.
Management adjustment of £(380)m applied in December 2021 has been discontinued following an update in the
underlying ECL model that now fully recognises the 100% government guarantee against BBLS exposure within BUK
Business Banking. However, we continue to hold the £(4)m (December 2021: £7m) adjustment against CBILS as the 80%
government guarantee is not fully recognised in the models. In instances where Barclays has assessed the BBLS exposure to
have not met strict assessment criteria, no claim has been made against the government guarantee resulting in an
impairment allowance against these loans of £22m (December 2021: £16m) as at the balance sheet date.
Additionally, while the government supported loans are covered by guarantees, many BBLS customers have other financing
arrangements with Barclays which are not covered by the government guarantee. Noting the elevated levels of delinquency
across the BBLS population, Barclays has applied an adjustment of £0.1bn to the £2.6bn gross exposure to BBLS customers
outside the scheme.
Credit Risk
Barclays PLC 48

-- 50 of 109 --

Analysis of management value at risk (VaR)
The table below shows the total management VaR on a diversified basis by asset class. Total management VaR includes all
trading positions in Barclays Bank Group and it is calculated with a one-day holding period. VaR limits are applied to total
management VaR and by asset class. Additionally, the market risk management function applies VaR sub-limits to material
businesses and trading desks.
Management VaR (95%) by asset class
Half year ended 30.06.22 Half year ended 31.12.21 Half year ended 30.06.21
Average High Low Average High Low Average High Low
£m £m £m £m £m £m £m £m £m
Credit risk 16 24 8 10 13 7 18 30 9
Interest rate risk 10 19 4 5 9 4 8 15 4
Equity risk 10 29 4 8 29 4 10 15 6
Basis risk 9 24 4 4 7 3 7 10 4
Spread risk 5 10 3 4 6 3 4 6 3
Foreign exchange risk 10 25 2 4 16 1 3 6 2
Commodity risk — 1 — — 1 — — 1 —
Inflation risk 6 17 3 3 5 2 2 3 2
Diversification effect1 (39) n/a n/a (23) n/a n/a (30) n/a n/a
Total management VaR 27 43 13 15 34 6 22 36 13
1 Diversification effects recognise that forecast losses from different assets or businesses are unlikely to occur concurrently, hence the expected aggregate
loss is lower than the sum of the expected losses from each area. Historical correlations between losses are taken into account in making these
assessments. The high and low VaR figures reported for each category did not necessarily occur on the same day as the high and low VaR reported as a
whole. Consequently, a diversification effect balance for the high and low VaR figures would not be meaningful and is therefore omitted from the above
table.
Average management VaR increased 80% to £27m (H221: £15m) driven by elevated market volatility and defensive risk
positioning. Risk taking during the period remained within risk appetite.
Market Risk
Barclays PLC 49

-- 51 of 109 --

The Group has a comprehensive Key Risk Control Framework for managing its liquidity risk. The liquidity framework meets
the PRA standards and is designed to maintain liquidity resources that are sufficient in amount and quality, and a funding
profile that is appropriate to meet the Group’s Liquidity Risk Appetite (LRA). The liquidity framework is delivered via a
combination of policy formation, review and governance, analysis, stress testing, limit setting and monitoring.
Liquidity risk stress testing
The liquidity risk stress assessment measures the potential contractual and contingent stress outflows under a range of
scenarios, which are then used to determine the size of the liquidity pool that is immediately available to meet anticipated
outflows if a stress occurs. The short-term scenarios include a 30 day Barclays-specific stress event, a 90 day market-wide
stress event and a 30 day combined scenario consisting of both a Barclays specific and market-wide stress event. The Group
also runs a long-term liquidity stress test, which measures the anticipated outflows over a 12 month market-wide scenario.
The LCR requirement takes into account the relative stability of different sources of funding and potential incremental
funding requirements in a stress. The LCR is designed to promote short-term resilience of a bank’s liquidity risk profile by
holding sufficient high quality liquid assets to survive an acute stress scenario lasting for 30 days.
As at 30 June 2022, the Group held eligible liquid assets in excess of 100% of net stress outflows to its internal and external
regulatory requirements.
Liquidity coverage ratio
As at
30.06.22
As at
31.12.21
£bn £bn
Eligible liquidity buffer 331 285
Net stress outflows (212) (169)
Surplus 119 116
Liquidity coverage ratio 156% 168%
The Group plans to maintain its surplus to the internal and regulatory stress requirements at an efficient level, while
considering risks to market funding conditions and its liquidity position. The continuous reassessment of these risks may
lead to execution of appropriate actions to resize the liquidity pool.
Treasury and Capital Risk
Barclays PLC 50

-- 52 of 109 --

Composition of the Group liquidity pool
As at 30.06.22
As at
31.12.21
Liquidity pool
Liquidity pool of which LCR eligible1
Liquidity pool	Cash Level 1 Level 2A
£bn £bn £bn £bn £bn
Cash and deposits with central banks2 288 284 — — 245
Government bonds3
AAA to AA- 33 — 24 1 26
A+ to A- 5 — — 5 2
BBB+ to BBB- — — — — —
Total government bonds 38 — 24 6 28
Other
Government Guaranteed Issuers, PSEs and GSEs 8 — 6 1 6
International Organisations and MDBs 3 — 4 — 5
Covered bonds 4 — 2 2 6
Other 2 — — — 1
Total other 17 — 12 3 18
Total as at 30 June 2022 343 284 36 9 291
Total as at 31 December 2021 291 243 37 5
1 The LCR eligible liquidity pool is adjusted for trapped liquidity and other regulatory deductions. It also incorporates other CRR as amended by CRR II
qualifying assets that are not eligible under Barclays’ internal risk appetite.
2 Includes cash held at central banks and surplus cash at central banks related to payment schemes. 99% (December 2021: over 99%) was placed with the
Bank of England, US Federal Reserve, European Central Bank, Bank of Japan and Swiss National Bank.
3 Of which over 81% (December 2021: over 82%) comprised UK, US, French, German, Japanese, Swiss and Dutch securities.
The Group liquidity pool increased to £343bn as at 30 June 2022 (December 2021: £291bn) driven by continued deposit
growth and an increase in wholesale funding, which were partly offset by an increase in business funding consumption.
During H122, the month-end liquidity pool ranged from £309bn to £343bn (H221: £290bn to £308bn), and the month-end
average balance was £324bn (H221: £296bn). The liquidity pool is held unencumbered and is not used to support payment
or clearing requirements. Such requirements are treated as part of our regular business funding. The liquidity pool is
intended to offset stress outflows, and comprises the above cash and unencumbered assets.
As at 30 June 2022, 64% (December 2021: 58%) of the liquidity pool was located in Barclays Bank PLC, 25% (December
2021: 30%) in Barclays Bank UK PLC and 6% (December 2021: 7%) in Barclays Bank Ireland PLC. The residual portion of the
liquidity pool is held outside of these entities, predominantly in US subsidiaries, to meet entity-specific stress outflows and
local regulatory requirements. To the extent the use of this residual portion of the liquidity pool is restricted due to local
regulatory requirements, it is assumed to be unavailable to the rest of the Group in calculating the LCR.
The composition of the pool is subject to limits and controls set by the respective entity Boards and independent liquidity
risk, credit risk and market risk functions. In addition, the investment of the liquidity pool is monitored for concentration by
issuer, currency and asset type. Given returns generated by these highly liquid assets, the risk and reward profile is
continuously managed.
Treasury and Capital Risk
Barclays PLC 51

-- 53 of 109 --

Deposit funding
As at 30.06.22 As at
31.12.21
Loans and
advances at
amortised
cost
Deposits at
amortised
cost
Loan: deposit
ratio1
Loan: deposit
ratio1
Funding of loans and advances £bn £bn % %
Barclays UK 224 262 85 85
Barclays International 167 307 54 52
Head Office 5 —
Barclays Group 396 569 70 70
1 The loan: deposit ratio is calculated as loans and advances at amortised cost divided by deposits at amortised cost.
Funding structure and funding relationships
The basis for liquidity risk management is a funding structure that reduces the probability of a liquidity stress leading to an
inability to meet funding obligations as they fall due. The Group’s overall funding strategy is to develop a diversified funding
base (geographically, by type and by counterparty) and maintain access to a variety of alternative funding sources, to
provide protection against unexpected fluctuations, while minimising the cost of funding.
Within this, the Group aims to align the sources and uses of funding. As such, retail and corporate loans and advances are
largely funded by deposits in the relevant entities, with the surplus primarily funding the liquidity pool. The majority of
reverse repurchase agreements are matched by repurchase agreements. Derivative liabilities and assets are largely matched.
A substantial proportion of balance sheet derivative positions qualify for counterparty netting and the remaining portions are
largely offset when netted against cash collateral received and paid. Wholesale debt and equity is used to fund residual
assets.
These funding relationships as at 30 June 2022 are summarised below:
Restated1
As at
30.06.22
As at
31.12.21
As at
30.06.22
As at
31.12.21
Assets £bn £bn Liabilities and equity £bn £bn
Loans and advances at amortised cost2 381 358 Deposits at amortised cost 569 519
Group liquidity pool 343 291 <1 Year wholesale funding 84 67
>1 Year wholesale funding 97 101
Reverse repurchase agreements, trading
portfolio assets, cash collateral and
settlement balances 426 388
Repurchase agreements, trading portfolio
liabilities, cash collateral and settlement
balances 387 330
Derivative financial instruments 345 263 Derivative financial instruments 321 257
Other assets3 94 84 Other liabilities 60 40
Equity 71 70
Total assets 1,589 1,384 Total liabilities and equity 1,589 1,384
1 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page
73 for more information. The contractual maturity profile of Senior unsecured (privately placed) has been restated to reflect the impact of the Over-issuance
of Securities.
2 Adjusted for liquidity pool debt securities reported at amortised cost of £15bn (December 2021: £3bn).
3 Other assets include fair value assets that are not part of reverse repurchase agreements or trading portfolio assets, and other asset categories.
Treasury and Capital Risk
Barclays PLC 52

-- 54 of 109 --

Composition of wholesale funding
Wholesale funding outstanding (excluding repurchase agreements) was £181.5bn (December 2021: £167.5bn). In H122, the
Group issued £3.5bn of MREL eligible instruments from Barclays PLC (the Parent company) in a range of tenors and
currencies.
Our operating companies also access wholesale funding markets to maintain their stable and diversified funding bases.
Barclays Bank PLC continued to issue in the shorter-term and medium-term notes markets. In addition, Barclays Bank UK
PLC continued to issue in the shorter-term markets.
Wholesale funding of £84.2bn (December 2021: £66.7bn1) matures in less than one year, representing 46% (December
2021: 40%1) of total wholesale funding outstanding. This includes £19.4bn (December 2021: £24.9bn1) related to term
funding2.
Maturity profile of wholesale funding2,3
<1 1-3 3-6 6-12 <1 1-2 2-3 3-4 4-5 >5
month months months months year years years years years years Total
£bn £bn £bn £bn £bn £bn £bn £bn £bn £bn £bn
Barclays PLC (the Parent
company)
Senior unsecured (public
benchmark) — — — 0.2 0.2 6.9 7.7 5.5 3.5 14.0 37.8
Senior unsecured (privately
placed) — — — — — 0.2 — — — 1.2 1.4
Subordinated liabilities — — — — — — 1.0 1.7 — 7.4 10.1
Barclays Bank PLC (including
subsidiaries)
Certificates of deposit and
commercial paper 9.7 11.4 18.1 10.8 50.0 0.1 2.1 — — — 52.2
Asset backed commercial paper 3.7 4.5 0.2 0.2 8.6 — — — — — 8.6
Senior unsecured (public
benchmark) — — — — — 0.6 — — — — 0.6
Senior unsecured (privately
placed)4 7.6 1.8 1.9 3.9 15.2 6.3 7.5 2.1 3.2 20.3 54.6
Asset backed securities 0.6 — — 0.1 0.7 0.4 2.3 0.4 0.2 1.4 5.4
Subordinated liabilities — 0.1 1.2 0.2 1.5 0.1 0.1 — 0.1 — 1.8
Barclays Bank UK PLC
(including subsidiaries)
Certificates of deposit and
commercial paper 6.1 0.1 — — 6.2 — — — — — 6.2
Senior unsecured (public
benchmark) — — — — — — — — — 0.1 0.1
Covered Bonds — — — 1.8 1.8 — — — — 0.9 2.7
Total as at 30 June 2022 27.7 17.9 21.4 17.2 84.2 14.6 20.7 9.7 7.0 45.3 181.5
Of which secured 4.3 4.5 0.2 2.1 11.1 0.4 2.3 0.4 0.2 2.3 16.7
Of which unsecured 23.4 13.4 21.2 15.1 73.1 14.2 18.4 9.3 6.8 43.0 164.8
Total as at 31 December 20211 14.1 21.7 15.5 15.4 66.7 15.4 15.1 9.9 11.4 49.0 167.5
Of which secured 2.4 6.4 0.6 0.5 9.9 1.9 2.0 0.1 0.3 2.4 16.6
Of which unsecured 11.7 15.3 14.9 14.9 56.8 13.5 13.1 9.8 11.1 46.6 150.9
1 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page
73 for more information. The contractual maturity profile of financial liabilities designated at fair value has been restated to reflect the impact of the Over-
issuance of Securities. Securities issued by BBPLC in excess of the maximum aggregate offering price registered under Barclays Bank PLC's 2019 F-3 and
Predecessor Shelf with a value of £6,997m have been classified as "on demand".
2 The composition of wholesale funds comprises the balance sheet reported financial liabilities at fair value, debt securities in issue and subordinated
liabilities. It does not include participation in the central bank facilities reported within repurchase agreements and other similar secured borrowing.
3 Term funding comprises public benchmark and privately placed senior unsecured notes, covered bonds, asset-backed securities and subordinated debt
where the original maturity of the instrument is more than 1 year.
4 Includes structured notes of £45.9bn, of which £8.5bn matures within one year.
Treasury and Capital Risk
Barclays PLC 53

-- 55 of 109 --

Credit ratings
In addition to monitoring and managing key metrics related to the financial strength of the Group, Barclays also solicits
independent credit ratings from Standard & Poor’s Global (S&P), Moody’s, Fitch, and Rating and Investment Information
(R&I). These ratings assess the creditworthiness of the Group, its subsidiaries and its branches, and are based on reviews of a
broad range of business and financial attributes including capital strength, profitability, funding, liquidity, asset quality,
strategy and governance.
Barclays Bank PLC
Standard &
Poor's Moody's Fitch
Long-term A / Positive A1 / Stable A+ / Stable
Short-term A-1 P-1 F1
Barclays Bank UK PLC
Long-term A / Positive A1 / Stable A+ / Stable
Short-term A-1 P-1 F1
Barclays PLC
Long-term BBB / Positive Baa2 /Positive A / Stable
Short-term A-2 P-2 F1
As at 30 June 2022, all solicited ratings and outlooks with all agencies remained unchanged since 31 December 2021.
In June 2021, S&P revised the outlooks of Barclays PLC, Barclays Bank PLC and Barclays Bank UK PLC to positive from stable,
whilst affirming all ratings. The revisions reflect the view that Barclays is delivering a stronger, more consistent business
profile and financial performance.
In November 2021, Moody’s revised the outlook of Barclays PLC to positive from stable, whilst affirming all ratings. The
revisions reflect Moody’s view that the level and stability of the Group’s earnings could further improve once global
macroeconomic conditions normalise, recognising the balanced earnings streams and stable operating costs.
In July 2021, Fitch revised the outlooks of Barclays PLC, Barclays Bank PLC and Barclays Bank UK PLC to stable from negative,
whilst affirming all ratings. The revisions reflected improved expectations for economic recovery in Barclays’ key markets
and the Group’s resilient performance through the pandemic.
Barclays also solicits issuer ratings from R&I. In November 2021, R&I upgraded the issuer ratings of Barclays PLC and
Barclays Bank PLC by one notch to A and A+ respectively.
A credit rating downgrade could result in outflows to meet collateral requirements on existing contracts. Outflows related to
credit rating downgrades are included in the LRA stress scenarios and a portion of the liquidity pool is held against this risk.
Credit ratings downgrades could also result in reduced funding capacity and increased funding costs.
The contractual collateral requirement following one- and two-notch long-term and associated short-term downgrades
across all credit rating agencies, would result in outflows of £1bn and £3bn respectively, and are provided for in determining
an appropriate liquidity pool size given the Group’s liquidity risk appetite. These numbers do not assume any management or
restructuring actions that could be taken to reduce posting requirements. These outflows do not include the potential
liquidity impact from loss of unsecured funding, such as from money market funds, or loss of secured funding capacity.
However, unsecured and secured funding stresses are included in the LRA stress scenarios and a portion of the liquidity pool
is held against these risks.
Treasury and Capital Risk
Barclays PLC 54

-- 56 of 109 --

Regulatory minimum requirements
Capital
The Group’s Overall Capital Requirement for CET1 is 10.9% comprising a 4.5% Pillar 1 minimum, a 2.5% Capital
Conservation Buffer (CCB), a 1.5% Global Systemically Important Institution (G-SII) buffer, a 2.4% Pillar 2A requirement and
a 0% Countercyclical Capital Buffer (CCyB).
The Group’s CCyB is based on the buffer rate applicable for each jurisdiction in which the Group has exposures. On 11
March 2020, the Financial Policy Committee (FPC) set the CCyB rate for UK exposures at 0% with immediate effect. The
buffer rates set by other national authorities for non-UK exposures are not currently material. Overall, this results in a 0.0%
CCyB for the Group. On 13 December 2021, the FPC announced that a CCyB rate of 1% for UK exposures has been re-
introduced and will be applicable from 13 December 2022. On 5 July 2022, the FPC announced that the UK CCyB rate will be
increased from 1% to 2% and will be applicable from 5 July 2023.
The Group’s Pillar 2A requirement as per the PRA’s Individual Capital Requirement was set as a nominal amount. When
expressed as a percentage of RWAs this was 4.2% of which at least 56.25% needed to be met with CET1 capital, equating to
approximately 2.4% of RWAs. The Pillar 2A requirement is subject to at least annual review and is based on a point in time
assessment.
The Group’s CET1 target ratio of 13-14% takes into account headroom above requirements which includes a confidential
institution-specific PRA buffer. The Group remains above its minimum capital regulatory requirements including the PRA
buffer.
Leverage
The Group is subject to a UK leverage ratio requirement of 3.8%. This comprises the 3.25% minimum requirement, a G-SII
additional leverage ratio buffer (G-SII ALRB) of 0.53% and a countercyclical leverage ratio buffer of 0.0%. Although the
leverage ratio is expressed in terms of Tier 1 (T1) capital, 75% of the minimum requirement, equating to 2.4375%, needs to
be met with CET1 capital. In addition, the G-SII ALRB must be covered solely with CET1 capital. The CET1 capital held
against the 0.53% G-SII ALRB was £6.0bn.
The Group is also required to disclose an average UK leverage ratio which is based on capital on the last day of each month
in the quarter and an exposure measure for each day in the quarter.
MREL
The Group is required to meet the higher of: (i) two times the sum of 8% Pillar 1 and 4.2% Pillar 2A; and (ii) 6.75% of
leverage exposures plus capital buffers, including the above mentioned confidential institution-specific PRA buffer. CET1
capital cannot be counted towards both MREL and the capital buffers, meaning that the buffers will effectively be applied
above MREL requirements.
Significant regulatory updates in the period
Capital and RWAs
On 1 January 2022 the PRA’s implementation of Basel III standards took effect including the re-introduction of the 100%
CET1 capital deduction for qualifying software intangible assets and the introduction of the Standardised Approach for
Counterparty Credit Risk (SA-CCR) which replaces the Current Exposure Method (CEM) for Standardised derivative
exposures as a more risk sensitive approach. In addition, the PRA also implemented IRB roadmap changes which includes
revisions to the criteria for definition of default, probability of default (PD) and loss given default (LGD) estimation to ensure
supervisory consistency and increase transparency of IRB models.
Leverage
From 1 January 2022, UK banks became subject to a single UK leverage ratio requirement meaning that the CRR leverage
ratio no longer applies. Central bank claims can be excluded from the UK leverage ratio measure as long as they are
matched by qualifying liabilities (rather than deposits).
References to CRR, as amended by CRR II mean, unless otherwise specified, CRR as amended by CRR II, as it forms part of
UK law pursuant to the European Union (Withdrawal) Act 2018. On 31 March 2022, the temporary transitional powers
(TTP) available to UK regulators to delay or phase in on-shoring of European Union legislation into UK law ended with full
compliance of the on-shored regulations required from 1 April 2022.
Treasury and Capital Risk
Barclays PLC 55

-- 57 of 109 --

Impact of Over-issuance of Securities
Basis of preparation
In March 2022, the Group became aware that Barclays Bank PLC had issued securities in excess of the amount it had
registered with the SEC under Barclays Bank PLC’s 2019 F-3 and subsequently became aware that securities had also been
issued in excess of the amount it had registered with the SEC under the Predecessor Shelf. The securities issued in excess of
the registered amount comprised structured products and exchange traded notes. As these securities were not issued in
compliance with the Securities Act, a right of rescission has arisen for certain purchasers of the securities. A proportion of
these costs associated with the right of rescission are attributable to the financial statements for the year ended 31
December 2021, resulting in the restatement of the 2021 figures in the disclosures below.
Prior to the restatement, litigation and conduct charges in the income statement in relation to 2021 were under reported by
£220m (pre-tax). This resulted in a CET1 capital decrease of £170m from £47,497m to £47,327m. Both the transitional and
fully loaded CET1 ratios remained unchanged at 15.1% and 14.7% respectively. The T1 ratio moved from 19.2% to 19.1%
and the total capital ratio moved from 22.3% to 22.2%.
The leverage exposure increased £1.9bn to recognise on a regulatory basis, the potential commitment relating to the
rescission offer (see 'Other matters' on page 6). This resulted in the UK leverage ratio moving from 5.3% to 5.2% whilst the
average UK leverage ratio remained unchanged at 4.9%.
Total own funds and eligible liabilities decreased £0.2bn to £108bn, which was in excess of a restated requirement to hold
£94bn of own funds and eligible liabilities.
Treasury and Capital Risk
Barclays PLC 56

-- 58 of 109 --

Restated1
Capital ratios2,3,4 As at
30.06.22
As at
31.03.22
As at
31.12.21
CET1 13.6% 13.8% 15.1%
T1 17.1% 17.1% 19.1%
Total regulatory capital 19.9% 20.1% 22.2%
Capital resources £m £m £m
Total equity excluding non-controlling interests per the balance sheet 69,627 68,465 69,052
Less: other equity instruments (recognised as AT1 capital) (12,357) (11,119) (12,259)
Adjustment to retained earnings for foreseeable ordinary share dividends (595) (968) (666)
Adjustment to retained earnings for foreseeable repurchase of shares (568) (1,000) —
Adjustment to retained earnings for foreseeable other equity coupons (32) (39) (32)
Other regulatory adjustments and deductions
Additional value adjustments (PVA) (1,810) (1,864) (1,585)
Goodwill and intangible assets (8,232) (8,035) (6,804)
Deferred tax assets that rely on future profitability excluding temporary differences (1,010) (938) (1,028)
Fair value reserves related to gains or losses on cash flow hedges 4,673 3,343 852
Gains or losses on liabilities at fair value resulting from own credit (62) 4 892
Defined benefit pension fund assets (3,785) (3,225) (2,619)
Direct and indirect holdings by an institution of own CET1 instruments (20) (20) (50)
Adjustment under IFRS 9 transitional arrangements 642 601 1,229
Other regulatory adjustments 220 64 345
CET1 capital 46,691 45,269 47,327
AT1 capital
Capital instruments and related share premium accounts 12,357 11,119 12,259
Qualifying AT1 capital (including minority interests) issued by subsidiaries — — 637
Other regulatory adjustments and deductions (60) (60) (80)
AT1 capital 12,297 11,059 12,816
T1 capital 58,988 56,328 60,143
T2 capital
Capital instruments and related share premium accounts 8,442 8,334 8,713
Qualifying T2 capital (including minority interests) issued by subsidiaries 1,277 1,540 1,113
Credit risk adjustments (excess of impairment over expected losses) 73 98 73
Other regulatory adjustments and deductions (160) (160) (160)
Total regulatory capital 68,620 66,140 69,882
Total RWAs 344,516 328,830 314,136
1 Capital metrics as at 31 December 2021 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 56 for
more information. The transitional CET1 ratio remains unchanged at 15.1%.
2 CET1, T1 and T2 capital, and RWAs are calculated applying the transitional arrangements of the CRR as amended by CRR II. This includes IFRS 9
transitional arrangements and the grandfathering of CRR II non-compliant capital instruments. December 2021 comparatives include the grandfathering of
CRR non-compliant capital instruments.
3 The fully loaded CET1 ratio, as is relevant for assessing against the conversion trigger in Barclays PLC AT1 securities, was 13.4%, with £46.0bn of CET1
capital and £344.3bn of RWAs calculated without applying the transitional arrangements of the CRR as amended by CRR II.
4 The Group’s CET1 ratio, as is relevant for assessing against the conversion trigger in Barclays Bank PLC 7.625% Contingent Capital Notes, was 13.6%. For
this calculation CET1 capital and RWAs are calculated applying the transitional arrangements under the CRR as amended by CRR II, including the IFRS 9
transitional arrangements. The benefit of the Financial Services Authority (FSA) October 2012 interpretation of the transitional provisions, relating to the
implementation of CRD IV, expired in December 2017.
Treasury and Capital Risk
Barclays PLC 57

-- 59 of 109 --

Movement in CET1 capital
Three months
ended
30.06.22
Six months
ended
30.06.22
£m £m
Opening CET1 capital1 45,269 47,327
Profit for the period attributable to equity holders 1,270 2,889
Own credit relating to derivative liabilities (76) (97)
Ordinary share dividends paid and foreseen (291) (593)
Purchased and foreseeable share repurchase — (1,000)
Other equity coupons paid and foreseen (192) (414)
Increase in retained regulatory capital generated from earnings 711 785
Net impact of share schemes 132 (136)
Fair value through other comprehensive income reserve (550) (759)
Currency translation reserve 1,333 1,703
Other reserves 11 35
Increase in other qualifying reserves 926 843
Pension remeasurements within reserves 423 1,090
Defined benefit pension fund asset deduction (560) (1,166)
Net impact of pensions (137) (76)
Additional value adjustments (PVA) 54 (225)
Goodwill and intangible assets (197) (1,428)
Deferred tax assets that rely on future profitability excluding those arising from temporary differences (72) 18
Direct and indirect holdings by an institution of own CET1 instruments — 30
Adjustment under IFRS 9 transitional arrangements 41 (587)
Other regulatory adjustments 96 4
Decrease in regulatory capital due to adjustments and deductions (78) (2,188)
Closing CET1 capital 46,691 46,691
1 Opening balance as at 31 December 2021 has been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 56
for further details.
CET1 capital decreased £0.6bn to £46.7bn (December 2021: £47.3bn).
CET1 capital decreased by £1.7bn as a result of regulatory changes that took effect from 1 January 2022 including the re-
introduction of the 100% CET1 capital deduction for qualifying software intangible assets and a reduction in IFRS9
transitional relief due to the relief applied to the pre-2020 impairment charge reducing to 25% in 2022 from 50% in 2021
and the relief applied to the post-2020 impairment charge reducing to 75% in 2022 from 100% in 2021.
£2.9bn of capital generated from profits, after absorbing the £0.6bn net of tax impact of the Over-issuance of Securities,
was partially offset by distributions of £2bn comprising:
• £1bn for share buybacks announced with FY21 results
• £0.6bn accrual towards a FY22 dividend
• £0.4bn of equity coupons paid
Other significant movements in the period were:
• £0.8bn decrease in the fair value through other comprehensive income reserve primarily due to losses on bonds as a
result of an increase in yields
• £1.7bn increase in the currency translation reserves driven by the appreciation of period end USD against GBP
Treasury and Capital Risk
Barclays PLC 58

-- 60 of 109 --

RWAs by risk type and business
Credit risk Counterparty credit risk Market Risk
Operational
risk
Total
RWAs
STD IRB STD IRB
Settlement
Risk CVA STD IMA
As at 30.06.22 £m £m £m £m £m £m £m £m £m £m
Barclays UK 6,613 53,958 253 — — 76 236 — 11,047 72,183
Corporate and Investment Bank 40,055 71,737 18,739 22,099 440 3,357 17,466 28,423 25,296 227,612
Consumer, Cards and Payments 25,516 3,643 256 34 — 64 28 195 6,424 36,160
Barclays International 65,571 75,380 18,995 22,133 440 3,421 17,494 28,618 31,720 263,772
Head Office 3,488 6,069 — — — — — — (996) 8,561
Barclays Group 75,672 135,407 19,248 22,133 440 3,497 17,730 28,618 41,771 344,516
As at 31.03.22
Barclays UK 6,989 54,241 229 — — 57 155 — 11,047 72,718
Corporate and Investment Bank 35,325 70,831 16,422 21,047 268 3,675 17,068 23,551 25,296 213,483
Consumer, Cards and Payments 21,289 3,459 242 12 — 37 110 34 6,424 31,607
Barclays International 56,614 74,290 16,664 21,059 268 3,712 17,178 23,585 31,720 245,090
Head Office 5,532 6,486 — — — — — — (996) 11,022
Barclays Group 69,135 135,017 16,893 21,059 268 3,769 17,333 23,585 41,771 328,830
As at 31.12.21
Barclays UK 7,195 53,408 426 — — 138 100 — 11,022 72,289
Corporate and Investment Bank 29,420 64,416 15,223 19,238 105 2,289 17,306 27,308 25,359 200,664
Consumer, Cards and Payments 20,770 2,749 215 18 — 21 — 57 6,391 30,221
Barclays International 50,190 67,165 15,438 19,256 105 2,310 17,306 27,365 31,750 230,885
Head Office 4,733 7,254 — — — — — — (1,025) 10,962
Barclays Group 62,118 127,827 15,864 19,256 105 2,448 17,406 27,365 41,747 314,136
Movement analysis of RWAs Credit risk Counterparty
credit risk Market risk Operational
risk Total RWAs
£m £m £m £m £m
Opening RWAs (as at 31.12.21) 189,945 37,673 44,771 41,747 314,136
Book size 12,781 1,611 60 24 14,476
Acquisitions and disposals (209) — — — (209)
Book quality (3,101) 117 — — (2,984)
Model updates — — — — —
Methodology and policy 3,458 3,352 — — 6,810
Foreign exchange movements1 8,205 2,565 1,517 — 12,287
Total RWA movements 21,134 7,645 1,577 24 30,380
Closing RWAs (as at 30.06.22) 211,079 45,318 46,348 41,771 344,516
1 Foreign exchange movements does not include foreign exchange for modelled market risk or operational risk.
Overall RWAs increased £30.4bn to £344.5bn (December 2021: £314.1bn)
Credit risk RWAs increased £21.1bn:
• A £12.8bn increase in book size primarily driven by a £7.8bn increase in lending activities mainly within CIB and a £4.5bn
temporary increase in RWAs reflecting the hedging arrangements designed to manage the risk of the rescission offer
relating to the Over-issuance of Securities, which are expected to reverse after the rescission offer has been completed in
Q322
• A £0.2bn decrease in acquisitions and disposals primarily driven by partial disposal of Barclays' equity stake in Absa in
April 2022, offset by GAP portfolio acquisition
• A £3.1bn decrease in book quality primarily driven by the benefit in mortgages from an increase in the House Price Index
(HPI)
• A £3.5bn increase in methodology and policy as a result of regulatory changes that took effect from 1 January 2022,
relating to implementation of IRB roadmap changes partially offset by the reversal of the software intangibles benefit
• A £8.2bn increase in FX primarily due to appreciation of period end USD against GBP
Treasury and Capital Risk
Barclays PLC 59

-- 61 of 109 --

Counterparty Credit risk RWAs increased £7.6bn:
• A £1.6bn increase in book size primarily due to an increase in trading activities within SFTs and derivatives
• A £3.4bn increase in methodology and policy as a result of regulatory changes that took effect from 1 January 2022,
relating to the introduction of SA-CCR
• A £2.6bn increase in FX primarily due to appreciation of period end USD against GBP
Market risk RWAs increased £1.6bn:
• A £0.1bn increase in book size primarily driven by a £8.4bn increase due to client and trading activities, offset by a
£6.9bn decrease in Stressed Value at Risk (SVaR) model adjustment as a result of changes in portfolio composition and a
£1.4bn reduction in Structural FX
• A £1.5bn increase in FX primarily due to appreciation of period end USD against GBP
Treasury and Capital Risk
Barclays PLC 60

-- 62 of 109 --

Restated1
Leverage ratios2,3
As at
30.06.22
As at
31.03.22
As at
31.12.21
£m £m £m
Average UK leverage ratio 4.7% 4.8% 4.9%
Average T1 capital 57,689 56,701 59,739
Average UK leverage exposure 1,233,537 1,179,381 1,229,041
UK leverage ratio 5.1% 5.0% 5.2%
CET1 capital 46,691 45,269 47,327
AT1 capital 12,297 11,059 12,179
T1 capital 58,988 56,328 59,506
UK leverage exposure 1,151,214 1,123,531 1,137,904
UK leverage exposure
Accounting assets
Derivative financial instruments 344,855 289,822 262,572
Derivative cash collateral 66,909 64,836 58,177
Securities financing transactions (SFTs) 193,682 186,417 170,853
Loans and advances and other assets 983,784 955,020 892,683
Total IFRS assets 1,589,230 1,496,095 1,384,285
Regulatory consolidation adjustments (3,546) (3,605) (3,665)
Derivatives adjustments
Derivatives netting (288,727) (235,071) (236,881)
Adjustments to collateral (53,328) (52,181) (50,929)
Net written credit protection 28,102 19,729 15,509
Potential future exposure (PFE) on derivatives 85,469 85,619 137,291
Total derivatives adjustments (228,484) (181,904) (135,010)
SFTs adjustments 29,784 29,095 24,544
Regulatory deductions and other adjustments (22,758) (22,332) (20,219)
Weighted off-balance sheet commitments 127,400 119,933 115,047
Qualifying central bank claims (294,477) (260,196) (210,134)
Settlement netting (45,935) (53,555) (16,944)
UK leverage exposure 1,151,214 1,123,531 1,137,904
1 Capital and leverage metrics as at 31 December 2021 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation
on page 56 for further details.
2 Capital and leverage measures are calculated applying the transitional arrangements of the CRR as amended by CRR II.
3 Fully loaded average UK leverage ratio was 4.6%, with £57.0bn of T1 capital and £1,232.9bn of leverage exposure. Fully loaded UK leverage ratio was 5.1%,
with £58.3bn of T1 capital and £1,150.6bn of leverage exposure. Fully loaded UK leverage ratios are calculated without applying the transitional
arrangements of the CRR as amended by CRR II.
The UK leverage ratio decreased to 5.1% (December 2021: 5.2%) primarily due to a £13.3bn increase in the leverage
exposure. The UK leverage exposure increased to £1,151.2bn (December 2021: £1,137.9bn), due to the following significant
movements:
• £36.8bn increase in derivative financial instruments post additional regulatory netting and adjustments for cash
collateral primarily driven by client and trading activity in CIB and the application of a 1.4 multiplier introduced under SA-
CCR
• £34.4bn increase in loans and advances at amortised cost primarily driven by increased lending
• £28.1bn increase in SFTs primarily driven by client activity in CIB
• £12.6bn increase in net written credit protection primarily driven by the inclusion of credit default swap options from 1
January 2022
Treasury and Capital Risk
Barclays PLC 61

-- 63 of 109 --

• £51.8bn decrease in PFE on derivatives primarily driven by increased netting eligibility due to the introduction of SA-CCR
• £39.8bn decrease due to an £84.3bn increase in the qualifying central bank claims exemption primarily due to the
matching of allowable liabilities rather than deposits introduced under the UK leverage framework review, partially offset
by a £44.6bn increase in cash
• £20.0bn decrease in trading portfolio assets primarily due to decreases in Equities
The average UK Leverage Ratio decreased to 4.7% (December 2021: 4.9%) primarily due to a £2.1bn decrease in average T1
capital largely as a result of regulatory changes effective from 1 January 2022 and the redemption of AT1 instruments in
Q122.
Treasury and Capital Risk
Barclays PLC 62

-- 64 of 109 --

MREL
MREL requirements including buffers1,2,3,4 Total requirement (£m) based on Requirement as a percentage of:
Restated1 Restated1
As at
30.06.22
As at
31.03.22
As at
31.12.21
As at
30.06.22
As at
31.03.22
As at
31.12.21
Requirement based on RWAs (minimum requirement) 98,096 94,947 77,302 28.5% 28.9% 24.6%
Requirement based on UK leverage exposure3 91,532 89,025 93,975 8.0% 7.9% 6.9%
Restated1
Own funds and eligible liabilities1,3 As at
30.06.22
As at
31.03.22
As at
31.12.21
£m £m £m
CET1 capital 46,691 45,269 47,327
AT1 capital instruments and related share premium accounts5 12,297 11,059 12,179
T2 capital instruments and related share premium accounts5 8,355 8,272 8,626
Eligible liabilities 39,137 37,886 39,889
Total Barclays PLC (the Parent company) own funds and eligible liabilities 106,480 102,486 108,021
Total RWAs 344,516 328,830 314,136
Total UK leverage exposure4 1,151,214 1,123,531 1,356,191
Restated1
Own funds and eligible liabilities ratios as a
percentage of:1 As at
30.06.22
As at
31.03.22
As at
31.12.21
Total RWAs 30.9% 31.2% 34.4%
Total UK leverage exposure4 9.2% 9.1% 8.0%
As at 30 June 2022, Barclays PLC (the Parent company) held £106.5bn of own funds and eligible liabilities equating to
30.9% of RWAs. This was in excess of the Group's MREL requirement, excluding the PRA buffer, to hold £98.1bn of own
funds and eligible liabilities equating to 28.5% of RWAs. The Group remains above its MREL regulatory requirement
including the PRA buffer.
1 Capital and leverage metrics as at 31 December 2021 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation
on page 56 for further details.
2 Minimum requirement excludes the confidential institution-specific PRA buffer.
3 CET1, T1 and T2 capital, and RWAs are calculated applying IFRS 9 transitional arrangements.
4 As at 31 December 2021, MREL requirements were on a CRR leverage basis which, from 1 January 2022, was no longer applicable for UK banks.
5 Includes other AT1 capital regulatory adjustments and deductions of £60m (December 2021: £80m), and other T2 credit risk adjustments and deductions
of £87m (December 2021: £87m).
Treasury and Capital Risk
Barclays PLC 63

-- 65 of 109 --

The Directors (the names of whom are set out below) are required to prepare the financial statements on a going concern
basis unless it is not appropriate to do so. In making this assessment, the directors have considered information relating to
present and future conditions. Each of the Directors confirm that to the best of their knowledge, the condensed consolidated
interim financial statements set out on pages 67 to 72 have been prepared in accordance with International Accounting
Standard 34, ‘Interim Financial Reporting’, as adopted by the UK, and that the interim management report herein includes a
fair review of the information required by Disclosure Guidance and Transparency Rules 4.2.7R and 4.2.8R namely:
• an indication of important events that have occurred during the six months ended 30 June 2022 and their impact on
the condensed consolidated interim financial statements, and a description of the principal risks and uncertainties for
the remaining six months of the financial year
• any related party transactions in the six months ended 30 June 2022 that have materially affected the financial position
or performance of Barclays during that period and any changes in the related party transactions described in the last
Annual Report that could have a material effect on the financial position or performance of Barclays in the six months
ended 30 June 2022
Signed on 27 July 2022 on behalf of the Board by
C.S. Venkatakrishnan Anna Cross
Group Chief Executive Group Finance Director
Barclays PLC Board of Directors
Chairman Executive Directors Non-Executive Directors
Nigel Higgins C.S. Venkatakrishnan Mike Ashley
Anna Cross Robert Berry
Tim Breedon CBE
Mohamed A. El-Erian
Dawn Fitzpatrick
Mary Francis CBE
Crawford Gillies
Brian Gilvary
Diane Schueneman
Julia Wilson
Statement of Directors' Responsibilities
Barclays PLC 64

-- 66 of 109 --

Conclusion
We have been engaged by Barclays PLC ("the company" or "the group") to review the condensed set of financial statements
in the Interim Results Announcement for the six months ended 30 June 2022 which comprises:
• the condensed consolidated income statement and condensed consolidated statement of comprehensive income for the
period then ended;
• the condensed consolidated balance sheet as at 30 June 2022;
• the condensed consolidated statement of changes in equity for the period then ended;
• the condensed consolidated cash flow statement for the period then ended; and
• the related explanatory notes.
Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial
statements in the Interim Results Announcement for the six months ended 30 June 2022 is not prepared, in all material
respects, in accordance with IAS 34 Interim Financial Reporting as adopted for use in the UK and the Disclosure Guidance
and Transparency Rules (“the DTR”) of the UK’s Financial Conduct Authority (“the UK FCA”).
Basis for conclusion
We conducted our review in accordance with International Standard on Review Engagements (UK) 2410 Review of Interim
Financial Information Performed by the Independent Auditor of the Entity (“ISRE (UK) 2410”) issued for use in the UK. A
review of interim financial information consists of making enquiries, primarily of persons responsible for financial and
accounting matters, and applying analytical and other review procedures. We read the other information contained in the
Interim Results Announcement and consider whether it contains any apparent misstatements or material inconsistencies
with the information in the condensed set of financial statements.
A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK)
and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might
be identified in an audit. Accordingly, we do not express an audit opinion.
Conclusions relating to going concern
Based on our review procedures, which are less extensive than those performed in an audit as described in the Basis for
conclusion section of this report, nothing has come to our attention that causes us to believe that the directors have
inappropriately adopted the going concern basis of accounting, or that the directors have identified material uncertainties
relating to going concern that have not been appropriately disclosed.
This conclusion is based on the review procedures performed in accordance with ISRE (UK) 2410. However, future events or
conditions may cause the group to cease to continue as a going concern, and the above conclusions are not a guarantee
that the group will continue in operation.
Directors’ responsibilities
The Interim Results Announcement is the responsibility of, and has been approved by, the directors. The directors are
responsible for preparing the half-yearly financial report in accordance with the DTR of the UK FCA.
As disclosed in note 1, the Basis of preparation, the annual financial statements of the Barclays Group are prepared in
accordance with UK-adopted international accounting standards.
The directors are responsible for preparing the condensed set of financial statements included in the Interim Results
Announcement in accordance with IAS 34 as adopted for use in the UK.
In preparing the condensed set of financial statements, the directors are responsible for assessing the group’s ability to
continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of
accounting unless the directors either intend to liquidate the group or to cease operations, or have no realistic alternative but
to do so.
Our responsibility
Our responsibility is to express to the company a conclusion on the condensed set of financial statements in the Interim
Results Announcement based on our review. Our conclusion, including our conclusions relating to going concern, are based
on procedures that are less extensive than audit procedures, as described in the Basis for conclusion section of this report.
Independent Review Report to Barclays PLC
Barclays PLC 65

-- 67 of 109 --

The purpose of our review work and to whom we owe our responsibilities
This report is made solely to the company in accordance with the terms of our engagement to assist the company in
meeting the requirements of the DTR of the UK FCA. Our review has been undertaken so that we might state to the
company those matters we are required to state to it in this report and for no other purpose. To the fullest extent permitted
by law, we do not accept or assume responsibility to anyone other than the company for our review work, for this report, or
for the conclusions we have reached.
Stuart Crisp
for and on behalf of KPMG LLP
Chartered Accountants
15 Canada Square
London, E14 5GL
27 July 2022
Independent Review Report to Barclays PLC
Barclays PLC 66

-- 68 of 109 --

Condensed consolidated income statement (unaudited)
Restated2
Notes1
Half year
ended
30.06.22
Half year
ended
30.06.21
£m £m
Interest and similar income 7,134 5,279
Interest and similar expense (2,371) (1,376)
Net interest income 4,763 3,903
Fee and commission income 3 4,726 4,682
Fee and commission expense 3 (1,302) (976)
Net fee and commission income 3 3,424 3,706
Net trading income 5,013 3,482
Net investment income (116) 152
Other income 120 72
Total income 13,204 11,315
Credit impairment (charges)/releases (341) 742
Net operating income 12,863 12,057
Staff costs 4 (4,583) (4,334)
Infrastructure, administration and general expenses 5 (2,687) (2,798)
Litigation and conduct 15 (1,857) (176)
Operating expenses (9,127) (7,308)
Share of post-tax results of associates and joint ventures (3) 154
Profit on disposal of subsidiaries, associates and joint ventures — (1)
Profit before tax 3,733 4,902
Tax charge 6 (823) (742)
Profit after tax 2,910 4,160
Attributable to:
Equity holders of the parent 2,475 3,752
Other equity instrument holders 414 389
Total equity holders of the parent 2,889 4,141
Non-controlling interests 7 21 19
Profit after tax 2,910 4,160
Earnings per share p p
Basic earnings per ordinary share 8 14.8 21.9
Diluted earnings per ordinary share 8 14.5 21.3
1 For Notes to the Financial Statements see pages 73 to 100.
2 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page
73 for more information.
Condensed Consolidated Financial Statements
Barclays PLC 67

-- 69 of 109 --

Condensed consolidated statement of comprehensive income (unaudited)
Restated2
Half year
ended
30.06.22
Half year
ended
30.06.21
Notes1 £m £m
Profit after tax 2,910 4,160
Other comprehensive income/(loss) that may be recycled to profit or loss:3
Currency translation reserve 19 1,703 (495)
Fair value through other comprehensive income reserve 19 (913) (365)
Cash flow hedging reserve 19 (3,818) (911)
Other comprehensive loss that may be recycled to profit (3,028) (1,771)
Other comprehensive income/(loss) not recycled to profit or loss:3
Retirement benefit remeasurements 16 1,090 103
Fair value through other comprehensive income reserve 19 154 115
Own credit 19 855 (47)
Other comprehensive income not recycled to profit 2,099 171
Other comprehensive loss for the period (929) (1,600)
Total comprehensive income for the period 1,981 2,560
Attributable to:
Equity holders of the parent 1,960 2,541
Non-controlling interests 21 19
Total comprehensive income for the period 1,981 2,560
1 For Notes to the Financial Statements see pages 73 to 100.
2 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page
73 for more information.
3 Reported net of tax.
Condensed Consolidated Financial Statements
Barclays PLC 68

-- 70 of 109 --

Condensed consolidated balance sheet (unaudited)
Restated2
As at
30.06.22
As at
31.12.21
Assets Notes1 £m £m
Cash and balances at central banks 283,136 238,574
Cash collateral and settlement balances 132,623 92,542
Loans and advances at amortised cost 12 395,824 361,451
Reverse repurchase agreements and other similar secured lending 1,639 3,227
Trading portfolio assets 127,004 147,035
Financial assets at fair value through the income statement 212,723 191,972
Derivative financial instruments 10 344,855 262,572
Financial assets at fair value through other comprehensive income 63,194 61,753
Investments in associates and joint ventures 911 999
Goodwill and intangible assets 13 8,245 8,061
Property, plant and equipment 3,582 3,555
Current tax assets 551 261
Deferred tax assets 6 5,044 4,619
Retirement benefit assets 16 5,233 3,879
Other assets 4,666 3,785
Total assets 1,589,230 1,384,285
Liabilities
Deposits at amortised cost 12 568,670 519,433
Cash collateral and settlement balances 124,724 79,371
Repurchase agreements and other similar secured borrowing 28,566 28,352
Debt securities in issue 115,906 98,867
Subordinated Liabilities 14 11,871 12,759
Trading portfolio liabilities 76,638 54,169
Financial liabilities designated at fair value 255,136 250,960
Derivative financial instruments 10 321,396 256,883
Current tax liabilities 449 689
Deferred tax liabilities 6 5 37
Retirement benefit liabilities 16 309 311
Other liabilities 11,538 10,505
Provisions 15 3,426 1,908
Total liabilities 1,518,634 1,314,244
Equity
Called up share capital and share premium 17 4,508 4,536
Other reserves 19 (218) 1,770
Retained earnings 52,980 50,487
Shareholders' equity attributable to ordinary shareholders of the parent 57,270 56,793
Other equity instruments 18 12,357 12,259
Total equity excluding non-controlling interests 69,627 69,052
Non-controlling interests 7 969 989
Total equity 70,596 70,041
Total liabilities and equity 1,589,230 1,384,285
1 For Notes to the Financial Statements see pages 73 to 100.
2 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page
73 for more information.
Condensed Consolidated Financial Statements
Barclays PLC 69

-- 71 of 109 --

Condensed consolidated statement of changes in equity (unaudited)
Restated1 Restated1 Restated1
Called up
share capital
and share
premium2
Other equity
instruments2
Other
reserves2
Retained
earnings Total
Non-
controlling
interests3
Total
equity
Half year ended 30.06.22 £m £m £m £m £m £m £m
Balance as at 1 January 2022 4,536 12,259 1,770 50,487 69,052 989 70,041
Profit after tax — 414 — 2,475 2,889 21 2,910
Currency translation movements — — 1,703 — 1,703 — 1,703
Fair value through other
comprehensive income reserve — — (759) — (759) — (759)
Cash flow hedges — — (3,818) — (3,818) — (3,818)
Retirement benefit remeasurements — — — 1,090 1,090 — 1,090
Own credit — — 855 — 855 — 855
Total comprehensive income for the
period — 414 (2,019) 3,565 1,960 21 1,981
Employee share schemes and
hedging thereof 33 — — 417 450 — 450
Issue and redemption of other equity
instruments — 115 — 25 140 (20) 120
Other equity instruments coupon paid — (414) — — (414) — (414)
Partial disposal of ABSA holding — — (39) 39 — — —
Vesting of employee share schemes — — 7 (464) (457) — (457)
Dividends paid — — — (664) (664) (21) (685)
Repurchase of shares (61) — 61 (432) (432) — (432)
Other movements — (17) 2 7 (8) — (8)
Balance as at 30 June 2022 4,508 12,357 (218) 52,980 69,627 969 70,596
Half year ended 31.12.2021
Balance as at 1 July 2021 4,568 11,167 2,856 48,401 66,992 1,064 68,056
Profit after tax — 415 — 2,453 2,868 28 2,896
Currency translation movements — — 364 — 364 — 364
Fair value through other
comprehensive income reserve — — (38) — (38) — (38)
Cash flow hedges — — (1,517) — (1,517) — (1,517)
Retirement benefit remeasurements — — — 540 540 — 540
Own credit — — 33 — 33 — 33
Total comprehensive income for the
period — 415 (1,158) 2,993 2,250 28 2,278
Employee share schemes and
hedging thereof 35 — — (54) (19) — (19)
Issue and redemption of other equity
instruments — 1,078 — 6 1,084 (75) 1,009
Other equity instruments coupon paid — (415) — — (415) — (415)
Vesting of employee share schemes — — (3) (13) (16) — (16)
Dividends paid — — — (339) (339) (28) (367)
Repurchase of shares (67) — 67 (500) (500) — (500)
Other movements — 14 8 (7) 15 — 15
Balance as at 31 December 2021 4,536 12,259 1,770 50,487 69,052 989 70,041
1 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page
73 for more information.
2 Details of share capital, other equity instruments and other reserves are shown on pages 89 to 90.
3 Details of non-controlling interests are shown on page 78.
Condensed Consolidated Financial Statements
Barclays PLC 70

-- 72 of 109 --

Condensed consolidated statement of changes in equity (unaudited)
Restated1 Restated1 Restated1
Called up
share capital
and share
premium2
Other equity
instruments2
Other
reserves2
Retained
earnings Total
Non-
controlling
interests3
Total
equity
Half year ended 30.06.2021 £m £m £m £m £m £m £m
Balance as at 1 January 2021 4,637 11,172 4,461 45,527 65,797 1,085 66,882
Profit after tax — 389 — 3,752 4,141 19 4,160
Currency translation movements — — (495) — (495) — (495)
Fair value through other
comprehensive income reserve — — (250) — (250) — (250)
Cash flow hedges — — (911) — (911) — (911)
Retirement benefit remeasurements — — — 103 103 — 103
Own credit — — (47) — (47) — (47)
Total comprehensive income for the
period — 389 (1,703) 3,855 2,541 19 2,560
Employee share schemes and
hedging thereof 25 — — 289 314 — 314
Other equity instruments coupon paid — (389) — — (389) — (389)
Vesting of employee share schemes — — 4 (397) (393) — (393)
Dividends paid — — — (173) (173) (16) (189)
Repurchase of shares (94) — 94 (700) (700) — (700)
Other movements — (5) — — (5) (24) (29)
Balance as at 30 June 2021 4,568 11,167 2,856 48,401 66,992 1,064 68,056
1 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page
73 for more information.
2 Details of share capital, other equity instruments and other reserves are shown on pages 89 to 90.
3 Details of non-controlling interests are shown on page 78.
Condensed Consolidated Financial Statements
Barclays PLC 71

-- 73 of 109 --

Condensed consolidated cash flow statement (unaudited)
Restated1
Half year
ended
30.06.22
Half year
ended
30.06.21
£m £m
Profit before tax 3,733 4,902
Adjustment for non-cash items (7,115) 6,977
Net (increase)/decrease in loans and advances at amortised cost (17,667) 432
Net increase in deposits at amortised cost 49,237 19,859
Net increase in debt securities in issue 19,748 13,041
Changes in other operating assets and liabilities 14,719 (5,559)
Corporate income tax paid (401) (712)
Net cash from operating activities 62,254 38,940
Net cash from investing activities (14,939) (3,389)
Net cash from financing activities (5,500) (2,562)
Effect of exchange rates on cash and cash equivalents 7,047 (5,535)
Net increase in cash and cash equivalents 48,862 27,454
Cash and cash equivalents at beginning of the period 259,206 210,142
Cash and cash equivalents at end of the period 308,068 237,596
1 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page
73 for more information.
Condensed Consolidated Financial Statements
Barclays PLC 72

-- 74 of 109 --

1. Basis of preparation
These condensed consolidated interim financial statements ("the financial statements") for the six months ended 30 June
2022 have been prepared in accordance with the Disclosure Guidance and Transparency Rules (DTR) of the UK’s Financial
Conduct Authority (FCA) and IAS 34, Interim Financial Reporting, as published by the International Accounting Standards
Board (IASB) and adopted by the UK.
The condensed consolidated interim financial statements should be read in conjunction with the annual financial statements
for the year ended 31 December 2021. The annual financial statements for the year ended 31 December 2021 were prepared
in accordance with international accounting standards in conformity with the requirements of the Companies Act 2006 and
in accordance with International Financial Reporting Standards (IFRS) and interpretations (IFRICs) as issued by the IASB and
adopted by the UK.
The accounting policies and methods of computation used in these condensed consolidated interim financial statements are
the same as those used in the Barclays PLC Annual Report 2021.
1. Going concern
The financial statements are prepared on a going concern basis, as the Directors are satisfied that the Group and parent
company have the resources to continue in business for a period of at least 12 months from approval of the interim financial
statements. In making this assessment, the Directors have considered a wide range of information relating to present and
future conditions and includes a review of a working capital report (WCR). The WCR is used by the Directors to assess the
future performance of the business and that it has the resources in place that are required to meet its ongoing regulatory
requirements. The WCR also includes an assessment of the impact of internally generated stress testing scenarios on the
liquidity and capital requirement forecasts. The stress tests used were based upon an assessment of reasonably possible
downside economic scenarios that the Group could experience.
The WCR indicated that the Group had sufficient capital in place to support its future business requirements and remained
above its regulatory minimum requirements in the internal stress scenarios.
2. Other disclosures
The Credit risk disclosures on pages 27 to 48 form part of these interim financial statements.
Restatement of financial statements
The comparatives in these condensed consolidated interim financial statements for the six months ended 30 June 2022 (the
financial statements) have been restated to reflect both a provision and contingent liability disclosure in respect of the
impact of an over-issuance of securities (the Over-issuance of Securities) in excess of the maximum aggregate offering price
registered under Barclays Bank PLC’s shelf registration statement on Form F-3, as declared effective by the SEC in August
2019 (2019 F-3) and Barclays Bank PLC’s predecessor shelf registration statement on Form F-3 filed in 2018 (Predecessor
Shelf).
Due to a historic SEC settlement order, at the time the 2019 F-3 was filed and the Predecessor Shelf was amended, Barclays
Bank PLC had ceased to be a “well-known seasoned issuer” (or WKSI) and had become an “ineligible issuer”, as defined in
Rule 405 under the Securities Act of 1933, as amended (Securities Act), thus being required to register upfront a certain
amount of securities with the SEC.
In March 2022, Barclays Bank PLC became aware that it had issued securities in the US materially in excess of the amount it
had registered with the SEC under the 2019 F-3 and subsequently became aware that securities had also been issued in
excess of the amount it had registered with the SEC under the Predecessor Shelf. The securities that were issued in this
period comprise structured notes and exchange traded notes (ETNs). As such, certain offers and sales of these securities
were not made in compliance with the Securities Act, giving rise to rights of rescission for certain purchasers of the
securities. Under Section 12(a)(1) of the Securities Act, certain purchasers of unregistered securities have a right to recover,
upon the tender of such security, the consideration paid for such security with interest, less the amount of any income
received, or damages if the purchaser no longer owns the security (the Rescission Price). As a result, Barclays Bank PLC has
elected to make a rescission offer to eligible purchasers of the relevant affected securities at the Rescission Price (the
Rescission Offer).
A proportion of the expected costs associated with the rights of rescission of certain investors are attributable to Barclays
PLC’s financial statements for the year ended 31 December 2021. Accordingly, the comparatives in these financial
statements have been restated. The restatement impacts the consolidated income statement, the consolidated statement of
Financial Statement Notes
Barclays PLC 73

-- 75 of 109 --

comprehensive income, the consolidated balance sheet, the consolidated statement of changes in equity, and the
consolidated cash flow statement for the year ended 31 December 2021, as well as quarterly and half yearly financial
information that is presented within this document. There was no material effect on Barclays PLC’s previously reported
financial statements for the year ended 31 December 2020 and 2019.
The table below reflects each of the consolidated financial statement line items that were affected by the restatement:
Impact on the consolidated income statement As reported Restatement As restated
Half year ended 30.06.21 £m £m £m
Litigation and conduct (99) (77) (176)
Operating expenses (7,231) (77) (7,308)
Profit before tax 4,979 (77) 4,902
Taxation (759) 17 (742)
Profit after tax 4,220 (60) 4,160
Year ended 31.12.21 £m £m £m
Litigation and conduct (177) (220) (397)
Operating expenses (14,439) (220) (14,659)
Profit before tax 8,414 (220) 8,194
Taxation (1,188) 50 (1,138)
Profit after tax 7,226 (170) 7,056
Impact on the consolidated statement of comprehensive income
Half year ended 30.06.21 £m £m £m
Profit after tax 4,220 (60) 4,160
Total comprehensive income for the period 2,620 (60) 2,560
Year ended 31.12.21 £m £m £m
Profit after tax 7,226 (170) 7,056
Total comprehensive income for the period 5,008 (170) 4,838
Impact on the cash flow statement
Half year ended 30.06.21 £m £m £m
Profit before tax 4,979 (77) 4,902
Adjustment for non-cash items 6,900 77 6,977
Impact on the consolidated balance sheet
As at 31.12.21 £m £m £m
Current tax liabilities 739 (50) 689
Provisions 1,688 220 1,908
Total liabilities 1,314,074 170 1,314,244
Retained earnings 50,657 (170) 50,487
Total equity 70,211 (170) 70,041
Financial Statement Notes
Barclays PLC 74

-- 76 of 109 --

2. Segmental reporting
Analysis of results by business
Barclays
UK
Barclays
International
Head
Office
Barclays
Group
Half year ended 30.06.22 £m £m £m £m
Total income 3,373 9,940 (109) 13,204
Credit impairment (charges)/releases (48) (310) 17 (341)
Net operating income/(expenses) 3,325 9,630 (92) 12,863
Operating costs (2,083) (5,042) (145) (7,270)
Litigation and conduct (25) (1,832) — (1,857)
Total operating expenses (2,108) (6,874) (145) (9,127)
Other net income/(expenses)1 — 13 (16) (3)
Profit/(loss) before tax 1,217 2,769 (253) 3,733
As at 30.06.22 £bn £bn £bn £bn
Total assets 318.8 1,250.6 19.8 1,589.2
Restated2 Restated2
Barclays
UK
Barclays
International
Head
Office
Barclays
Group
Half year ended 30.06.21 £m £m £m £m
Total income 3,199 8,218 (102) 11,315
Credit impairment releases 443 293 6 742
Net operating income/(expenses) 3,642 8,511 (96) 12,057
Operating costs (2,114) (4,606) (412) (7,132)
Litigation and conduct (22) (161) 7 (176)
Total operating expenses (2,136) (4,767) (405) (7,308)
Other net income1 — 22 131 153
Profit/(loss) before tax 1,506 3,766 (370) 4,902
As at 31.12.21 £bn £bn £bn £bn
Total assets 321.2 1,044.1 19.0 1,384.3
1 Other net income/(expenses) represents the share of post-tax results of associates and joint ventures, profit (or loss) on disposal of subsidiaries, associates
and joint ventures and gains on acquisitions.
2 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page
73 for more information.
Split of income by geographic region1
Half year
ended
30.06.22
Half year
ended
30.06.21
£m £m
United Kingdom 7,972 5,895
Europe 1,311 1,222
Americas 3,200 3,608
Africa and Middle East 31 20
Asia 690 570
Total 13,204 11,315
1 The geographical analysis is based on the location of the office where the transactions are recorded.
Financial Statement Notes
Barclays PLC 75

-- 77 of 109 --

3. Net fee and commission income
Fee and commission income is disaggregated below and includes a total for fees in scope of IFRS 15, Revenue from
Contracts with Customers:
Barclays UK
Barclays
International Head Office Total
Half year ended 30.06.22 £m £m £m £m
Fee type
Transactional1 515 1,448 — 1,963
Advisory 83 511 — 594
Brokerage and execution 125 762 — 887
Underwriting and syndication — 1,102 — 1,102
Other 29 80 2 111
Total revenue from contracts with customers 752 3,903 2 4,657
Other non-contract fee income — 69 — 69
Fee and commission income1 752 3,972 2 4,726
Fee and commission expense (147) (1,153) (2) (1,302)
Net fee and commission income 605 2,819 — 3,424
Barclays UK
Barclays
International Head Office Total
Half year ended 30.06.21 £m £m £m £m
Fee type
Transactional 408 1,181 — 1,589
Advisory 83 459 1 543
Brokerage and execution 109 553 — 662
Underwriting and syndication — 1,715 — 1,715
Other 35 73 3 111
Total revenue from contracts with customers 635 3,981 4 4,620
Other non-contract fee income — 62 — 62
Fee and commission income 635 4,043 4 4,682
Fee and commission expense1 (108) (861) (7) (976)
Net fee and commission income 527 3,182 (3) 3,706
1 Barclays has corrected the presentation of the scheme fees incurred when Barclays acts as an “acquirer” as part of the payment transaction cycle. From
2022 onwards, the scheme fees reported under "Barclays International" are presented within fees and commission income under "Transactional" fee type,
which had previously been recognised in fees and commission expense. The reclassification into Fee and Commission income is a reduction of £103m for
H122. The comparatives have not been restated as the effect is not considered material although the effect would have been a reduction of H121: £88m
with no impact on Net fee and commission income. There is no impact on Net assets or Cash flows reported.
Transactional fees are service charges on deposit accounts, cash management services and transactional processing fees.
These include interchange and merchant fee income generated from credit and bank card usage.
Advisory fees are generated from wealth management services and investment banking advisory services related to mergers,
acquisitions and financial restructurings.
Brokerage and execution fees are earned for executing client transactions with various exchanges and over-the-counter
markets and assisting clients in clearing transactions.
Underwriting and syndication fees are earned for the distribution of client equity or debt securities and the arrangement and
administration of a loan syndication. These include commitment fees to provide loan financing.
Financial Statement Notes
Barclays PLC 76

-- 78 of 109 --

4. Staff costs
Half year
ended
30.06.22
Half year
ended
30.06.21
Compensation costs £m £m
Upfront bonus charge 705 824
Deferred bonus charge 280 262
Other incentives 44 6
Performance costs 1,029 1,092
Salaries 2,278 2,117
Social security costs 377 336
Post-retirement benefits 282 275
Other compensation costs 241 223
Total compensation costs 4,207 4,043
Other resourcing costs
Outsourcing 268 171
Redundancy and restructuring (15) 23
Temporary staff costs 53 55
Other 70 42
Total other resourcing costs 376 291
Total staff costs 4,583 4,334
Barclays Group compensation costs as a % of total income 31.9% 35.7%
No material awards have yet been granted in relation to the 2022 bonus pool as decisions regarding incentive awards are not
taken by the Remuneration Committee until the performance for the full year can be assessed. The current year bonus
charge for the first six months represents an accrual for estimated costs in accordance with accounting requirements. One
of the primary considerations when evaluating the accrual is Group and business level returns, aligning colleague and
shareholder interests.
The Group has entered into physically settled forward contracts to hedge the settlement of certain share-based payment
schemes. The present value of the fixed forward price to be paid under these outstanding contracts is £287m and has been
recorded in retained earnings.
5. Infrastructure, administration and general expenses
Half year
ended
30.06.22
Half year
ended
30.06.21
Infrastructure costs £m £m
Property and equipment 744 709
Depreciation and amortisation 863 832
Lease payments 14 20
Impairment of property, equipment and intangible assets 21 304
Total infrastructure costs 1,642 1,865
Administration and general expenses
Consultancy, legal and professional fees 288 262
Marketing and advertising 206 163
Other administration and general expenses 551 508
Total administration and general expenses 1,045 933
Total infrastructure, administration and general expenses 2,687 2,798
Financial Statement Notes
Barclays PLC 77

-- 79 of 109 --

6. Tax
The tax charge for H122 was £823m (restated1 H121: £742m), representing an effective tax rate (ETR) of 22.0% (restated1
H121: 15.1%). The ETR for H122 includes a charge recognised for the re-measurement of the Group’s UK deferred tax assets
(DTAs) due to the enactment of legislation in Q122 which will result in the UK banking surcharge rate being reduced from
8% to 3% effective from 1 April 2023. The ETR excluding the impact of this downward re-measurement of UK DTAs was
12.8%, which includes a 5.8% benefit relating to adjustments in respect of prior years. Included in the H122 tax charge is a
credit of £110m (H121: £104m) in respect of payments made on AT1 instruments that are classified as equity for
accounting purposes. The H121 ETR included a benefit recognised for the re-measurement of the Group’s UK DTAs as a
result of the enactment of legislation to increase the UK corporation tax rate to 25% effective from 1 April 2023.
The re-measurement of UK DTAs has resulted in the Group's DTAs decreasing by £318m with a tax charge in the income
statement of £346m and a tax credit within other comprehensive income of £28m.
In October 2021, the OECD and G20 Inclusive Framework on Base Erosion and Profit Shifting announced plans to introduce
a global minimum tax rate of 15%. The model rules were released by the OECD in December 2021 with further guidance
published in March 2022. Draft legislation published by the UK government on 20 July 2022 to implement the global
minimum tax regime is expected to apply for accounting periods beginning on or after 31 December 2023. The Group is
reviewing the published OECD model rules and guidance and will review further guidance as well as new legislation to be
released by governments implementing this new tax regime as it is published to assess the potential impact of new
legislation.
In the USA, the proposed Build Back Better Act was passed by the House of Representatives in 2021 but it was not passed by
the Senate and it is uncertain whether various proposals contained in the Act will progress further. The Act included
proposals to implement material changes to international tax provisions, including amendments to the Base Erosion and
Anti-Abuse Tax and the imposition of an alternative minimum tax based on accounting profits. It is unclear at this time
whether any of these proposals could have a significant impact on the Group if enacted. The Group will continue to monitor
developments and assess the potential impact of any future legislative changes ultimately enacted.
1 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page
73 for more information.
As at
30.06.22
As at
31.12.21
Deferred tax assets and liabilities £m £m
UK 3,046 2,183
USA 1,530 2,006
Other territories 468 430
Deferred tax assets 5,044 4,619
Deferred tax liabilities (5) (37)
Analysis of deferred tax assets
Temporary differences 3,871 3,399
Tax losses 1,173 1,220
Deferred tax assets 5,044 4,619
7. Non-controlling interests
Profit attributable to
non-controlling interests
Equity attributable to
non-controlling interests
Half year
ended
30.06.22
Half year
ended
30.06.21
As at
30.06.22
As at
31.12.21
£m £m £m £m
Barclays Bank PLC issued:
- Preference shares 15 13 529 529
- Upper T2 instruments 6 3 438 458
Other non-controlling interests — 3 2 2
Total 21 19 969 989
Financial Statement Notes
Barclays PLC 78

-- 80 of 109 --

8. Earnings per share
Restated1
Half year
ended
30.06.22
Half year
ended
30.06.21
£m £m
Profit attributable to ordinary equity holders of the parent 2,475 3,752
m m
Basic weighted average number of shares in issue 16,684 17,140
Number of potential ordinary shares 428 467
Diluted weighted average number of shares 17,112 17,607
p p
Basic earnings per ordinary share 14.8 21.9
Diluted earnings per ordinary share 14.5 21.3
1 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page
73 for more information.
9. Dividends on ordinary shares
A half year dividend for 2022 of 2.25p (H121: 2p) per ordinary share will be paid on 16 September 2022 to shareholders on
the register on 12 August 2022.
Half year ended 30.06.22 Half year ended 30.06.21
Per share Total Per share Total
Dividends paid during the period p £m p £m
Full year dividend paid during period 4.0 664 1.0 173
For qualifying American Depositary Receipt (ADR) holders, the half year dividend of 2.25p per ordinary share becomes 9.0p
per American Depositary Share (representing 4 shares). The depositary bank will post the half year dividend on 16
September 2022 to ADR holders on the record at close of business on 12 August 2022.
The Directors have confirmed their intention to initiate a share buyback of up to £500m after the balance sheet date. The
share buyback is expected to commence in the third quarter of 2022. The financial statements for the six months ended 30
June 2022 do not reflect the impact of the proposed share buyback, which will be accounted for as and when shares are
repurchased by the Company.
Financial Statement Notes
Barclays PLC 79

-- 81 of 109 --

10. Derivative financial instruments
Contract
notional
amount
Fair value
Assets Liabilities
As at 30.06.22 £m £m £m
Foreign exchange derivatives 6,732,093 135,207 (123,662)
Interest rate derivatives 44,275,712 130,628 (116,541)
Credit derivatives 1,640,043 8,128 (8,228)
Equity and stock index and commodity derivatives 2,510,981 70,066 (71,830)
Derivative assets/(liabilities) held for trading 55,158,829 344,029 (320,261)
Derivatives in hedge accounting relationships
Derivatives designated as cash flow hedges 139,040 701 (21)
Derivatives designated as fair value hedges 107,809 106 (1,054)
Derivatives designated as hedges of net investments 4,097 19 (60)
Derivative assets/(liabilities) designated in hedge accounting relationships 250,946 826 (1,135)
Total recognised derivative assets/(liabilities) 55,409,775 344,855 (321,396)
As at 31.12.21
Foreign exchange derivatives 5,824,856 76,140 (74,437)
Interest rate derivatives 38,816,432 125,846 (114,803)
Credit derivatives 1,272,104 5,682 (6,561)
Equity and stock index and commodity derivatives 1,899,382 54,010 (59,946)
Derivative assets/(liabilities) held for trading 47,812,774 261,678 (255,747)
Derivatives in hedge accounting relationships
Derivatives designated as cash flow hedges 114,313 798 (3)
Derivatives designated as fair value hedges 102,815 59 (1,129)
Derivatives designated as hedges of net investments 2,423 37 (4)
Derivative assets/(liabilities) designated in hedge accounting relationships 219,551 894 (1,136)
Total recognised derivative assets/(liabilities) 48,032,325 262,572 (256,883)
The IFRS netting posted against derivative assets was £55bn including £12bn of cash collateral netted (December 2021:
£24bn including £4bn cash collateral netted) and £55bn for liabilities including £12bn of cash collateral netted (December
2021: £24bn including £4bn of cash collateral netted). Derivative asset exposures would be £306bn (December 2021:
£237bn) lower than reported under IFRS if netting were permitted for assets and liabilities with the same counterparty or for
which the Group holds cash collateral of £40bn (December 2021: £35bn). Similarly, derivative liabilities would be £293bn
(December 2021: £235bn) lower reflecting counterparty netting and cash collateral placed of £26bn (December 2021:
£32bn). In addition, non-cash collateral of £13bn (December 2021: £6bn) was held in respect of derivative assets and £3bn
(December 2021: £2bn) was placed in respect of derivative liabilities. Collateral amounts are limited to net on balance sheet
exposure so as to not include over-collateralisation.
Financial Statement Notes
Barclays PLC 80

-- 82 of 109 --

11. Fair value of financial instruments
This section should be read in conjunction with Note 17, Fair value of financial instruments of the Barclays PLC Annual
Report 2021 which provides more detail about accounting policies adopted, valuation methodologies used in calculating fair
value and the valuation control framework which governs oversight of valuations. There have been no changes in the
accounting policies adopted or the valuation methodologies used.
Valuation
The following table shows the Group’s assets and liabilities that are held at fair value disaggregated by valuation technique
(fair value hierarchy) and balance sheet classification:
Valuation technique using
Quoted
market prices
Observable
inputs
Significant
unobservable
inputs
(Level 1) (Level 2) (Level 3) Total
As at 30.06.22 £m £m £m £m
Trading portfolio assets 58,419 64,329 4,256 127,004
Financial assets at fair value through the income statement 1,115 202,026 9,582 212,723
Derivative financial instruments 11,653 329,329 3,873 344,855
Financial assets at fair value through other comprehensive income 22,455 40,696 43 63,194
Investment property — — 5 5
Total assets 93,642 636,380 17,759 747,781
Trading portfolio liabilities (47,870) (28,686) (82) (76,638)
Financial liabilities designated at fair value (193) (254,496) (447) (255,136)
Derivative financial instruments (12,674) (304,343) (4,379) (321,396)
Total liabilities (60,737) (587,525) (4,908) (653,170)
As at 31.12.21
Trading portfolio assets 80,926 63,828 2,281 147,035
Financial assets at fair value through the income statement 5,093 177,167 9,712 191,972
Derivative financial instruments 6,150 252,412 4,010 262,572
Financial assets at fair value through other comprehensive income 22,009 39,706 38 61,753
Investment property — — 7 7
Total assets 114,178 533,113 16,048 663,339
Trading portfolio liabilities (27,529) (26,613) (27) (54,169)
Financial liabilities designated at fair value (174) (250,376) (410) (250,960)
Derivative financial instruments (6,571) (244,253) (6,059) (256,883)
Total liabilities (34,274) (521,242) (6,496) (562,012)
Financial Statement Notes
Barclays PLC 81

-- 83 of 109 --

The following table shows the Group’s Level 3 assets and liabilities that are held at fair value disaggregated by product type:
As at 30.06.22 As at 31.12.21
Assets Liabilities Assets Liabilities
£m £m £m £m
Interest rate derivatives 1,573 (1,849) 1,091 (1,351)
Foreign exchange derivatives 786 (560) 376 (374)
Credit derivatives 234 (615) 323 (709)
Equity derivatives 1,280 (1,355) 2,220 (3,625)
Corporate debt 1,171 (13) 1,205 (21)
Reverse repurchase and repurchase agreements 178 (188) 13 (172)
Non-asset backed loans 8,660 — 6,405 —
Asset backed securities 291 — 558 —
Equity cash products 422 (3) 393 —
Private equity investments 1,297 (8) 1,095 (6)
Other1 1,867 (317) 2,369 (238)
Total 17,759 (4,908) 16,048 (6,496)
1 Other includes commercial real estate loans, funds and fund-linked products, asset backed loans, issued debt, commercial paper, government sponsored
debt and investment property.
Assets and liabilities reclassified between Level 1 and Level 2
During the period, there were no material transfers between Level 1 and Level 2 (period ended 31 December 2021: no
material transfers between Level 1 and Level 2).
Level 3 movement analysis
The following table summarises the movements in the balances of Level 3 assets and liabilities during the period. The table
shows gains and losses and includes amounts for all financial assets and liabilities that are held at fair value transferred to
and from Level 3 during the period. Transfers have been reflected as if they had taken place at the beginning of the period.
Asset and liability moves between Level 2 and Level 3 are primarily due to i) an increase or decrease in observable market
activity related to an input or ii) a change in the significance of the unobservable input, with assets and liabilities classified as
Level 3 if an unobservable input is deemed significant.
Financial Statement Notes
Barclays PLC 82

-- 84 of 109 --

Level 3 movement analysis
Total gains and (losses)
in the period recognised
in the income statement
Total gains
or (losses)
recognised
in OCI
Transfers
As at
01.01.22 Purchases Sales Issues
Settle-
ments
Trading
income
Other
income In Out
As at
30.06.22
£m £m £m £m £m £m £m £m £m £m £m
Corporate debt 389 90 (144) — (17) 54 — — 43 (11) 404
Non-asset backed loans 758 2,448 (459) — — 11 — — 50 (113) 2,695
Asset backed securities 454 72 (80) — (297) (20) — — 100 (66) 163
Equity cash products 303 21 (56) — — 24 — — 52 (17) 327
Other 377 326 (42) — (5) 56 — — 39 (84) 667
Trading portfolio assets 2,281 2,957 (781) — (319) 125 — — 284 (291) 4,256
Non-asset backed loans 5,647 1,847 (757) — (484) (334) — — 52 (9) 5,962
Equity cash products 90 — — — — 3 2 — — — 95
Private equity investments 1,095 99 (16) — (1) 84 (26) — 59 (4) 1,290
Other 2,880 4,817 (5,579) — (156) 11 182 — 99 (19) 2,235
Financial assets at fair value
through the income statement 9,712 6,763 (6,352) — (641) (236) 158 — 210 (32) 9,582
Private equity investments — — — — — — — 1 6 — 7
Asset backed securities 38 — — — — — — (2) — — 36
Assets at fair value through
other comprehensive income 38 — — — — — — (1) 6 — 43
Investment property 7 — (1) — — — (1) — — — 5
Trading portfolio liabilities (27) (35) 3 — — (29) — — — 6 (82)
Financial liabilities designated
at fair value (410) (5) — (13) 47 (22) — — (81) 37 (447)
Interest rate derivatives (260) 25 — — (4) (305) (9) — 271 6 (276)
Foreign exchange derivatives 2 — — — (9) 273 — — (65) 25 226
Credit derivatives (386) (36) 5 — 60 (99) — — 20 55 (381)
Equity derivatives (1,405) (83) — — 171 980 (1) — (9) 272 (75)
Net derivative financial
instruments1 (2,049) (94) 5 — 218 849 (10) — 217 358 (506)
Total 9,552 9,586 (7,126) (13) (695) 687 147 (1) 636 78 12,851
1 Derivative financial instruments are represented on a net basis. On a gross basis, derivative financial assets were £3,873m and derivative financial liabilities
were £4,379m.
Financial Statement Notes
Barclays PLC 83

-- 85 of 109 --

Level 3 movement analysis
As at
01.01.21 Purchases Sales Issues
Settle-
ments
Total gains and (losses)
in the period recognised
in the income statement Total gains
or (losses)
recognised
in OCI
Transfers
As at
30.06.21
Trading
income
Other
income In Out
£m £m £m £m £m £m £m £m £m £m £m
Corporate debt 151 305 (87) — — 25 — — 40 (11) 423
Non-asset backed loans 709 620 (131) — (84) 13 — — 124 (106) 1,145
Asset backed securities 686 112 (294) — — (10) — — 43 (48) 489
Equity cash products 214 13 (17) — — 32 — — 29 (9) 262
Other 103 21 — — (51) (1) — — 162 (1) 233
Trading portfolio assets 1,863 1,071 (529) — (135) 59 — — 398 (175) 2,552
Non-asset backed loans 5,580 698 (299) — (687) (119) — — 69 (48) 5,194
Equity cash products 326 160 (194) — — (171) 18 — 1 — 140
Private equity investments 874 106 (9) — (8) (5) 92 — — (71) 979
Other 1,726 2,291 (2,389) — (162) (19) 1 — 16 — 1,464
Financial assets at fair value
through the income statement 8,506 3,255 (2,891) — (857) (314) 111 — 86 (119) 7,777
Non-asset backed loans 106 — — — — — — — — (106) —
Asset backed securities 47 4 — — (5) — — 2 — — 48
Assets at fair value through
other comprehensive income 153 4 — — (5) — — 2 — (106) 48
Investment property 10 — (2) — — — — — — — 8
Trading portfolio liabilities (28) (3) 14 — — (7) — — — 7 (17)
Financial liabilities designated at
fair value (355) — — — 98 7 (2) — (78) 18 (312)
Interest rate derivatives (2) 9 — — 33 (121) 4 — 21 (297) (353)
Foreign exchange derivatives 1 — — — 58 (6) — — 3 (34) 22
Credit derivatives (155) (117) 2 — (5) 12 (1) — 1 (1) (264)
Equity derivatives (1,614) (315) (1) — (32) (221) (1) — 28 808 (1,348)
Net derivative financial
instruments1 (1,770) (423) 1 — 54 (336) 2 — 53 476 (1,943)
Total 8,379 3,904 (3,407) — (845) (591) 111 2 459 101 8,113
1 Derivative financial instruments are represented on a net basis. On a gross basis, derivative financial assets were £3,657m and derivative financial liabilities
were £5,600m.
Financial Statement Notes
Barclays PLC 84

-- 86 of 109 --

Unrealised gains and losses on Level 3 financial assets and liabilities
The following table discloses the unrealised gains and losses recognised in the period arising on Level 3 financial assets and
liabilities held at the period end.
Half year ended 30.06.22 Half year ended 30.06.21
Income statement Other
compre
hensive
income Total
Income statement Other
compre
hensive
income Total
Trading
income
Other
income
Trading
income
Other
income
£m £m £m £m £m £m £m £m
Trading portfolio assets 121 — — 121 35 — — 35
Financial assets at fair value
through the income statement (165) (22) — (187) (201) 114 — (87)
Financial assets at fair value
through other comprehensive
income — — (1) (1) — — — —
Investment properties — (1) — (1) — — — —
Trading portfolio liabilities (35) — — (35) (6) — — (6)
Financial liabilities designated at
fair value (14) — — (14) 7 — — 7
Net derivative financial
instruments 862 (1) — 861 (367) — — (367)
Total 769 (24) (1) 744 (532) 114 — (418)
Valuation techniques and sensitivity analysis
Sensitivity analysis is performed on products with significant unobservable inputs (Level 3) to generate a range of reasonably
possible alternative valuations. The sensitivity methodologies applied take account of the nature of valuation techniques
used, as well as the availability and reliability of observable proxy and historical data and the impact of using alternative
models.
Current year valuation and sensitivity methodologies are consistent with those described within Note 17, Fair value of
financial instruments in the Barclays PLC Annual Report 2021.
Sensitivity analysis of valuations using unobservable inputs
As at 30.06.22 As at 31.12.21
Favourable changes Unfavourable changes Favourable changes Unfavourable changes
Income
statement Equity
Income
statement Equity
Income
statement Equity
Income
statement Equity
£m £m £m £m £m £m £m £m
Interest rate derivatives 75 — (108) — 51 — (79) —
Foreign exchange derivatives 15 — (22) — 20 — (28) —
Credit derivatives 111 — (115) — 111 — (103) —
Equity derivatives 107 — (112) — 187 — (195) —
Corporate debt 36 — (35) — 38 — (28) —
Non-asset backed loans 298 — (334) — 165 — (256) —
Equity cash products 73 — (129) — 42 — (61) —
Private equity investments 272 1 (286) (1) 246 — (236) —
Other1 27 — (36) — 20 — (19) —
Total 1,014 1 (1,177) (1) 880 — (1,005) —
1 Other includes commercial real estate loans, funds and fund-linked products, asset backed loans, issued debt, commercial paper, government sponsored
debt and investment property.
The effect of stressing unobservable inputs to a range of reasonably possible alternatives, alongside considering the impact
of using alternative models, would be to increase fair values by up to £1,015m (December 2021: £880m) or to decrease fair
values by up to £1,178m (December 2021: £1,005m) with substantially all the potential effect impacting profit and loss
rather than reserves.
Financial Statement Notes
Barclays PLC 85

-- 87 of 109 --

Significant unobservable inputs
The valuation techniques and significant unobservable inputs for assets and liabilities recognised at fair value and classified
as Level 3 are consistent with Note 17, Fair value of financial instruments in the Barclays PLC Annual Report 2021.
Fair value adjustments
Key balance sheet valuation adjustments are quantified below:
As at
30.06.22
As at
31.12.21
£m £m
Exit price adjustments derived from market bid-offer spreads (539) (506)
Uncollateralised derivative funding (82) (127)
Derivative credit valuation adjustments (388) (212)
Derivative debit valuation adjustments 208 91
• Exit price adjustments derived from market bid-offer spreads increased by £33m to £539m as a result of movements in
market bid offer spreads.
• Uncollateralised derivative funding decreased by £45m to £82m as a result of reduction in uncollateralised funding
exposure due to increases in interest rates which offset impact of wider funding spreads.
• Derivative credit valuation adjustments increased by £176m to £388m as a result of widening input counterparty credit
spreads
• Derivative debit valuation adjustments increased by £117m to £208m as a result of widening input own credit spreads
Portfolio exemption
The Group uses the portfolio exemption in IFRS 13, Fair Value Measurement to measure the fair value of groups of financial
assets and liabilities. Instruments are measured using the price that would be received to sell a net long position (i.e. an
asset) for a particular risk exposure or to transfer a net short position (i.e. a liability) for a particular risk exposure in an
orderly transaction between market participants at the balance sheet date under current market conditions. Accordingly, the
Group measures the fair value of the group of financial assets and liabilities consistently with how market participants would
price the net risk exposure at the measurement date.
Unrecognised gains as a result of the use of valuation models using unobservable inputs
The amount that has yet to be recognised in income that relates to the difference between the transaction price (the fair
value at initial recognition) and the amount that would have arisen had valuation models using unobservable inputs been
used on initial recognition, less amounts subsequently recognised, is £117m (December 2021: £133m) for financial
instruments measured at fair value and £221m (December 2021: £230m) for financial instruments carried at amortised cost.
There are additions and FX gains of £19m (December 2021: £59m) and amortisation and releases of £35m (December
2021: £42m) for financial instruments measured at fair value and additions of £nil (December 2021: £nil) and amortisation
and releases of £9m (December 2021: £17m) for financial instruments carried at amortised cost.
Third party credit enhancements
Structured and brokered certificates of deposit issued by the Group are insured up to $250,000 per depositor by the Federal
Deposit Insurance Corporation (FDIC) in the United States. The FDIC is funded by premiums that Barclays and other banks
pay for deposit insurance coverage. The carrying value of these issued certificates of deposit that are designated under the
IFRS 9 fair value option includes this third party credit enhancement. The on balance sheet value of these brokered
certificates of deposit amounted to £3,065m (December 2021: £790m).
Financial Statement Notes
Barclays PLC 86

-- 88 of 109 --

Comparison of carrying amounts and fair values for assets and liabilities not held at fair value
Valuation methodologies employed in calculating the fair value of financial assets and liabilities measured at amortised cost
are consistent with those described within Note 17, Fair value of financial instruments in the Barclays PLC Annual Report
2021.
The following table summarises the fair value of financial assets and liabilities measured at amortised cost on the Group’s
balance sheet.
As at 30.06.22 As at 31.12.21
Carrying
amount Fair value
Carrying
amount Fair value
Financial assets £m £m £m £m
Loans and advances at amortised cost 395,824 396,475 361,451 362,424
Reverse repurchase agreements and other similar secured lending 1,639 1,639 3,227 3,227
Financial liabilities
Deposits at amortised cost (568,670) (568,715) (519,433) (519,436)
Repurchase agreements and other similar secured borrowing (28,566) (28,569) (28,352) (28,358)
Debt securities in issue (115,906) (115,777) (98,867) (100,657)
Subordinated liabilities (11,871) (11,799) (12,759) (13,334)
12. Loans and advances and deposits at amortised cost
As at
30.06.22
As at
31.12.21
£m £m
Loans and advances at amortised cost to banks 12,532 9,698
Loans and advances at amortised cost to customers 337,220 319,922
Debt securities at amortised cost 46,072 31,831
Total loans and advances at amortised cost 395,824 361,451
Deposits at amortised cost from banks 29,891 17,819
Deposits at amortised cost from customers 538,779 501,614
Total deposits at amortised cost 568,670 519,433
13. Goodwill and intangible assets
Goodwill and intangible assets are allocated to business operations according to business segments as follows:
As at 30.06.22 As at 31.12.21
Goodwill Intangibles Total Goodwill Intangibles Total
£m £m £m £m £m £m
Barclays UK 3,560 1,247 4,807 3,560 1,233 4,793
Barclays International 308 3,079 3,387 291 2,930 3,221
Head Office 44 7 51 42 5 47
Total 3,912 4,333 8,245 3,893 4,168 8,061
The Group performed an impairment review to assess the recoverability of its goodwill and intangible asset balances as at 31
December 2021. The outcome of this review is disclosed on pages 382-385 of the Barclays PLC Annual Report 2021. No
impairment was recognised as a result of the review as value in use exceeded carrying amount. A review of the Group's
goodwill and intangible assets as at 30 June 2022 did not identify the presence of impairment.
Financial Statement Notes
Barclays PLC 87

-- 89 of 109 --

14. Subordinated liabilities
Half year
ended
30.06.22
Year ended
31.12.21
£m £m
Opening balance as at 1 January 12,759 16,341
Issuances 259 1,890
Redemptions (1,180) (4,807)
Other 33 (665)
Closing balance 11,871 12,759
Issuances of £259m comprise £128m USD Floating Rate Notes, £89m ZAR Floating Rate Notes and £42m EUR Floating Rate
Notes issued externally by Barclays subsidiaries.
Redemptions of £1,180m comprise £1,039m notes issued externally by Barclays Bank PLC, £74m USD Floating Rate Notes
issued externally by a Barclays subsidiary and £67m GBP Undated Subordinated Loan Notes (secured) issued externally by a
Barclays securitisation special purpose vehicle (SPV). £1,039m notes issued externally by Barclays Bank PLC comprise
£838m EUR 6.625% Fixed Rate Subordinated Notes, £147m USD 6.86% Callable Perpetual Core Tier One Notes, £42m EUR
Subordinated Floating Rate Notes and £12m GBP 6% Callable Perpetual Core Tier One Notes.
Other movements predominantly comprise foreign exchange movements and fair value hedge adjustments.
15. Provisions
Restated1
As at
30.06.22 As at
31.12.21
£m £m
Customer redress 1,985 530
Legal, competition and regulatory matters 418 226
Redundancy and restructuring 216 326
Undrawn contractually committed facilities and guarantees 526 542
Onerous contracts — 5
Sundry provisions 281 279
Total 3,426 1,908
1 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page
73 for more information.
Over-issuance of securities
As at 30 June 2022, Barclays PLC has recognised a balance sheet provision of £1,757m (December 2021: £220m) in relation
to the Over-issuance of Securities (see Basis of preparation on page 73 for more information), out of which £1,592m
(December 2021: £220m) is due to the over-issuance of structured notes (within Customer redress) and £165m (December
2021: nil) relates to liabilities that could be incurred arising out of ongoing discussions in respect of a potential SEC
resolution (within Legal, competition and regulatory matters).
The amount of the provision in relation to the rescission rights of investors in over-issued structured notes is determined by
(among other things) the market value of the structured notes subject to the Rescission Offer, participation rates in such
Rescission Offer, prevailing interest rates, and movements in foreign exchange rates. The majority of the structured notes
subject to the Rescission Offer provide an equity linked return to investors. As such, the value of these notes is highly
sensitive to movements in the price of individual securities and a range of indices.
The increase in the provision of £1,372m predominantly reflects a reduction in the market value of the structured notes and
additional accrued interest that would be payable to investors on rescission. The US equity markets have been volatile during
the first half of 2022, with significant reductions in the value of US equity indices such as the S&P 500 from the year end
2021 levels, which has led to a reduction in the market value of the structured notes, and increased the size of the provision.
The provision does not include the impact of market hedges that have been entered into subsequent to the year-end and
were initiated from the end of the first quarter of 2022 to reduce the net volatility to the income statement. When
Financial Statement Notes
Barclays PLC 88

-- 90 of 109 --

determining these market hedges, consideration was given to changes in the rescission costs which would arise from
volatility in the market along with the positioning of the Markets business.
The structured notes also accrue interest on a monthly basis (at current prevailing interest rates and participation rate
assumptions this is c£34m a month) until the Rescission Price has been paid. The provision also assumes that not all
structured note investors whose securities are out of the money will accept the Rescission Offer. If all investors were to
accept the Rescission Offer, the provision would increase by c£60m.
The remaining increase in the provision of £165m results from Barclays PLC’s estimate of the potential SEC resolution.
16. Retirement benefits
As at 30 June 2022, the Group’s IAS 19 net pension surplus across all schemes was £4.9bn (December 2021: £3.6bn). The
UK Retirement Fund (UKRF), which is the Group’s main scheme, had an IAS 19 net pension surplus of £5.2bn (December
2021: £3.8bn). The movement for the UKRF was driven by an overall increase in AA corporate bond yields (used for
discounting future liabilities), a reduction in long-term expected price inflation assumption and the payment of deficit
reduction contributions. These movements were partially offset by the fall in the value of UKRF's assets and the impact of
high recent inflation on the liabilities.
UKRF funding valuations
The latest annual update as at 30 September 2021 showed the funding position had improved to a surplus of £0.6bn from a
deficit of £0.9bn shown at 30 September 2020. The improvement was mainly due to £0.7bn of deficit reduction
contributions and favourable asset returns, partially offset by higher expected long term price inflation. The deficit recovery
plan agreed at the last triennial valuation requires deficit reduction contributions from Barclays Bank PLC of £294m in 2022
and £286m in 2023. The deficit reduction contributions are in addition to the regular contributions to meet the Group’s
share of the cost of benefits accruing over each year. £147m of the 2022 deficit reduction contributions were paid in April,
with the remaining £147m due in September. The next triennial actuarial valuation of the UKRF is due to be completed in
2023 with an effective date of 30 September 2022.
During 2019 and 2020, the UKRF, the Group’s main pension scheme, subscribed for non-transferable listed senior fixed rate
notes for £1.25bn issued by entities consolidated within the Group under IFRS 10. As a result of these transactions, the CET1
impact of the 2019 and 2020 deficit contributions was deferred until 2023, 2024 and 2025 upon maturity of the notes.
Following the PRA’s statement on 13 April 2022, Barclays is planning to unwind these transactions and to agree the terms
and timing of this unwind with the UKRF Trustee as part of the next triennial actuarial valuation as at 30 September 2022.
Upon unwind, this would result in a c.30bps reduction to the CET1 ratio potentially being accelerated to Q4 2022 from 2023,
2024 and 2025.
17. Called up share capital
Ordinary
share capital
Share
premium
Total share
capital and
share
premium
Half year ended 30.06.22 £m £m £m
Opening balance as at 1 January 4,188 348 4,536
Issue of shares under employee share schemes 6 27 33
Repurchase of shares (61) — (61)
Closing balance 4,133 375 4,508
Called up share capital comprises 16,531m (December 2021: 16,752m) ordinary shares of 25p each. The decrease is mainly
due to the repurchase of 244m shares as part of the £1.0bn share buyback announced in the FY21 results, partially offset by
an increase due to the issuance of shares under employee share schemes.
Financial Statement Notes
Barclays PLC 89

-- 91 of 109 --

18. Other equity instruments
Half year
ended
30.06.22
Year ended
31.12.21
£m £m
Opening balance as at 1 January 12,259 11,172
Issuances 1,247 1,078
Redemptions (1,132) —
Securities held by the Group (17) 9
Closing balance 12,357 12,259
Other equity instruments of £12,357m (December 2021: £12,259m) comprise AT1 securities issued by Barclays PLC. There
was one issuance and one redemption in the six months to 30 June 2022.
The AT1 securities are perpetual securities with no fixed maturity and are structured to qualify as AT1 instruments under
prevailing capital rules applicable as at the relevant issue date. AT1 securities are undated and are redeemable, at the option
of Barclays PLC, in whole on (i) the initial call date, or on any fifth anniversary after the initial call date or (ii) any day falling in
a named period ending on the initial reset date, or on any fifth anniversary after the initial reset date. In addition, the AT1
securities are redeemable, at the option of Barclays PLC, in whole in the event of certain changes in the tax or regulatory
treatment of the securities. Any redemptions require the prior consent of the PRA.
All Barclays PLC AT1 securities will be converted into ordinary shares of Barclays PLC, at a pre-determined price, should the
fully loaded CET1 ratio of the Group fall below 7%.
19. Other reserves
As at
30.06.22
As at
31.12.21
£m £m
Currency translation reserve 4,443 2,740
Fair value through other comprehensive income reserve (1,081) (283)
Cash flow hedging reserve (4,671) (853)
Own credit reserve (103) (960)
Other reserves and treasury shares 1,194 1,126
Total (218) 1,770
Currency translation reserve
The currency translation reserve represents the cumulative gains and losses on the retranslation of the Group’s net
investment in foreign operations, net of the effects of hedging.
As at 30 June 2022, there was a credit balance of £4,443m (December 2021: £2,740m credit) in the currency translation
reserve. The £1,703m credit movement principally reflects the weakening of GBP against USD during the period.
Fair value through other comprehensive income reserve
The fair value through other comprehensive income reserve represents the changes in the fair value of fair value through
other comprehensive income investments since initial recognition.
As at 30 June 2022, there was a debit balance of £1,081m (December 2021: £283m debit) in the fair value through other
comprehensive income reserve. The loss of £798m is principally driven by a loss of £1,237m from the decrease in fair value
of bonds due to increasing bond yields, £5m of net gains transferred to the income statement and £39m of gains transferred
to retained earnings on sale of 7.45% equity stake in Absa Group Limited. This is partially offset by a gain of £153m due to
an increase in the Absa Group Limited share price and a tax credit of £326m.
Financial Statement Notes
Barclays PLC 90

-- 92 of 109 --

Cash flow hedging reserve
The cash flow hedging reserve represents the cumulative gains and losses on effective cash flow hedging instruments that
will be recycled to the income statement when the hedged transactions affect profit or loss.
As at 30 June 2022, there was a debit balance of £4,671m (December 2021: £853m debit) in the cash flow hedging reserve.
The decrease of £3,818m principally reflects a £4,747m decrease in the fair value of interest rate swaps held for hedging
purposes as major interest rate forward curves increased and £429m of gains transferred to the income statement. This is
partially offset by a tax credit of £1,358m.
Own credit reserve
The own credit reserve reflects the cumulative own credit gains and losses on financial liabilities at fair value. Amounts in the
own credit reserve are not recycled to profit or loss in future periods.
As at 30 June 2022, there was a debit balance of £103m (December 2021: £960m debit) in the own credit reserve. The
movement of £857m principally reflects a £1,258m gain from the widening of Barclays’ funding spreads partially offset by a
tax charge of £403m.
Other reserves and treasury shares
Other reserves relate to redeemed ordinary and preference shares issued by the Group. Treasury shares relate to Barclays
PLC shares held principally in relation to the Group’s various share schemes.
As at 30 June 2022, there was a credit balance of £1,194m (December 2021: £1,126m credit) in other reserves and treasury
shares. This is driven by an increase of £61m due to the repurchase of 244m shares as part of the £1.0bn share buyback and
a £7m increase in the treasury shares balance held in relation to employee share schemes.
20. Contingent liabilities and commitments
As at
30.06.22
As at
31.12.21
Contingent liabilities and financial guarantees £m £m
Guarantees and letters of credit pledged as collateral security 16,463 15,549
Performance guarantees, acceptances and endorsements 5,877 5,797
Total 22,340 21,346
Commitments
Documentary credits and other short-term trade related transactions 1,888 1,584
Standby facilities, credit lines and other commitments 396,038 344,127
Total 397,926 345,711
Further details on contingent liabilities, where it is not practicable to disclose an estimate of the potential financial effect on
Barclays relating to legal and competition and regulatory matters can be found in Note 21.
21. Legal, competition and regulatory matters
The Group faces legal, competition and regulatory challenges, many of which are beyond our control. The extent of the
impact of these matters cannot always be predicted but may materially impact our operations, financial results, condition
and prospects. Matters arising from a set of similar circumstances can give rise to either a contingent liability or a provision,
or both, depending on the relevant facts and circumstances.
The recognition of provisions in relation to such matters involves critical accounting estimates and judgments in accordance
with the relevant accounting policies applicable to Note 15, Provisions. We have not disclosed an estimate of the potential
financial impact or effect on the Group of contingent liabilities where it is not currently practicable to do so. Various matters
detailed in this note seek damages of an unspecified amount. While certain matters specify the damages claimed, such
claimed amounts do not necessarily reflect the Group’s potential financial exposure in respect of those matters.
Matters are ordered under headings corresponding to the financial statements in which they are disclosed.
Financial Statement Notes
Barclays PLC 91

-- 93 of 109 --

1. Barclays PLC and Barclays Bank PLC
Investigations into certain advisory services agreements
FCA proceedings
In 2008, Barclays Bank PLC and Qatar Holdings LLC entered into two advisory service agreements (the Agreements). The
Financial Conduct Authority (FCA) conducted an investigation into whether the Agreements may have related to Barclays
PLC’s capital raisings in June and November 2008 (the Capital Raisings) and therefore should have been disclosed in the
announcements or public documents relating to the Capital Raisings. In 2013, the FCA issued warning notices (the Notices)
finding that Barclays PLC and Barclays Bank PLC acted recklessly and in breach of certain disclosure-related listing rules, and
that Barclays PLC was also in breach of Listing Principle 3. The financial penalty provided in the Notices is £50m. Barclays
PLC and Barclays Bank PLC continue to contest the findings. Following the conclusion of the Serious Fraud Office (SFO)
proceedings against certain former Barclays executives resulting in their acquittals, the FCA proceedings, which were stayed,
have resumed. A hearing took place before the Regulatory Decisions Committee in the first quarter of 2022 and a decision is
expected in the second half of 2022.
Investigations into LIBOR and other benchmarks and related civil actions
Regulators and law enforcement agencies, including certain competition authorities, from a number of governments have
conducted investigations relating to Barclays Bank PLC’s involvement in allegedly manipulating certain financial benchmarks,
such as LIBOR. Various individuals and corporates in a range of jurisdictions have threatened or brought civil actions against
the Group and other banks in relation to the alleged manipulation of LIBOR and/or other benchmarks.
USD LIBOR civil actions
The majority of the USD LIBOR cases, which have been filed in various US jurisdictions, have been consolidated for pre-trial
purposes in the US District Court in the Southern District of New York (SDNY). The complaints are substantially similar and
allege, among other things, that Barclays PLC, Barclays Bank PLC, Barclays Capital Inc. (BCI) and other financial institutions
individually and collectively violated provisions of the US Sherman Antitrust Act (Antitrust Act), the US Commodity Exchange
Act (CEA), the US Racketeer Influenced and Corrupt Organizations Act (RICO), the Securities Exchange Act of 1934 and
various state laws by manipulating USD LIBOR rates.
Putative class actions and individual actions seek unspecified damages with the exception of one lawsuit, in which the
plaintiffs are seeking no less than $100m in actual damages and additional punitive damages against all defendants,
including Barclays Bank PLC. Some of the lawsuits also seek trebling of damages under the Antitrust Act and RICO. Barclays
Bank PLC has previously settled certain claims. Two class action settlements, where Barclays Bank PLC has respectively paid
$7.1m and $20m, have received final court approval. Barclays Bank PLC also settled two further matters for $7.5m, and
$1.95m respectively.
Sterling LIBOR civil actions
In 2016, two putative class actions filed in the SDNY against Barclays Bank PLC, BCI and other Sterling LIBOR panel banks
alleging, among other things, that the defendants manipulated the Sterling LIBOR rate in violation of the Antitrust Act, CEA
and RICO, were consolidated. The defendants’ motion to dismiss the claims was granted in 2018. The plaintiffs have
appealed the dismissal.
Japanese Yen LIBOR civil actions
In 2012, a putative class action was filed in the SDNY against Barclays Bank PLC and other Japanese Yen LIBOR panel banks
by a lead plaintiff involved in exchange-traded derivatives and members of the Japanese Bankers Association’s Euroyen
Tokyo Interbank Offered Rate (Euroyen TIBOR) panel. The complaint alleges, among other things, manipulation of the
Euroyen TIBOR and Yen LIBOR rates and breaches of the CEA and the Antitrust Act. In 2014, the court dismissed the
plaintiff’s antitrust claims, and, in 2020, the court dismissed the plaintiff’s remaining CEA claims. The plaintiff has appealed
the lower court’s dismissal of such claims.
In 2015, a second putative class action, making similar allegations to the above class action, was filed in the SDNY against
Barclays PLC, Barclays Bank PLC and BCI. Barclays and the plaintiffs have reached a settlement of $17.75m for both actions,
which is subject to court approval.
Financial Statement Notes
Barclays PLC 92

-- 94 of 109 --

SIBOR/SOR civil action
In 2016, a putative class action was filed in the SDNY against Barclays PLC, Barclays Bank PLC, BCI and other defendants,
alleging manipulation of the Singapore Interbank Offered Rate (SIBOR) and Singapore Swap Offer Rate (SOR). The plaintiffs
and remaining defendants (which includes Barclays Bank PLC) have reached a joint settlement to resolve this matter for
$91m, which has received preliminary court approval. A final court approval hearing has been scheduled for November
2022. The financial impact of Barclays’ share of the joint settlement is not expected to be material to the Group’s operating
results, cash flows or financial position.
ICE LIBOR civil actions
In 2019, several putative class actions were filed in the SDNY against a panel of banks, including Barclays PLC, Barclays Bank
PLC, BCI, other financial institution defendants and Intercontinental Exchange Inc. and certain of its affiliates (ICE), asserting
antitrust claims that defendants manipulated USD LIBOR through defendants’ submissions to ICE. These actions have been
consolidated. The defendants’ motion to dismiss was granted in 2020 and the plaintiffs appealed. In February 2022, the
dismissal was affirmed on appeal. The plaintiffs have not sought U.S. Supreme Court review. This matter is now concluded.
In August 2020, an ICE LIBOR-related action was filed by a group of individual plaintiffs in the US District Court for the
Northern District of California on behalf of individual borrowers and consumers of loans and credit cards with variable
interest rates linked to USD ICE LIBOR. The plaintiffs' motion seeking, among other things, preliminary and permanent
injunctions to enjoin the defendants from continuing to set LIBOR or enforce any financial instrument that relies in whole or
in part on USD LIBOR was denied. The defendants have moved to dismiss the case.
Non-US benchmarks civil actions
There remains one claim, issued in 2017, against Barclays Bank PLC and other banks in the UK in connection with alleged
manipulation of LIBOR. Proceedings have also been brought in a number of other jurisdictions in Europe, Argentina and
Israel relating to alleged manipulation of LIBOR and EURIBOR. Additional proceedings in other jurisdictions may be brought
in the future.
Credit Default Swap civil action
A putative antitrust class action is pending in New Mexico federal court against Barclays Bank PLC, BCI and various other
financial institutions. The plaintiffs, the New Mexico State Investment Council and certain New Mexico pension funds, allege
that the defendants conspired to manipulate the benchmark price used to value Credit Default Swap (CDS) contracts at
settlement (i.e. the CDS final auction price). The plaintiffs allege violations of US antitrust laws and the CEA, and unjust
enrichment under state law. The defendants have moved to dismiss the case.
Foreign Exchange investigations and related civil actions
In 2015, the Group reached settlements totalling approximately $2.38bn with various US federal and state authorities and
the FCA in relation to investigations into certain sales and trading practices in the Foreign Exchange market.
The European Commission announced two settlements in May 2019 and the Group paid penalties totalling approximately
€210m. In June 2019, the Swiss Competition Commission announced two settlements and the Group paid penalties totalling
approximately CHF27m. In December 2021, the European Commission announced a final settlement which required the
Group to pay penalties totalling approximately €54m, which amount has been provided for in previous periods. The financial
impact of any ongoing investigations is not expected to be material to the Group’s operating results, cash flows or financial
position.
Various individuals and corporates in a range of jurisdictions have threatened or brought civil actions against the Group and
other banks in relation to alleged manipulation of Foreign Exchange markets.
FX opt out civil action
In 2018, Barclays Bank PLC and BCI settled a consolidated action filed in the SDNY, alleging manipulation of Foreign
Exchange markets (Consolidated FX Action), for a total amount of $384m. Also in 2018, a group of plaintiffs who opted out
of the Consolidated FX Action filed a complaint in the SDNY against Barclays PLC, Barclays Bank PLC, BCI and other
defendants. Some of the plaintiffs' claims were dismissed in 2020.
Financial Statement Notes
Barclays PLC 93

-- 95 of 109 --

Retail basis civil action
In 2015, a putative class action was filed against several international banks, including Barclays PLC and BCI, on behalf of a
proposed class of individuals who exchanged currencies on a retail basis at bank branches (Retail Basis Claims). The SDNY
has ruled that the Retail Basis Claims are not covered by the settlement agreement in the Consolidated FX Action. The Court
subsequently dismissed all Retail Basis Claims against the Group and all other defendants. The plaintiffs have filed an
amended complaint.
Non-US FX civil actions
Legal proceedings have been brought or are threatened against Barclays PLC, Barclays Bank PLC, BCI and Barclays Execution
Services Limited (BX) in connection with alleged manipulation of Foreign Exchange in the UK, a number of other jurisdictions
in Europe, Israel, Brazil and Australia. Additional proceedings may be brought in the future.
The above-mentioned proceedings include two purported class actions filed against Barclays PLC, Barclays Bank PLC, BX,
BCI and other financial institutions in the UK Competition Appeal Tribunal (CAT) in 2019 following the settlements with the
European Commission described above. The CAT refused to certify these claims in the first quarter of 2022 although the
claimants are seeking permission to appeal. Also in 2019, a separate claim was filed in the UK in the High Court of Justice
(High Court), and subsequently transferred to the CAT, by various banks and asset management firms against Barclays Bank
PLC and other financial institutions alleging breaches of European and UK competition laws related to FX trading.
Metals related civil actions
A number of US civil complaints, each on behalf of a proposed class of plaintiffs, have been consolidated and transferred to
the SDNY. The complaints allege that Barclays Bank PLC and other members of The London Gold Market Fixing Ltd.
manipulated the prices of gold and gold derivative contracts in violation of the Antitrust Act and other federal laws. The
parties have reached a joint settlement to resolve this matter for $50m, which has received preliminary court approval, with
the final court approval hearing scheduled for August 2022. The financial impact of Barclays’ share of the joint settlement is
not expected to be material to the Group’s operating results, cash flows or financial position. A separate US civil complaint
by a proposed class of plaintiffs against a number of banks, including Barclays Bank PLC, BCI and BX, alleging manipulation
of the price of silver in violation of the CEA, the Antitrust Act and state antitrust and consumer protection laws, has been
dismissed as against the Barclays entities. The plaintiffs have the option to seek the court’s permission to appeal.
Civil actions have also been filed in Canadian courts against Barclays PLC, Barclays Bank PLC, Barclays Capital Canada Inc.
and BCI on behalf of proposed classes of plaintiffs alleging manipulation of gold and silver prices.
US residential mortgage related civil actions
There are two pending US Residential Mortgage-Backed Securities (RMBS) related civil actions arising from unresolved
repurchase requests submitted by Trustees for certain RMBS, alleging breaches of various loan-level representations and
warranties (R&Ws) made by Barclays Bank PLC and/or a subsidiary acquired in 2007. In one action, the Barclays defendants’
motion for summary judgment was granted in June 2022 and the plaintiffs’ R&W breach claim was dismissed. The plaintiffs
may appeal. The other repurchase action is pending.
Barclays Bank PLC has reached settlements to resolve two other repurchase actions, which have received final court
approval. Payment of the settlement amount of one of those repurchase actions was completed in the first quarter of 2022,
and the other will be completed in the third quarter of 2022. The financial impact of the settlements is not expected to be
material to the Group’s operating results, cash flows or financial position.
In 2020, a civil litigation claim was filed in the New Mexico First Judicial District Court by the State of New Mexico against six
banks, including BCI, on behalf of two New Mexico state pension funds and the New Mexico State Investment Council
relating to legacy RMBS purchases. As to BCI, the complaint alleges that the funds purchased approximately $22m in RMBS
underwritten by BCI. The parties have reached a joint settlement to resolve this matter for $32.5m. The settlement was paid
in April 2022. The financial impact of BCI’s share of the joint settlement is not material to the Group’s operating results, cash
flows or financial position.
Government and agency securities civil actions
Treasury auction securities civil actions
Consolidated putative class action complaints filed in US federal court against Barclays Bank PLC, BCI and other financial
institutions under the Antitrust Act and state common law allege that the defendants (i) conspired to manipulate the US
Treasury securities market and/or (ii) conspired to prevent the creation of certain platforms by boycotting or threatening to
Financial Statement Notes
Barclays PLC 94

-- 96 of 109 --

boycott such trading platforms. The court dismissed the consolidated action in March 2021. The plaintiffs filed an amended
complaint. The defendants’ motion to dismiss the amended complaint was granted in March 2022. The plaintiffs are
appealing this decision.
In addition, certain plaintiffs have filed a related, direct action against BCI and certain other financial institutions, alleging that
defendants conspired to fix and manipulate the US Treasury securities market in violation of the Antitrust Act, the CEA and
state common law.
Supranational, Sovereign and Agency bonds civil actions
Civil antitrust actions have been filed in the SDNY and Federal Court of Canada in Toronto against Barclays Bank PLC, BCI,
BX, Barclays Capital Securities Limited and, with respect to the civil action filed in Canada only, Barclays Capital Canada, Inc.
and other financial institutions alleging that the defendants conspired to fix prices and restrain competition in the market for
US dollar-denominated Supranational, Sovereign and Agency bonds.
In one of the actions filed in the SDNY, the court granted the defendants’ motion to dismiss the plaintiffs’ complaint. The
dismissal was affirmed on appeal; however, the district court subsequently informed the parties of a potential conflict. The
motion to dismiss were assigned to a new district court judge and the plaintiffs have moved to vacate the dismissal order.
The plaintiffs have voluntarily dismissed the other SDNY action. In the Federal Court of Canada action, the plaintiffs reached
settlements with a small number of banks in 2020 (not including Barclays Capital Canada, Inc.). The plaintiffs have
commenced the class certification process. There is no court scheduled deadline and the action remains at an early stage.
Variable Rate Demand Obligations civil actions
Civil actions have been filed against Barclays Bank PLC and BCI and other financial institutions alleging the defendants
conspired or colluded to artificially inflate interest rates set for Variable Rate Demand Obligations (VRDOs). VRDOs are
municipal bonds with interest rates that reset on a periodic basis, most commonly weekly. Two actions in state court have
been filed by private plaintiffs on behalf of the states of Illinois and California. Three putative class action complaints have
been consolidated in the SDNY. In the consolidated SDNY class action, certain of the plaintiffs’ claims were dismissed in
November 2020 and defendants’ motion for partial dismissal of the amended consolidated complaint was granted in part
and denied in part in June 2022. In the California action, the plaintiffs’ claims were dismissed in June 2021. The plaintiffs have
appealed the dismissal.
Odd-lot corporate bonds antitrust class action
In 2020, BCI, together with other financial institutions, were named as defendants in a putative class action. The complaint
alleges a conspiracy to boycott developing electronic trading platforms for odd-lots and price fixing. The plaintiffs demand
unspecified money damages. The defendants’ motion to dismiss was granted in 2021 and the plaintiffs have appealed the
dismissal. The district court subsequently informed the parties of a potential conflict and the case was reassigned to a new
district court judge. The plaintiffs have filed a motion seeking a ruling that would vacate the dismissal and allow the plaintiffs
to file an amended complaint if the appeals court remands the case for further proceedings.
Interest rate swap and credit default swap US civil actions
Barclays PLC, Barclays Bank PLC and BCI, together with other financial institutions that act as market makers for interest rate
swaps (IRS) are named as defendants in several antitrust class actions which were consolidated in the SDNY in 2016. The
complaints allege the defendants conspired to prevent the development of exchanges for IRS and demand unspecified
money damages.
In 2018, trueEX LLC filed an antitrust class action in the SDNY against a number of financial institutions including Barclays
PLC, Barclays Bank PLC and BCI based on similar allegations with respect to trueEX LLC’s development of an IRS platform. In
2017, Tera Group Inc. filed a separate civil antitrust action in the SDNY claiming that certain conduct alleged in the IRS cases
also caused the plaintiff to suffer harm with respect to the Credit Default Swaps market. In 2018 and 2019, respectively, the
court dismissed certain claims in both cases for unjust enrichment and tortious interference but denied motions to dismiss
the federal and state antitrust claims, which remain pending.
BDC Finance L.L.C.
In 2008, BDC Finance L.L.C. (BDC) filed a complaint in the Supreme Court of the State of New York (NY Supreme Court),
demanding damages of $298m, alleging that Barclays Bank PLC had breached a contract in connection with a portfolio of
total return swaps governed by an ISDA Master Agreement (the Master Agreement). Following a trial, the court ruled in
2018 that Barclays Bank PLC was not a defaulting party, which was affirmed on appeal. In April 2021, the trial court entered
judgement in favour of Barclays Bank PLC for $3.3m and as yet to be determined legal fees and costs. BDC appealed. In
Financial Statement Notes
Barclays PLC 95

-- 97 of 109 --

January 2022, the appellate court reversed the trial court’s summary judgment decision in favour of Barclays Bank PLC and
remanded the case to the lower court for further proceedings, with the trial scheduled to commence in the fourth quarter of
2022.
In 2011, BDC’s investment advisor, BDCM Fund Adviser, L.L.C. and its parent company, Black Diamond Capital Holdings,
L.L.C. also sued Barclays Bank PLC and BCI in Connecticut State Court for unspecified damages allegedly resulting from
Barclays Bank PLC’s conduct relating to the Master Agreement, asserting claims for violation of the Connecticut Unfair Trade
Practices Act and tortious interference with business and prospective business relations. This case is currently stayed.
Civil actions in respect of the US Anti-Terrorism Act
There are a number of civil actions, on behalf of more than 4,000 plaintiffs, filed in US federal courts in the US District Court
in the Eastern District of New York (EDNY) and SDNY against Barclays Bank PLC and a number of other banks. The
complaints generally allege that Barclays Bank PLC and those banks engaged in a conspiracy to facilitate US dollar-
denominated transactions for the Iranian Government and various Iranian banks, which in turn funded acts of terrorism that
injured or killed the plaintiffs or the plaintiffs’ family members. The plaintiffs seek to recover damages for pain, suffering and
mental anguish under the provisions of the US Anti-Terrorism Act, which allow for the trebling of any proven damages.
The court granted the defendants’ motions to dismiss three out of the six actions in the EDNY. The plaintiffs have appealed
in one action. The remaining actions are stayed pending a decision on the appeal. Out of the two actions in the SDNY, the
court also granted the defendants’ motion to dismiss the first action, which is stayed pending a decision on the EDNY appeal.
The second SDNY action is stayed, pending any appeal on the dismissal of the first.
Shareholder derivative action
In November 2020, a purported Barclays shareholder filed a putative derivative action in New York state court against BCI
and a number of current and former members of the Board of Directors of Barclays PLC and senior executives or employees
of the Group. The shareholder filed the claim on behalf of nominal defendant Barclays PLC, alleging that the individual
defendants harmed the company through breaches of their duties, including under the Companies Act 2006. The plaintiff
seeks damages on behalf of Barclays PLC for the losses that Barclays PLC allegedly suffered as a result of these alleged
breaches. An amended complaint was filed in April 2021, which BCI and certain other defendants moved to dismiss. The
motion to dismiss was granted in April 2022. The plaintiffs are appealing the decision.
Derivative transactions civil action
In 2021, Vestia (a Dutch housing association) brought a claim against Barclays Bank PLC in the UK in the High Court in
relation to a series of derivative transactions entered into with Barclays Bank PLC between 2008 and 2011, seeking damages
of £329m. Barclays Bank PLC is defending the claim and has made a counterclaim.
Timeshare loans, skilled person review, and associated matters
In August 2020, the FCA granted an application by Clydesdale Financial Services Limited (CFS), which trades as Barclays
Partner Finance and houses Barclays’ point-of-sale finance business, for a validation order with respect to certain loans to
customers brokered between April 2014 and April 2016 by ASL, a timeshare operator, which did not, at the point of sale,
hold the necessary broker licence. As a condition to the validation order, the FCA required CFS to undertake a skilled person
review of the assessment of affordability processes for the loans brokered by ASL (ASL Loans) as well as CFS’ policies and
procedures for assessing affordability and oversight of brokers more generally, and dictated a remediation methodology in
the event that ASL Loans did not pass the affordability test. CFS voluntarily agreed to remediate the ASL Loans, in
accordance with the FCA’s methodology and the remediation exercise is substantively complete. The remaining scope of the
skilled person review is also complete. The skilled person made a number of observations, some of which were adverse,
about both current and historic affordability practices as well as current oversight practices. CFS is not required to conduct a
full back book review but, following a review of certain cohorts of loans to determine historic affordability and/or broker
oversight practices that may have caused customer harm, where harm is identified, CFS’ intention is to remediate. To date
CFS has identified a number of areas for remediation but the scoping exercise is ongoing. Separately, and notwithstanding
this, CFS decided in March 2022 to extend the proactive remediation of ASL Loans beyond those brokered between April
2014 to April 2016 to include the full portfolio of ASL Loans brokered between 2006 and 2018. In the first quarter of 2022, a
customer remediation provision of £181m has been recognised in relation to the remediation of the ASL Loans originated
outside the April 2014 to April 2016 period. This provision represents the best estimate as at 30 June 2022.
CFS continues to review complaints about other legacy partner finance loans, however, it is not currently possible to predict
the outcome of this review or the financial impact on the Group.
Financial Statement Notes
Barclays PLC 96

-- 98 of 109 --

Over-issuance of securities in the US
Barclays Bank PLC maintains a US shelf registration statement with the Securities and Exchange Commission (SEC) in order
to issue securities to US investors. In May 2017, Barclays Bank PLC was the subject of an SEC settlement order as a result of
which it lost its status as a “well-known seasoned issuer” (or WKSI) and was required to register a specified amount of
securities to be issued under any US shelf registration statements filed with the SEC.
On 10 March 2022, executive management became aware that Barclays Bank PLC had issued securities materially in excess
of the set amount under its 2019 US shelf registration statement (2019 F-3) and subsequently became aware that securities
had also been issued in excess of the set amount under the predecessor US shelf registration statement (the Predecessor
Shelf). The securities that have been over-issued comprise structured notes and exchange traded notes (ETNs). Securities
issued in excess of the amount registered are considered to be “unregistered securities” for the purposes of US securities
laws, with certain purchasers of those securities having a right to recover, upon the tender of such security to Barclays Bank
PLC, the consideration paid for such security with interest, less the amount of any income received, or to recover damages
from Barclays Bank PLC if the purchaser no longer owns the security and had sold the security at a loss (the Rescission
Price). Barclays Bank PLC is expected to launch a rescission offer on 1 August 2022, by which Barclays Bank PLC will offer to
repurchase the relevant affected securities for the rescission price (the Rescission Offer). Although the Rescission Offer is
expected to reduce liability with respect to potential private civil claims, it will not necessarily prevent such claims from being
asserted against Barclays Bank PLC and/or its affiliates, including claims under applicable US federal securities laws.
Further, the Rescission Offer does not bar the SEC and other regulators from pursuing enforcement actions against Barclays
Bank PLC and its affiliates, which are expected to result in fines, penalties and/or other sanctions. The Group is engaged
with, and responding to inquiries and requests for information from, various regulators, including the SEC. The SEC’s
investigation into this matter is at an advanced stage and the Group has had preliminary discussions with the staff of the
SEC's Division of Enforcement about resolving this matter.
As at 30 June 2022, Barclays PLC has recognised a balance sheet provision of £1,757m (December 2021: £220m) in relation
to this matter, out of which £1,592m (December 2021: £220m) relates to the over-issuance of structured notes and £165m
(December 2021: nil) relates to liabilities that could be incurred arising out of ongoing discussions in respect of a potential
SEC resolution.
A contingent liability exists in relation to the over-issuance of ETNs due to evidentiary challenges and the high level of
trading in the securities. A contingent liability also exists in relation to any potential civil claims or enforcement actions taken
against Barclays Bank PLC and/or its affiliates, but Barclays Bank PLC is unable to assess the likelihood of liabilities that may
arise out of such claims or actions. Any liabilities, claims or actions in connection with the over-issuance of securities under
its 2019 F-3 and the Predecessor Shelf could have an adverse effect on Barclays Bank PLC’s and the Group’s business,
financial condition, results of operations and reputation as a frequent issuer in the securities markets.
Investigation into the use of unapproved communications platforms
In July 2022, Barclays Bank PLC and BCI reached an agreement in principle with the staff of the SEC's Division of Enforcement
and the staff of the Commodity Futures Trading Commission (CFTC) in connection with investigations by the SEC and the
CFTC of Barclays Bank PLC, BCI and other financial institutions as part of a financial industry sweep regarding compliance
with record-keeping obligations in connection with business-related communications sent over unapproved electronic
messaging platforms. The SEC and the CFTC found that Barclays Bank PLC and BCI failed to comply with their respective
record keeping rules, where such communications were sent or received by employees over electronic messaging channels
that had not been approved by the bank for business use by employees. The proposed resolution with the SEC and the CFTC,
will include Barclays Bank PLC and BCI paying a combined $125m civil monetary penalty to the SEC and a $75m civil
monetary penalty to the CFTC. There will also be non-financial components to the settlements which have yet to be finalised
and agreed with the SEC and CFTC. Subject to final agreement of the terms of the settlements and related documentation, as
well as the SEC's and CFTC's approval, the civil monetary penalties are expected to be paid during the third quarter of 2022.
2. Barclays PLC, Barclays Bank PLC and Barclays Bank UK PLC
HM Revenue & Customs (HMRC) assessments concerning UK Value Added Tax
In 2018, HMRC issued notices that have the effect of removing certain overseas subsidiaries that have operations in the UK
from Barclays’ UK VAT group, in which group supplies between members are generally free from VAT. The notices have
retrospective effect and correspond to assessments of £181m (inclusive of interest), of which Barclays would expect to
attribute an amount of approximately £128m to Barclays Bank UK PLC and £53m to Barclays Bank PLC. HMRC’s decision has
been appealed to the First Tier Tribunal (Tax Chamber).
Financial Statement Notes
Barclays PLC 97

-- 99 of 109 --

Local authority civil actions concerning LIBOR
Following settlement by Barclays Bank PLC of various governmental investigations concerning certain benchmark interest
rate submissions referred to above in ‘Investigations into LIBOR and other benchmarks and related civil actions’, in the UK,
certain local authorities brought claims in 2018 against Barclays Bank PLC and Barclays Bank UK PLC asserting that they
entered into loans between 2006 and 2008 in reliance on misrepresentations made by Barclays Bank PLC in respect of its
conduct in relation to LIBOR. Barclays Bank PLC and Barclays Bank UK PLC were successful in their applications to strike out
the claims. The claims have been settled on terms such that the parties have agreed not to pursue these claims further and
to bear their own costs. The financial impact of the settlements is not material to the Group’s operating results, cash flows or
financial position.
3. Barclays PLC
Alternative trading systems
In 2020, a claim was brought against Barclays PLC in the UK in the High Court by various shareholders regarding Barclays
PLC’s share price based on the allegations contained within a complaint by the New York State Attorney General (NYAG) in
2014. Such claim was settled in 2016, as previously disclosed. The more recent claim seeks unquantified damages and
Barclays is defending the claim. The NYAG complaint was filed against Barclays PLC and BCI in the NY Supreme Court
alleging, among other things, that Barclays PLC and BCI engaged in fraud and deceptive practices in connection with LX,
BCI’s SEC-registered alternative trading system.
General
The Group is engaged in various other legal, competition and regulatory matters in the UK, the US and a number of other
overseas jurisdictions. It is subject to legal proceedings brought by and against the Group which arise in the ordinary course
of business from time to time, including (but not limited to) disputes in relation to contracts, securities, debt collection,
consumer credit, fraud, trusts, client assets, competition, data management and protection, intellectual property, money
laundering, financial crime, employment, environmental and other statutory and common law issues.
The Group is also subject to enquiries and examinations, requests for information, audits, investigations and legal and other
proceedings by regulators, governmental and other public bodies in connection with (but not limited to) consumer
protection measures, compliance with legislation and regulation, wholesale trading activity and other areas of banking and
business activities in which the Group is or has been engaged. The Group is cooperating with the relevant authorities and
keeping all relevant agencies briefed as appropriate in relation to these matters and others described in this note on an
ongoing basis.
At the present time, Barclays PLC does not expect the ultimate resolution of any of these other matters to have a material
adverse effect on the Group’s financial position. However, in light of the uncertainties involved in such matters and the
matters specifically described in this note, there can be no assurance that the outcome of a particular matter or matters
(including formerly active matters or those matters arising after the date of this note) will not be material to Barclays PLC’s
results, operations or cash flow for a particular period, depending on, among other things, the amount of the loss resulting
from the matter(s) and the amount of profit otherwise reported for the reporting period.
22. Related party transactions
Related party transactions in the half year ended 30 June 2022 were similar in nature to those disclosed in the Barclays PLC
Annual Report 2021. No related party transactions that have taken place in the half year ended 30 June 2022 have materially
affected the financial position or the performance of the Group during this period.
23. Interest rate benchmark reform
Following the financial crisis, the reform and replacement of benchmark interest rates such as LIBOR became a priority for
global regulators. The FCA and other global regulators instructed market participants to prepare for the cessation of GBP,
EUR, CHF, JPY LIBOR and the 1-week and 2-month USD settings of LIBOR after the end of 2021, The remaining USD LIBOR
settings are scheduled to cease immediately after 30 June 2023.
How the Group is managing the transition to alternative benchmark rates
Barclays established a Group-wide LIBOR Transition Programme, further detail on the transition programme is available in
the Barclays PLC Annual Report 2021 (Page 417). This Programme oversaw transition for GBP, EUR, CHF and JPY LIBOR
exposures and continues to work to transition the remaining residual of unremediated exposures off of synthetic rates, in
addition to overseeing USD LIBOR transition in preparation for the 30 June 2023 cessation.
Financial Statement Notes
Barclays PLC 98

-- 100 of 109 --

The majority of GBP, EUR, CHF and JPY exposures have now transitioned off of LIBOR and good progress has been made
with the unremediated exposures reported at year-end 2021. A small residual population of GBP, EUR and JPY contracts
remain unremediated at the end of H1 2022. The majority of these have now reset onto GBP and JPY Synthetic LIBOR rates.
We continue to work with clients to bilaterally transition these trades and have raised potential risks regarding note holder
consent for securitised products and Local Authority consent for Public Finance Initiative (PFI) loan deals with our regulators.
The Barclays Group-wide LIBOR Transition Programme has also commenced focus on the transition of USD LIBOR
exposures impacted by the 30 June 2023 cessation timeline. As with GBP, EUR, CHF and JPY LIBOR, USD LIBOR transition
approaches will vary by product and nature of counterparty. H122 saw focused efforts to transition uncommitted lending
exposure with further wide scale client engagement for other products due to commence in H222. Both active conversion of
exposures and inclusion of fallback provisions will be leveraged for bilateral derivative and non-derivatives products. For
cleared derivatives, Barclays is working with central clearing counterparties (CCPs) on transition which is expected to follow
a market wide, standardised approach to reform similar to the CCP-led conversions in 2021.
The Group met the Q121 Federal Reserve Bank of New York milestone to cease new use of US dollar LIBOR, with limited
exceptions. The Group has put in place controls so that any exceptions or exemptions are approved.
24. Barclays PLC parent company balance sheet
As at
30.06.22
As at
31.12.21
Assets £m £m
Investment in subsidiaries 63,633 62,528
Loans and advances to subsidiaries 20,369 22,072
Financial assets at fair value through the income statement 24,052 25,091
Derivative financial instruments 5 4
Other assets 235 68
Total assets 108,294 109,763
Liabilities
Deposits at amortised cost 545 488
Debt securities in issue 22,389 25,658
Subordinated liabilities 10,070 9,301
Financial liabilities designated at fair value 16,888 16,319
Derivative financial instruments 540 43
Other liabilities 104 117
Total liabilities 50,536 51,926
Equity
Called up share capital 4,133 4,188
Share premium account 375 348
Other equity instruments 12,347 12,241
Other reserves 616 555
Retained earnings 40,287 40,505
Total equity 57,758 57,837
Total liabilities and equity 108,294 109,763
Investment in subsidiaries
The investment in subsidiaries of £63,633m (December 2021: £62,528m) predominantly relates to investments in the
ordinary shares of Barclays Bank PLC of £36,340m (December 2021: £35,590m) and their AT1 securities of £9,849m
(December 2021: £9,493m), as well as investments in the ordinary shares of Barclays Bank UK PLC of £14,245m (December
2021: £14,245m) and their AT1 securities of £2,570m (December 2021: £2,570m). Barclays PLC considers the carrying
value of its investment in subsidiaries to be fully recoverable.
Loans and advances to subsidiaries
During the period, loans and advances to subsidiaries decreased by £1,703m to £20,369m (December 2021: £22,072m).
The decrease was driven by the maturity of £2,296m intragroup loans to Barclays Bank PLC and the maturity of £836m
Financial Statement Notes
Barclays PLC 99

-- 101 of 109 --

intragroup loans to Barclays Bank UK PLC. There was also a £397m share buyback which took place in Q222. This was
partially offset by a foreign exchange impact of £1,326m due to depreciation of GBP against major currencies (although the
FX impact is offset across the balance sheet liabilities) and £1,010m dividend receipts from Barclays Bank UK PLC.
Financial assets and liabilities designated at fair value
Financial liabilities designated at fair value of £16,888m (December 2021: £16,319m) comprise material issuances during
the period of €2,250m Fixed Rate Resetting Senior Callable Notes and $400m Zero Coupon Callable Notes. The proceeds
raised through these transactions were used to invest in subsidiaries of Barclays PLC which are included within the financial
assets designated at fair value through the income statement balance of £24,052m (December 2021: £25,091m).
Subordinated liabilities and debt securities in issue
During the period, subordinated liabilities have increased to £10,070m (December 2021: £9,301m) largely driven by foreign
exchange impact of £819m due to depreciation of GBP against major currencies. Debt securities in issue of £22,389m
(December 2021: £25,658m) have reduced in the year due to the maturity of senior issuances.
Called up share capital and share premium
Called up share capital and share premium of Barclays PLC is £4,508m (December 2021: £4,536m). The decrease in the year
is primarily due to 244m shares repurchased with a total nominal value of £61m. This decrease was offset by £33m of
shares issued under employee share schemes.
Other equity instruments
Other equity instruments comprises AT1 securities issued by Barclays PLC. The increase in the year of £106m is driven by
one issuance (principal amount of £1,250m) and one redemption (principal amount of $1,500m).
Other reserves
As at 30 June 2022, there was a balance of £616m (December 2021: £555m) in other reserves. The increase is due to the
repurchase of shares as part of the share buyback.
Management of internal investments, loans and advances
Barclays PLC retains the discretion to manage the nature of its internal investments in subsidiaries according to their
regulatory and business needs. Barclays PLC may invest capital and funding into Barclays Bank PLC, Barclays Bank UK PLC
and other Group subsidiaries such as Barclays Execution Services Limited and the US Intermediate Holding Company (IHC).
Financial Statement Notes
Barclays PLC 100

-- 102 of 109 --

The Group’s management believes that the non-IFRS performance measures included in this document provide valuable
information to the readers of the financial statements as they enable the reader to identify a more consistent basis for
comparing the businesses’ performance between financial periods, and provide more detail concerning the elements of
performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of
the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is
monitored by management.
However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should
consider the IFRS measures as well.
Non-IFRS performance measures glossary
Measure Definition
Loan: deposit ratio Loans and advances at amortised cost divided by deposits at amortised cost. The components of
the calculation have been included on the page 52.
Period end allocated tangible equity Allocated tangible equity is calculated as 13.5% (2021: 13.5%) of RWAs for each business, adjusted
for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the
Group uses for capital planning purposes. Head Office allocated tangible equity represents the
difference between the Group’s tangible shareholders’ equity and the amounts allocated to
businesses.
Average tangible shareholders’
equity
Calculated as the average of the previous month’s period end tangible equity and the current
month’s period end tangible equity. The average tangible shareholders’ equity for the period is the
average of the monthly averages within that period.
Average allocated tangible equity Calculated as the average of the previous month’s period end allocated tangible equity and the
current month’s period end allocated tangible equity. The average allocated tangible equity for the
period is the average of the monthly averages within that period.
Return on average tangible
shareholders’ equity
Annualised profit after tax attributable to ordinary equity holders of the parent, as a proportion of
average shareholders’ equity excluding non-controlling interests and other equity instruments
adjusted for the deduction of intangible assets and goodwill. The components of the calculation
have been included on pages 102 to 104.
Return on average allocated tangible
equity
Annualised profit after tax attributable to ordinary equity holders of the parent, as a proportion of
average allocated tangible equity. The components of the calculation have been included on pages
102 to 105.
Cost: income ratio Total operating expenses divided by total income.
Loan loss rate Quoted in basis points and represents total annualised impairment charges divided by gross loans
and advances held at amortised cost at the balance sheet date. The components of the calculation
have been included on page 27. Quoted as zero when credit impairment is a net release.
Net interest margin Annualised net interest income divided by the sum of average customer assets. The components of
the calculation have been included on page 24.
Tangible net asset value per share Calculated by dividing shareholders’ equity, excluding non-controlling interests and other equity
instruments, less goodwill and intangible assets, by the number of issued ordinary shares. The
components of the calculation have been included on page 106.
Appendix: Non-IFRS Performance Measures
Barclays PLC 101

-- 103 of 109 --

Returns
Return on average tangible equity is calculated as profit after tax attributable to ordinary equity holders of the parent as a
proportion of average tangible equity, excluding non-controlling and other equity interests for businesses. Allocated tangible
equity has been calculated as 13.5% (2021: 13.5%) of RWAs for each business, adjusted for capital deductions, excluding
goodwill and intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office average
allocated tangible equity represents the difference between the Group’s average tangible shareholders’ equity and the
amounts allocated to businesses.
Profit/(loss)
attributable to
ordinary
equity
holders of the
parent
Average
tangible
equity
Return on
average
tangible
equity
Half year ended 30.06.22 £m £bn %
Barclays UK 854 10.0 17.0
Corporate and Investment Bank 1,895 31.8 11.9
Consumer, Cards and Payments 188 4.4 8.5
Barclays International 2,083 36.2 11.5
Head Office (462) 2.7 n/m
Barclays Group 2,475 48.9 10.1
Half year ended 30.06.211
Barclays UK 1,019 9.9 20.6
Corporate and Investment Bank 2,252 28.3 15.9
Consumer, Cards and Payments 386 4.0 19.1
Barclays International 2,638 32.3 16.3
Head Office 95 4.3 n/m
Barclays Group 3,752 46.5 16.1
1 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on
page 73 for more information.
Appendix: Non-IFRS Performance Measures
Barclays PLC 102

-- 104 of 109 --

Half year ended 30.06.22
Barclays UK
Corporate
and
Investment
Bank
Consumer,
Cards and
Payments
Barclays
International Head Office
Barclays
Group
Return on average tangible
shareholders' equity £m £m £m £m £m £m
Attributable profit/(loss) 854 1,895 188 2,083 (462) 2,475
£bn £bn £bn £bn £bn £bn
Average shareholders' equity 13.6 31.8 5.3 37.1 6.3 57.0
Average goodwill and intangibles (3.6) — (0.9) (0.9) (3.6) (8.1)
Average tangible shareholders' equity 10.0 31.8 4.4 36.2 2.7 48.9
Return on average tangible
shareholders' equity 17.0% 11.9% 8.5% 11.5% n/m 10.1%
Half year ended 30.06.211
Barclays UK
Corporate
and
Investment
Bank
Consumer,
Cards and
Payments
Barclays
International Head Office
Barclays
Group
Return on average tangible
shareholders' equity £m £m £m £m £m £m
Attributable profit 1,019 2,252 386 2,638 95 3,752
£bn £bn £bn £bn £bn £bn
Average shareholders' equity 13.5 28.3 4.6 32.9 8.0 54.4
Average goodwill and intangibles (3.6) — (0.6) (0.6) (3.7) (7.9)
Average tangible shareholders' equity 9.9 28.3 4.0 32.3 4.3 46.5
Return on average tangible
shareholders' equity 20.6% 15.9% 19.1% 16.3% n/m 16.1%
Performance measures excluding the Over-issuance of Securities
Profit attributable to ordinary equity
holders of the parent
Half year
ended
30.06.22
£m
Attributable profit 2,475
Post-tax impact of the Over-issuance of
Securities 581
Profit attributable to ordinary equity
holders of the parent excluding the
Over-issuance of Securities
3,056
Return on average tangible
shareholders' equity £bn
Average tangible shareholders' equity 48.9
Return on average tangible
shareholders' equity excluding the
Over-issuance of Securities
12.5 %
1 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on
page 73 for more information.
Appendix: Non-IFRS Performance Measures
Barclays PLC 103

-- 105 of 109 --

Barclays Group
Return on average tangible shareholders'
equity
Q222 Q122 Q4211 Q3211 Q2211 Q121 Q420 Q320
£m £m £m £m £m £m £m £m
Attributable profit 1,071 1,404 1,079 1,374 2,048 1,704 220 611
£bn £bn £bn £bn £bn £bn £bn £bn
Average shareholders' equity 57.1 56.9 56.1 56.5 54.4 54.4 55.7 56.4
Average goodwill and intangibles (8.1) (8.1) (8.1) (8.2) (7.9) (7.9) (8.1) (8.1)
Average tangible shareholders' equity 49.0 48.8 48.0 48.3 46.5 46.5 47.6 48.3
Return on average tangible shareholders'
equity 8.7% 11.5% 9.0% 11.4% 17.6% 14.7% 1.8% 5.1%
Barclays UK
Return on average allocated tangible
equity
Q222 Q122 Q421 Q321 Q221 Q121 Q420 Q320
£m £m £m £m £m £m £m £m
Attributable profit 458 396 420 317 721 298 160 113
£bn £bn £bn £bn £bn £bn £bn £bn
Average allocated equity 13.6 13.7 13.6 13.6 13.5 13.5 13.4 13.7
Average goodwill and intangibles (3.6) (3.6) (3.6) (3.6) (3.6) (3.6) (3.6) (3.6)
Average allocated tangible equity 10.0 10.1 10.0 10.0 9.9 9.9 9.8 10.1
Return on average allocated tangible
equity 18.4% 15.6% 16.8% 12.7% 29.1% 12.0% 6.5% 4.5%
1 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on
page 73 for more information.
Appendix: Non-IFRS Performance Measures
Barclays PLC 104

-- 106 of 109 --

Barclays International
Return on average allocated tangible
equity
Q222 Q122 Q4211 Q3211 Q2211 Q121 Q420 Q320
£m £m £m £m £m £m £m £m
Attributable profit 783 1,300 818 1,191 1,207 1,431 441 782
£bn £bn £bn £bn £bn £bn £bn £bn
Average allocated equity 38.2 36.0 33.8 32.7 33.0 32.8 31.1 31.2
Average goodwill and intangibles (0.9) (0.9) (0.9) (0.9) (0.6) (0.5) (0.6) (0.6)
Average allocated tangible equity 37.3 35.1 32.9 31.8 32.4 32.3 30.5 30.6
Return on average allocated tangible
equity 8.4% 14.8% 9.9% 14.9% 14.9% 17.7% 5.8% 10.2%
Corporate and Investment Bank
Return on average allocated tangible
equity
Q222 Q122 Q4211 Q3211 Q2211 Q121 Q420 Q320
£m £m £m £m £m £m £m £m
Attributable profit 579 1,316 695 1,085 989 1,263 413 627
£bn £bn £bn £bn £bn £bn £bn £bn
Average allocated equity 32.7 30.8 28.7 27.8 28.4 28.2 26.3 26.4
Average goodwill and intangibles — — — — — — — —
Average allocated tangible equity 32.7 30.8 28.7 27.8 28.4 28.2 26.3 26.4
Return on average allocated tangible
equity 7.1% 17.1% 9.7% 15.6% 14.0% 17.9% 6.3% 9.5%
Consumer, Cards and Payments
Return on average allocated tangible
equity
Q222 Q122 Q421 Q321 Q221 Q121 Q420 Q320
£m £m £m £m £m £m £m £m
Attributable profit/(loss) 204 (16) 123 106 218 168 28 155
£bn £bn £bn £bn £bn £bn £bn £bn
Average allocated equity 5.5 5.2 5.1 4.9 4.6 4.6 4.8 4.8
Average goodwill and intangibles (0.9) (0.9) (0.9) (0.9) (0.6) (0.5) (0.6) (0.6)
Average allocated tangible equity 4.6 4.3 4.2 4.0 4.0 4.1 4.2 4.2
Return on average allocated tangible
equity 17.8% (1.5)% 11.7% 10.5% 21.8% 16.5% 2.7% 14.7%
1 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on
page 73 for more information.
Appendix: Non-IFRS Performance Measures
Barclays PLC 105

-- 107 of 109 --

Tangible net asset value per share As at
30.06.22
Restated1
As at
31.12.21
Restated1
As at
30.06.21
£m £m £m
Total equity excluding non-controlling interests 69,627 69,052 66,992
Other equity instruments (12,357) (12,259) (11,167)
Goodwill and intangibles (8,245) (8,061) (8,196)
Tangible shareholders' equity attributable to ordinary shareholders of the parent 49,025 48,732 47,629
m m m
Shares in issue 16,531 16,752 16,998
p p p
Tangible net asset value per share 297 291 280
1 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on
page 73 for more information.
Appendix: Non-IFRS Performance Measures
Barclays PLC 106

-- 108 of 109 --

Results timetable1 Date
Ex-dividend date 11 August 2022
Dividend record date 12 August 2022
Cut off time of 5:00pm (UK time) for the receipt of Dividend Re-
investment Programme (DRIP) Application Form Mandate
26 August 2022
Dividend payment date 16 September 2022
Q322 Results Announcement 26 October 2022
For qualifying US and Canadian resident ADR holders, the half year dividend of 2.25p per ordinary share becomes 9.0p per ADS
(representing four shares). The ex-dividend, dividend record and dividend payment dates for ADR holders are as shown above
% Change3
Exchange rates2 30.06.22 31.12.21 30.06.21 31.12.21 30.06.21
Period end - USD/GBP 1.22 1.35 1.38 (10)% (12)%
6 month average - USD/GBP 1.30 1.36 1.39 (4)% (6)%
3 month average - USD/GBP 1.26 1.35 1.40 (7)% (10)%
Period end - EUR/GBP 1.16 1.19 1.17 (3)% (1)%
6 month average - EUR/GBP 1.19 1.17 1.15 2% 3%
3 month average - EUR/GBP 1.18 1.18 1.16 — 2%
Share price data
Barclays PLC (p) 153.12 187.00 171.12
Barclays PLC number of shares (m)4 16,531 16,752 16,998
For further information please contact
Investor relations Media relations
Chris Manners +44 (0) 20 7773 2136 Tom Hoskin +44 (0) 20 7116 4755
More information on Barclays can be found on our website: home.barclays
Registered office
1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number: 48839.
Registrar
Equiniti, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA, United Kingdom.
Tel: 0371 384 20555 from the UK or +44 121 415 7004 from overseas.
American Depositary Receipts (ADRs)
EQ Shareowner Services
P.O. Box 64854
St. Paul, MN 55164-0854
United States of America
shareowneronline.com
Toll Free Number: +1 800-990-1135
Outside the US +1 651-453-2128
Delivery of ADR certificates and overnight mail
EQ Shareowner Services, 1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120-4100, USA.
1 Note that this date is provisional and subject to change.
2 The average rates shown above are derived from daily spot rates during the year.
3 The change is the impact to GBP reported information.
4 The number of shares of 16,531m is different from the 16,509m quoted in the 1 July 2022 RNS because the share buyback transactions executed on the 29
and 30 June 2022 did not settle until 1 July 2022 and 4 July 2022.
5 Lines open 8.30am to 5.30pm (UK time), Monday to Friday, excluding UK public holidays in England and Wales.
Shareholder Information
Barclays PLC 107

-- 109 of 109 --